cov_id,study_id,study_name,month_start,year_start,month_end,year_end,year_publish,year_mid,country,region_actual,region_analysis,urban_rural,location,study_design,study_sample,sex,population,population_detail,age_group,reproductive_age,age_range,age_min,age_max,age_mean,age_median,age_iqr,hiv_status,hiv_tested,hiv_positive,hiv_prevalence,sti,num,denom,prev,specimen,test,sens,spec,adj_prev,adj_se,adj_prev_lwr,adj_prev_upr,adj_num,adj_denom
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Male,PHC/OPD attendees,PHC clients accessing oral PrEP,Adult,Y,15+,15,NR,NA,NA,NA,HIV negative,70,0,0,CT,14,70,0.2,urine,NAAT,87.8,99.3,0.231089798,0.055181408,0.133978602,0.344324044,13.48502061,58.35402829
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Male,PHC/OPD attendees,PHC clients accessing oral PrEP,Adult,Y,15+,15,NR,NA,NA,NA,HIV negative,70,0,0,NG,13,70,0.186,urine,NAAT,80.9,99.9,0.239191964,0.057498372,0.138493693,0.364115768,13.16610037,55.04407487
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Male,PHC/OPD attendees,PHC clients accessing oral PrEP,Adult,Y,15+,15,NR,NA,NA,NA,HIV negative,70,0,0,TV,0,70,0,urine,NAAT,96,97.7,0.014497945,0.014553457,0.000323951,0.052790935,0.977998186,67.45771295
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Female,PHC/OPD attendees,PHC clients accessing oral PrEP,Youth,Y,15 to 24,15,24,NA,NA,NA,HIV negative,362,0,0,CT,93,362,0.257,urine,NAAT,87,99.8,0.295365636,0.0266669,0.24486161,0.349174448,86.44476277,292.6703454
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Female,PHC/OPD attendees,PHC clients accessing oral PrEP,Youth,Y,15 to 24,15,24,NA,NA,NA,HIV negative,362,0,0,NG,51,362,0.141,urine,NAAT,91.6,100,0.155604982,0.020287353,0.117860577,0.198206841,49.67545625,319.2407836
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Female,PHC/OPD attendees,PHC clients accessing oral PrEP,Youth,Y,15 to 24,15,24,NA,NA,NA,HIV negative,362,0,0,TV,7,362,0.019,urine,NAAT,66.9,98.3,0.012657229,0.00985569,0.000496785,0.036986049,1.628437641,128.6567245
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Male,PHC/OPD attendees,PHC clients accessing oral PrEP,Youth,Y,15 to 24,15,24,NA,NA,NA,HIV negative,39,0,0,CT,11,39,0.282051282,urine,NAAT,87.8,99.3,0.329369754,0.081434331,0.182454019,0.491714342,10.97072923,33.30824737
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Male,PHC/OPD attendees,PHC clients accessing oral PrEP,Youth,Y,15 to 24,15,24,NA,NA,NA,HIV negative,39,0,0,NG,10,39,0.256410256,urine,NAAT,80.9,99.9,0.329999295,0.082455797,0.182243628,0.50498945,10.7314621,32.51965163
#23088,Mullick 2023,Project PrEP STI substudy,September,2020,December,2021,2023,2021,South Africa,SA,SA,Mixed,"Eastern Cape, KwaZulu-Natal, Tshwane",Cohort,Consecutive,Male,PHC/OPD attendees,PHC clients accessing oral PrEP,Youth,Y,15 to 24,15,24,NA,NA,NA,HIV negative,39,0,0,TV,0,39,0,urine,NAAT,96,97.7,0.025047609,0.024337591,0.000582803,0.09079427,1.032668111,41.2282116
#21618,Barnabas 2018,WISH,November,2013,February,2015,2018,2014,South Africa,SA,SA,Urban,Cape Town and Soweto,Cohort,Consecutive,Female,PHC/OPD attendees,Participants recruited from youth centres and the community,Youth,Y,16 to 22,16,22,NA,18,17-20,HIV negative,297,0,0,CT,88,297,0.3,genital fluid,NAAT,88.6,99.6,0.33380219,0.030578471,0.27432798,0.395578878,79.38711637,237.8268288
#21618,Barnabas 2018,WISH,November,2013,February,2015,2018,2014,South Africa,SA,SA,Urban,Cape Town and Soweto,Cohort,Consecutive,Female,PHC/OPD attendees,Participants recruited from youth centres and the community,Youth,Y,16 to 22,16,22,NA,18,17-20,HIV negative,297,0,0,NG,24,297,0.08,genital fluid,NAAT,93.3,99.2,0.082084185,0.017611607,0.050091516,0.119549374,19.93994155,242.9206262
#21618,Barnabas 2018,WISH,November,2013,February,2015,2018,2014,South Africa,SA,SA,Urban,Cape Town and Soweto,Cohort,Consecutive,Female,PHC/OPD attendees,Participants recruited from youth centres and the community,Youth,Y,16 to 22,16,22,NA,18,17-20,HIV negative,297,0,0,TV,16,297,0.05,genital fluid,NAAT,95,98,0.039275853,0.014282522,0.014127954,0.0707782,7.265075445,184.975627
#32161,Lagarde 2004,NA,January,2000,March,2000,2004,2000,Burkina Faso,WA,WA,Urban,Bobo-Dioulasso,Cross sectional,Random,Female,Population-representative survey participants,Adults living in households randomly selected for survey,Adult,Y,13 to 49,13,49,NA,NA,NA,Mixed,359,25,6.96E-02,CT,22,775,0.028,urine,NAAT,87,99.8,0.03174101,0.006933401,0.019573921,0.046225199,20.29272841,639.3220671
#32161,Lagarde 2004,NA,January,2000,March,2000,2004,2000,Burkina Faso,WA,WA,Urban,Bobo-Dioulasso,Cross sectional,Random,Female,Population-representative survey participants,Adults living in households randomly selected for survey,Adult,Y,13 to 49,13,49,NA,NA,NA,Mixed,359,25,6.96E-02,NG,0,775,0,urine,NAAT,91.6,100,0.001425494,0.001355453,3.87E-05,0.004906801,1.104441322,774.7778054
#32161,Lagarde 2004,NA,January,2000,March,2000,2004,2000,Burkina Faso,WA,WA,Urban,Bobo-Dioulasso,Cross sectional,Random,Female,Population-representative survey participants,Adults living in households randomly selected for survey,Adult,Y,13 to 49,13,49,NA,NA,NA,Mixed,359,25,6.96E-02,TV,142,940,0.151,genital fluid,culture,68.8,100,0.220588641,0.016654814,0.188710662,0.254661937,136.7267327,619.8267156
#32161,Lagarde 2004,NA,January,2000,March,2000,2004,2000,Burkina Faso,WA,WA,Urban,Bobo-Dioulasso,Cross sectional,Random,Male,Population-representative survey participants,Adults living in households randomly selected for survey,Adult,Y,13 to 49,13,49,NA,NA,NA,Mixed,449,20,4.45E-02,CT,13,736,0.018,urine,NAAT,87.8,99.3,0.013676213,0.005639811,0.003920772,0.025449696,5.799921549,424.0882692
#32161,Lagarde 2004,NA,January,2000,March,2000,2004,2000,Burkina Faso,WA,WA,Urban,Bobo-Dioulasso,Cross sectional,Random,Male,Population-representative survey participants,Adults living in households randomly selected for survey,Adult,Y,13 to 49,13,49,NA,NA,NA,Mixed,449,20,4.45E-02,NG,4,737,0.005,urine,NAAT,80.9,99.9,0.007074573,0.003716639,0.00136649,0.015632442,3.59762868,508.529463
#32161,Lagarde 2004,NA,January,2000,March,2000,2004,2000,Burkina Faso,WA,WA,Urban,Bobo-Dioulasso,Cross sectional,Random,Male,Population-representative survey participants,Adults living in households randomly selected for survey,Adult,Y,13 to 49,13,49,NA,NA,NA,Mixed,449,20,4.45E-02,TV,14,976,0.014,urine,culture,87.6,100,0.017494187,0.0045055,0.009979748,0.027861002,14.81278258,846.7259668
#23654,Sobngwi-Tambekou 2009,ANRS-1265,February,2002,July,2004,2009,2003,South Africa,SA,SA,Peri-urban,Orange Farm,RCT,Convenience,Male,HIV/STI prevention trial participants,Control group - Uncircumcised male volunteers recruited from community,Adult,Y,18 to 24,18,24,NA,NA,NA,Mixed,881,63,7.10E-02,CT,32,881,0.036,urine,NAAT,87.8,99.3,0.03487125,0.007348787,0.021490712,0.050644231,21.73146454,623.1914324
#23654,Sobngwi-Tambekou 2009,ANRS-1265,February,2002,July,2004,2009,2003,South Africa,SA,SA,Peri-urban,Orange Farm,RCT,Convenience,Male,HIV/STI prevention trial participants,Control group - Uncircumcised male volunteers recruited from community,Adult,Y,18 to 24,18,24,NA,NA,NA,Mixed,881,63,7.10E-02,NG,91,881,0.103,urine,NAAT,80.9,99.9,0.127885157,0.012480477,0.104524349,0.153476056,91.56965439,716.0303526
#23654,Sobngwi-Tambekou 2009,ANRS-1265,February,2002,July,2004,2009,2003,South Africa,SA,SA,Peri-urban,Orange Farm,RCT,Convenience,Male,HIV/STI prevention trial participants,Control group - Uncircumcised male volunteers recruited from community,Adult,Y,18 to 24,18,24,NA,NA,NA,Mixed,881,63,7.10E-02,TV,27,881,0.031,urine,NAAT,96,97.7,0.009952208,0.005800277,0.000861313,0.023196644,2.914724865,292.8721855
#21866,Cowan 2002,NA,October,1999,May,2001,2002,2000,Zimbabwe,EA,EA,Rural,Masvingo,Cross sectional,Consecutive,Male,Community members,Youth recruited from community via house visits,Youth,Y,16 to 19,16,19,NA,NA,NA,Mixed,314,16,5.10E-02,CT,3,314,0.01,urine,NAAT,87.8,99.3,0.008341891,0.006597019,0.000342002,0.024774655,1.585607192,190.0776605
#21866,Cowan 2002,NA,October,1999,May,2001,2002,2000,Zimbabwe,EA,EA,Rural,Masvingo,Cross sectional,Consecutive,Male,Community members,Youth recruited from community via house visits,Youth,Y,16 to 19,16,19,NA,NA,NA,Mixed,314,16,5.10E-02,NG,11,314,0.035,urine,NAAT,80.9,99.9,0.045706437,0.013186937,0.022786216,0.074485853,11.46433543,250.8254022
#21866,Cowan 2002,NA,October,1999,May,2001,2002,2000,Zimbabwe,EA,EA,Rural,Masvingo,Cross sectional,Consecutive,Female,Community members,Youth recruited from community via house visits,Youth,Y,16 to 19,16,19,NA,NA,NA,Mixed,259,17,6.60E-02,CT,6,259,0.023,urine,NAAT,87,99.8,0.028552684,0.011562483,0.010217151,0.054859805,5.923943479,207.474137
#21866,Cowan 2002,NA,October,1999,May,2001,2002,2000,Zimbabwe,EA,EA,Rural,Masvingo,Cross sectional,Consecutive,Female,Community members,Youth recruited from community via house visits,Youth,Y,16 to 19,16,19,NA,NA,NA,Mixed,259,17,6.60E-02,NG,5,259,0.019,urine,NAAT,91.6,100,0.025274092,0.010316989,0.00918916,0.04896427,5.84962005,231.4472896
#24004,Yegorov 2018,NA,September,2015,February,2016,2018,2015,Uganda,EA,EA,Peri-urban,Entebbe,Cross sectional,Convenience,Female,PHC/OPD attendees,"Women recruited from family planning clinic, child vaccination clinic, or general practice clinic",Adult,Y,18 to 45,18,NR,NA,30,25-34,HIV negative,25,0,0,CT,0,25,0,urine,NAAT,87,99.8,0.043410099,0.040920495,0.001108674,0.151968076,1.076528684,24.79903749
#24004,Yegorov 2018,NA,September,2015,February,2016,2018,2015,Uganda,EA,EA,Peri-urban,Entebbe,Cross sectional,Convenience,Female,PHC/OPD attendees,"Women recruited from family planning clinic, child vaccination clinic, or general practice clinic",Adult,Y,18 to 45,18,NR,NA,30,25-34,HIV negative,25,0,0,NG,1,25,0.04,urine,NAAT,91.6,100,0.081111458,0.054749401,0.011129426,0.212272641,2.016826353,24.86487602
#24004,Yegorov 2018,NA,September,2015,February,2016,2018,2015,Uganda,EA,EA,Peri-urban,Entebbe,Cross sectional,Convenience,Female,PHC/OPD attendees,"Women recruited from family planning clinic, child vaccination clinic, or general practice clinic",Adult,Y,18 to 45,18,NR,NA,30,25-34,HIV negative,25,0,0,TV,1,25,0.04,genital fluid,rapid antigen test,83.3,98.8,0.078863691,0.058499081,0.005154649,0.228011198,1.674094688,21.22769883
#21834,Clift 2003,AMREF Mine Health Project,November,2000,January,2001,2003,2000,Tanzania,EA,EA,Rural,Kakola,Cross sectional,Random,Male,Community members,Community members in sub-villages surrounding two mines,Adult,Y,16 to 54,16,54,28.9,NA,NA,Mixed,202,33,0.163,CT,10,202,0.05,urine,NAAT,87.8,99.3,0.053494808,0.01778474,0.023084784,0.09261918,8.563498585,160.0809283
#21834,Clift 2003,AMREF Mine Health Project,November,2000,January,2001,2003,2000,Tanzania,EA,EA,Rural,Kakola,Cross sectional,Random,Male,Community members,Community members in sub-villages surrounding two mines,Adult,Y,16 to 54,16,54,28.9,NA,NA,Mixed,202,33,0.163,NG,3,202,0.015,urine,NAAT,80.9,99.9,0.023173264,0.012050372,0.005581033,0.051713261,3.612359866,155.8848121
#21834,Clift 2003,AMREF Mine Health Project,November,2000,January,2001,2003,2000,Tanzania,EA,EA,Rural,Kakola,Cross sectional,Random,Female,Community members,Community members in sub-villages surrounding two mines,Adult,Y,16 to 54,16,54,28.4,NA,NA,Mixed,205,36,0.176,CT,5,205,0.025,urine,NAAT,87,99.8,0.031020786,0.013537192,0.010106238,0.062003912,5.088184668,164.0250067
#21834,Clift 2003,AMREF Mine Health Project,November,2000,January,2001,2003,2000,Tanzania,EA,EA,Rural,Kakola,Cross sectional,Random,Female,Community members,Community members in sub-villages surrounding two mines,Adult,Y,16 to 54,16,54,28.4,NA,NA,Mixed,205,36,0.176,NG,3,205,0.015,urine,NAAT,91.6,100,0.020918054,0.010430518,0.005740446,0.046260974,3.937765078,188.2472009
#22820,Maina 2016,NA,May,2013,September,2013,2016,2013,Kenya,EA,EA,Urban,Nairobi,Cross sectional,Consecutive,Female,FP attendees,Family planning clinic attendees at hospital,Adult,Y,20 to 49,20,49,NA,37,NA,Mixed,NA,NA,NR,CT,33,249,0.13,genital fluid,NAAT,88.6,99.6,0.148896901,0.024561821,0.104024248,0.199761393,31.27752315,210.0616132
#22820,Maina 2016,NA,May,2013,September,2013,2016,2013,Kenya,EA,EA,Urban,Nairobi,Cross sectional,Consecutive,Female,FP attendees,Family planning clinic attendees at hospital,Adult,Y,20 to 49,20,49,NA,37,NA,Mixed,NA,NA,NR,NG,0,249,0,genital fluid,culture,75.7,100,0.005218771,0.005065404,0.000150492,0.018213434,1.055932038,202.3334504
#22820,Maina 2016,NA,May,2013,September,2013,2016,2013,Kenya,EA,EA,Urban,Nairobi,Cross sectional,Consecutive,Female,FP attendees,Family planning clinic attendees at hospital,Adult,Y,20 to 49,20,49,NA,37,NA,Mixed,NA,NA,NR,TV,1,249,0.004,genital fluid,WM,52,100,0.015326681,0.010463632,0.001931638,0.041004338,2.112630146,137.8400276
#22239,Grabowski 2022,STIPS (RCSS),May,2019,October,2019,2022,2019,Uganda,EA,EA,Peri-urban and rural,Rakai,Cross sectional,Consecutive,Female,Population-representative survey participants,Inland community: participating in open population-based household census and HIV cohort study in 40 communities.,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,522,86,0.164750958,CT,50,521,0.096,genital fluid,NAAT,88.6,99.6,0.106221848,0.014877394,0.078990126,0.137074859,45.56209601,428.9333767
#22239,Grabowski 2022,STIPS (RCSS),May,2019,October,2019,2022,2019,Uganda,EA,EA,Peri-urban and rural,Rakai,Cross sectional,Consecutive,Female,Population-representative survey participants,Inland community: participating in open population-based household census and HIV cohort study in 40 communities.,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,522,86,0.164750958,NG,33,521,0.063,genital fluid,NAAT,93.3,99.2,0.061570837,0.011361873,0.041152546,0.084891833,27.5582576,447.5862114
#22239,Grabowski 2022,STIPS (RCSS),May,2019,October,2019,2022,2019,Uganda,EA,EA,Peri-urban and rural,Rakai,Cross sectional,Consecutive,Female,Population-representative survey participants,Inland community: participating in open population-based household census and HIV cohort study in 40 communities.,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,522,86,0.164750958,TV,71,522,0.136,genital fluid,rapid antigen test,83.3,98.8,0.152994403,0.018302847,0.117605214,0.190360327,59.18342063,386.8338941
#22239,Grabowski 2022,STIPS (RCSS),May,2019,October,2019,2022,2019,Uganda,EA,EA,Peri-urban and rural,Rakai,Cross sectional,Consecutive,Male,Population-representative survey participants,Inland community: participating in open population-based household census and HIV cohort study in 40 communities.,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,394,42,0.106598985,CT,38,394,0.096,genital fluid,NAAT,87.5,99.2,0.104501906,0.017335883,0.073024452,0.140698832,32.54027093,311.3844735
#22239,Grabowski 2022,STIPS (RCSS),May,2019,October,2019,2022,2019,Uganda,EA,EA,Peri-urban and rural,Rakai,Cross sectional,Consecutive,Male,Population-representative survey participants,Inland community: participating in open population-based household census and HIV cohort study in 40 communities.,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,394,42,0.106598985,NG,13,394,0.033,genital fluid,NAAT,96.1,99,0.026672617,0.009635484,0.010108019,0.048278138,7.458355795,279.6259519
#22239,Grabowski 2022,STIPS (RCSS),May,2019,October,2019,2022,2019,Uganda,EA,EA,Peri-urban and rural,Rakai,Cross sectional,Consecutive,Male,Population-representative survey participants,Inland community: participating in open population-based household census and HIV cohort study in 40 communities.,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,394,42,0.106598985,TV,15,394,0.038,genital fluid,rapid antigen test,83.3,98.8,0.034643798,0.012091921,0.013544574,0.061497923,7.924063827,228.7296512
#21822,Chitneni 2020,Health Famillies PrEP Study,NR,2018,NR,2019,2020,2019,Uganda,EA,EA,Rural,Mbarara,Cohort,Consecutive,Female,PHC/OPD attendees,"Women in HIV sero-discordant partnership attending HIV clinic, or women accessing HIV counseling and testing at PHC",Adult,Y,18 to 40,18,40,NA,30,26-34,HIV negative,94,0,0,CT,12,94,0.13,genital fluid,NAAT,88.6,99.6,0.149315401,0.038942258,0.082831438,0.229829518,12.50649245,83.75889113
#21822,Chitneni 2020,Health Famillies PrEP Study,NR,2018,NR,2019,2020,2019,Uganda,EA,EA,Rural,Mbarara,Cohort,Consecutive,Female,PHC/OPD attendees,"Women in HIV sero-discordant partnership attending HIV clinic, or women accessing HIV counseling and testing at PHC",Adult,Y,18 to 40,18,40,NA,30,26-34,HIV negative,94,0,0,NG,2,94,0.02,genital fluid,NAAT,93.3,99.2,0.02594522,0.018627562,0.001771046,0.07231314,1.889670478,72.83308635
#21822,Chitneni 2020,Health Famillies PrEP Study,NR,2018,NR,2019,2020,2019,Uganda,EA,EA,Rural,Mbarara,Cohort,Consecutive,Female,PHC/OPD attendees,"Women in HIV sero-discordant partnership attending HIV clinic, or women accessing HIV counseling and testing at PHC",Adult,Y,18 to 40,18,40,NA,30,26-34,HIV negative,94,0,0,TV,6,94,0.06,genital fluid,NAAT,95,98,0.057234906,0.028382834,0.012249609,0.12316299,3.833663098,66.98120701
#21773,Celentano 2010,NIMH Collaborative HIV/STD Prevention Trial,May,2003,October,2003,2010,2003,Zimbabwe,EA,EA,Rural,Thirty-two rural villages across eight rural districts,Cross sectional,Convenience,Female,Community members,Participants recruited from community: retail establishments in business centers of growth points in rural Zimbabwe,Adult,Y,18 to 30,18,30,NA,21,NA,Mixed,2596,779,0.3,CT,150,2503,0.06,genital fluid,NAAT,88.6,99.6,0.063827988,0.005468383,0.0536519,0.074636696,127.544035,1998.246223
#21773,Celentano 2010,NIMH Collaborative HIV/STD Prevention Trial,May,2003,October,2003,2010,2003,Zimbabwe,EA,EA,Rural,Thirty-two rural villages across eight rural districts,Cross sectional,Convenience,Female,Community members,Participants recruited from community: retail establishments in business centers of growth points in rural Zimbabwe,Adult,Y,18 to 30,18,30,NA,21,NA,Mixed,2596,779,0.3,NG,105,2475,0.042,genital fluid,NAAT,93.3,99.2,0.0375977,0.004379647,0.029388968,0.046751663,70.92526706,1886.425663
#21773,Celentano 2010,NIMH Collaborative HIV/STD Prevention Trial,May,2003,October,2003,2010,2003,Zimbabwe,EA,EA,Rural,Thirty-two rural villages across eight rural districts,Cross sectional,Convenience,Female,Community members,Participants recruited from community: retail establishments in business centers of growth points in rural Zimbabwe,Adult,Y,18 to 30,18,30,NA,21,NA,Mixed,2596,779,0.3,TV,426,2595,0.164,genital fluid,culture,68.8,100,0.238939606,0.010761227,0.218033152,0.261052988,375.2077693,1570.30379
#21773,Celentano 2010,NIMH Collaborative HIV/STD Prevention Trial,May,2003,October,2003,2010,2003,Zimbabwe,EA,EA,Rural,Thirty-two rural villages across eight rural districts,Cross sectional,Convenience,Male,Community members,Participants recruited from community: retail establishments in business centers of growth points in rural Zimbabwe,Adult,Y,18 to 30,18,30,NA,21,NA,Mixed,2942,344,0.117,CT,72,2918,0.025,urine,NAAT,87.8,99.3,0.020624126,0.003326974,0.014447735,0.027566741,37.63585546,1824.846106
#21773,Celentano 2010,NIMH Collaborative HIV/STD Prevention Trial,May,2003,October,2003,2010,2003,Zimbabwe,EA,EA,Rural,Thirty-two rural villages across eight rural districts,Cross sectional,Convenience,Male,Community members,Participants recruited from community: retail establishments in business centers of growth points in rural Zimbabwe,Adult,Y,18 to 30,18,30,NA,21,NA,Mixed,2942,344,0.117,NG,44,2912,0.015,urine,NAAT,80.9,99.9,0.017850882,0.002806857,0.012731116,0.02374027,39.72429721,2225.340865
#22721,Lemme 2013,MEMA kwa Vijana,June,2007,July,2008,2013,2008,Tanzania,EA,EA,Rural,"Geita, Kwimba, Missungwi and Sengerema districts, Mwanza",Cross sectional,Random,Male,Community members,"Community survey on youth sexual and repoductive health, as part of household census",Adult,Y,15 to 30,15,30,NA,23,NA,Mixed,7259,131,1.80E-02,CT,152,7256,0.020948181,urine,NAAT,87.8,99.3,0.016163378,0.001930974,0.012590087,0.020227719,68.93417859,4264.837384
#22721,Lemme 2013,MEMA kwa Vijana,June,2007,July,2008,2013,2008,Tanzania,EA,EA,Rural,"Geita, Kwimba, Missungwi and Sengerema districts, Mwanza",Cross sectional,Random,Male,Community members,"Community survey on youth sexual and repoductive health, as part of household census",Adult,Y,15 to 30,15,30,NA,23,NA,Mixed,7259,131,1.80E-02,NG,28,7256,0.003858875,urine,NAAT,80.9,99.9,0.003710398,0.000921629,0.002113851,0.005679834,16.14783725,4352.049711
#22721,Lemme 2013,MEMA kwa Vijana,June,2007,July,2008,2013,2008,Tanzania,EA,EA,Rural,"Geita, Kwimba, Missungwi and Sengerema districts, Mwanza",Cross sectional,Random,Female,Community members,"Community survey on youth sexual and repoductive health, as part of household census",Adult,Y,15 to 30,15,30,NA,22,NA,Mixed,6476,266,4.10E-02,CT,153,6472,0.023640297,urine,NAAT,87,99.8,0.025089321,0.002199465,0.020931674,0.029380587,126.8553164,5056.147903
#22721,Lemme 2013,MEMA kwa Vijana,June,2007,July,2008,2013,2008,Tanzania,EA,EA,Rural,"Geita, Kwimba, Missungwi and Sengerema districts, Mwanza",Cross sectional,Random,Female,Community members,"Community survey on youth sexual and repoductive health, as part of household census",Adult,Y,15 to 30,15,30,NA,22,NA,Mixed,6476,266,4.10E-02,NG,23,6472,0.00355377,urine,NAAT,91.6,100,0.004048521,0.000829443,0.0025914,0.005841106,23.72784825,5860.867566
#23345,Paz-Bailey 2005,NA,November,2001,February,2002,2005,2002,Botswana,SA,SA,Urban,"Gaborone, Selebi-Phikwe, Francistown",Cross sectional,Consecutive,Female,FP attendees,Women from family planning clinics,Adult,NR,NR,NR,NR,NR,NR,NR,Mixed,143,59,0.413,NG,7,268,0.026119403,urine,NAAT,91.6,100,0.032259917,0.011123213,0.014260175,0.057635752,8.140005447,252.3256759
#23345,Paz-Bailey 2005,NA,November,2001,February,2002,2005,2002,Botswana,SA,SA,Urban,"Gaborone, Selebi-Phikwe, Francistown",Cross sectional,Consecutive,Female,FP attendees,Women from family planning clinics,Adult,NR,NR,NR,NR,NR,NR,NR,Mixed,143,59,0.413,TV,15,221,0.067873303,genital fluid,culture,68.8,100,0.103969692,0.025666998,0.061023324,0.157285803,14.7023265,141.4097346
#23804,Tukur 2006,NA,May,2002,August,2002,2006,2002,Nigeria,WA,WA,Urban,Zaria,Case control,Consecutive,Female,FP attendees,Family planning attendees recruited as control group for study,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,16,120,0.133,genital fluid,rapid antigen test,56,99,0.235175651,0.056915726,0.133797814,0.353175762,13.05815598,55.52511899
#32468,Niemogha 2010,NA,NR,NR,NR,NR,2010,2007,Nigeria,WA,WA,Urban,Lagos,Cross sectional,Random,Female,FP attendees,Women attending family planning clinics... participants were from both private and government medical centres.,Adult,NR,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,3,43,0.07,genital fluid,culture and WM,52,100,0.170860393,0.079003965,0.048798932,0.352645146,3.878043595,22.69714784
#32468,Niemogha 2010,NA,NR,NR,NR,NR,2010,2007,Nigeria,WA,WA,Urban,Lagos,Cross sectional,Random,Female,GYN attendees,Women attending obstetrics/gynaecology centre... participants were from both private and government medical centres.,Adult,NR,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,1,50,0.02,genital fluid,culture and WM,52,100,0.072031087,0.050711451,0.008331965,0.201647172,1.872238983,25.9920968
#32468,Niemogha 2010,NA,NR,NR,NR,NR,2010,2007,Nigeria,WA,WA,Urban,Lagos,Cross sectional,Random,Female,Students,Apparently health undergraduate women,Youth,NR,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,0,56,0,genital fluid,culture and WM,52,100,0.033527598,0.032568954,0.001052227,0.120977121,1.024204597,30.54810563
#27382,Chigbu 2006,NA,NR,NR,MR,NR,2006,2003,Nigeria,WA,WA,Urban,Ogbor Hill (Aba),Cross sectional,Random,Female,FP attendees,Women attending the family planning clinic,Adult,Y,15 to 65,15,65,NA,NA,NA,Mixed,NA,NA,NR,NG,0,11,0,genital fluid,culture,75.7,100,0.101459243,0.092968468,0.00318707,0.339396175,1.070162351,10.54770683
#27382,Chigbu 2006,NA,NR,NR,MR,NR,2006,2003,Nigeria,WA,WA,Urban,Ogbor Hill (Aba),Cross sectional,Random,Female,FP attendees,Women attending the family planning clinic,Adult,Y,15 to 65,15,65,NA,NA,NA,Mixed,NA,NA,NR,TV,1,11,0.091,genital fluid,WM,52,100,0.29682691,0.183717348,0.037475792,0.739321625,1.835559426,6.183938742
#27382,Chigbu 2006,NA,NR,NR,MR,NR,2006,2003,Nigeria,WA,WA,Urban,Ogbor Hill (Aba),Cross sectional,Random,Female,GYN attendees,"Women attending the hospital for ""well women examination"" for routine examination (no specific gynecological problems or symptoms)",Adult,Y,15 to 65,15,65,NA,NA,NA,Mixed,NA,NA,NR,NG,2,23,0.086956522,genital fluid,culture,75.7,100,0.157773409,0.085347183,0.030442044,0.356412076,2.878181528,18.24250076
#27382,Chigbu 2006,NA,NR,NR,MR,NR,2006,2003,Nigeria,WA,WA,Urban,Ogbor Hill (Aba),Cross sectional,Random,Female,GYN attendees,"Women attending the hospital for ""well women examination"" for routine examination (no specific gynecological problems or symptoms)",Adult,Y,15 to 65,15,65,NA,NA,NA,Mixed,NA,NA,NR,TV,11,23,0.478,genital fluid,WM,52,100,0.818976828,0.124644951,0.533576569,0.990001278,7.814982568,9.542373234
#23637,Sineque 2024,NA,July,2021,May,2022,2024,2021,Mozambique,EA,EA,Peri-urban,"Zimpeto, Maputo",Cross sectional,Consecutive,Female,PHC/OPD attendees,Women accessing the DREAM health unit who were not pregnant and knew their HIV status,Adult,N,30 to 55,30,55,40.03,NA,NA,Mixed,117,61,0.521,CT,8,117,0.068,genital fluid,NAAT,88.6,99.6,0.081413411,0.027434437,0.036252301,0.141791169,8.089466784,99.36282783
#23637,Sineque 2024,NA,July,2021,May,2022,2024,2021,Mozambique,EA,EA,Peri-urban,"Zimpeto, Maputo",Cross sectional,Consecutive,Female,PHC/OPD attendees,Women accessing the DREAM health unit who were not pregnant and knew their HIV status,Adult,N,30 to 55,30,55,40.03,NA,NA,Mixed,117,61,0.521,NG,3,117,0.026,genital fluid,NAAT,93.3,99.2,0.028058513,0.017525817,0.002892866,0.069885003,2.491224628,88.78676566
#31017,Olusegun-Joseph 2016,NA,NR,NR,NR,NR,2016,2013,Nigeria,WA,WA,Urban,Lagos,Cross sectional,NR,Female,PHC/OPD attendees,Patients attending general hospital,Adult,N,16 to 55,16,55,NA,NA,NA,Mixed,NA,NA,NR,TV,5,200,0.025,genital fluid and urine,WM,52,100,0.057019836,0.022463374,0.021477355,0.107662454,6.075814524,106.5561561
#22906,Mbuvi 2024,NA,August,2021,May,2022,2024,2022,Kenya,EA,EA,Rural,"Mwingi, Kitui County",Cross sectional,Consecutive,Female,PHC/OPD attendees,Women seeking medical care at outpatient clinics of hospital,Adult,Y,15 to 44,15,44,NA,NA,NA,Mixed,NA,NA,NR,NG,8,322,0.025,genital fluid,culture,75.7,100,0.036654947,0.012123545,0.016715014,0.063736436,8.806184222,240.245452
#22906,Mbuvi 2024,NA,August,2021,May,2022,2024,2022,Kenya,EA,EA,Rural,"Mwingi, Kitui County",Cross sectional,Consecutive,Female,PHC/OPD attendees,Women seeking medical care at outpatient clinics of hospital,Adult,Y,15 to 44,15,44,NA,NA,NA,Mixed,NA,NA,NR,TV,12,322,0.037,genital fluid,WM,52,100,0.076843507,0.020936021,0.040540424,0.121401564,12.4365916,161.8431029
#25451,Compain 2019,NA,July,2017,July,2017,2019,2017,Chad,CA,CA,Urban,N'Djamena,Cross sectional,Convenience,Female,Community members,Women recruited through places of worship or women association networks in 5/10 randomly selected districts of city,Adult,N,20 to 65,20,65,35,NA,NA,Mixed,251,9,3.59E-02,CT,3,251,0.011952191,genital fluid,NAAT,88.6,99.6,0.013711522,0.008989977,0.001131925,0.035574307,2.294342063,167.3294962
#25451,Compain 2019,NA,July,2017,July,2017,2019,2017,Chad,CA,CA,Urban,N'Djamena,Cross sectional,Convenience,Female,Community members,Women recruited through places of worship or women association networks in 5/10 randomly selected districts of city,Adult,N,20 to 65,20,65,35,NA,NA,Mixed,251,9,3.59E-02,NG,1,251,0.003984064,genital fluid,NAAT,93.3,99.2,0.005587038,0.00527136,0.000187772,0.019115943,1.117081162,199.9415641
#25451,Compain 2019,NA,July,2017,July,2017,2019,2017,Chad,CA,CA,Urban,N'Djamena,Cross sectional,Convenience,Female,Community members,Women recruited through places of worship or women association networks in 5/10 randomly selected districts of city,Adult,N,20 to 65,20,65,35,NA,NA,Mixed,251,9,3.59E-02,TV,1,251,0.003984064,genital fluid,NAAT,95,98,0.00488197,0.004716009,0.000126019,0.017581045,1.066388878,218.4341361
#22680,Lafort 2003,RETRO-CI,November,2000,December,2000,2003,2000,Cote d'Ivoire,WA,WA,Urban,Abidjan,Cross sectional,Random,Female,FP attendees,Family planning clients consulting midwife,Adult,N,18 to 53,18,53,NA,28,NA,Mixed,NA,NA,NR,CT,21,368,0.057,genital fluid,NAAT,88.6,99.6,0.062694708,0.013767385,0.038392782,0.091314394,19.43747757,310.0337847
#22680,Lafort 2003,RETRO-CI,November,2000,December,2000,2003,2000,Cote d'Ivoire,WA,WA,Urban,Abidjan,Cross sectional,Random,Female,FP attendees,Family planning clients consulting midwife,Adult,N,18 to 53,18,53,NA,28,NA,Mixed,NA,NA,NR,NG,9,368,0.016,genital fluid,NAAT,93.3,99.2,0.020698217,0.009150919,0.006073252,0.040963109,5.010175922,242.0583386
#22680,Lafort 2003,RETRO-CI,November,2000,December,2000,2003,2000,Cote d'Ivoire,WA,WA,Urban,Abidjan,Cross sectional,Random,Female,FP attendees,Family planning clients consulting midwife,Adult,N,18 to 53,18,53,NA,28,NA,Mixed,NA,NA,NR,TV,26,368,0.071,genital fluid,WM,52,100,0.140343479,0.025578586,0.095086072,0.194926801,25.87952947,184.4013679
#31017,Olusegun-Joseph 2016,NA,NR,NR,NR,NR,2016,2013,Nigeria,WA,WA,Urban,Lagos,Cross sectional,NR,Female,Students,Students attending health center of Yaba College,Adult,Y,16 to 40,16,40,NA,NA,NA,Mixed,NA,NA,NR,TV,0,200,0,genital fluid and urine,WM,52,100,0.009775371,0.009471991,0.000292763,0.035792581,1.054672666,107.8908025
#32534,Kestelyn 2018,Ring Plus study,June,2013,January,2014,2018,2013,Rwanda,EA,EA,Urban,Kigali,RCT,Convenience,Female,HIV/STI prevention trial participants,Women recruited from previous studues or community recruitment meeting for participation in trial,Adult,Y,18 to 35,18,35,NA,28,20-35,Mixed,285,59,0.21,CT,15,186,0.08,genital fluid,NAAT,88.6,99.6,0.091447075,0.023320357,0.051332432,0.141298888,13.97074208,152.7740724
#32534,Kestelyn 2018,Ring Plus study,June,2013,January,2014,2018,2013,Rwanda,EA,EA,Urban,Kigali,RCT,Convenience,Female,HIV/STI prevention trial participants,Women recruited from previous studues or community recruitment meeting for participation in trial,Adult,Y,18 to 35,18,35,NA,28,20-35,Mixed,285,59,0.21,NG,15,186,0.08,genital fluid,NAAT,93.3,99.2,0.083638286,0.022218038,0.045238713,0.132795844,12.98571277,155.2603885
#32534,Kestelyn 2018,Ring Plus study,June,2013,January,2014,2018,2013,Rwanda,EA,EA,Urban,Kigali,RCT,Convenience,Female,HIV/STI prevention trial participants,Women recruited from previous studues or community recruitment meeting for participation in trial,Adult,Y,18 to 35,18,35,NA,28,20-35,Mixed,285,59,0.21,TV,13,186,0.07,genital fluid,WM,52,100,0.144309639,0.036673071,0.082686094,0.224840009,13.24990519,91.8158015
#22732,Lewis 2008,NA,July,2006,September,2006,2008,2006,South Africa,SA,SA,Urban,Carletonville,Cross sectional,Consecutive,Male,PHC/OPD attendees,Men visiting mobile van for STI screening / HIV testing,Adult,Y,17 to 73,17,73,33.5,NA,NA,Mixed,269,80,0.297,CT,26,301,0.086,urine,NAAT,87.8,99.3,0.094226379,0.018092027,0.061037824,0.132277464,24.56915582,260.7460458
#22732,Lewis 2008,NA,July,2006,September,2006,2008,2006,South Africa,SA,SA,Urban,Carletonville,Cross sectional,Consecutive,Male,PHC/OPD attendees,Men visiting mobile van for STI screening / HIV testing,Adult,Y,17 to 73,17,73,33.5,NA,NA,Mixed,269,80,0.297,NG,19,301,0.063,urine,NAAT,80.9,99.9,0.080300972,0.017698643,0.049337059,0.118704528,18.93247539,235.7689456
#22732,Lewis 2008,NA,July,2006,September,2006,2008,2006,South Africa,SA,SA,Urban,Carletonville,Cross sectional,Consecutive,Male,PHC/OPD attendees,Men visiting mobile van for STI screening / HIV testing,Adult,Y,17 to 73,17,73,33.5,NA,NA,Mixed,269,80,0.297,TV,43,301,0.143,urine,NAAT,96,97.7,0.130071196,0.021465548,0.090106653,0.174229843,31.94199309,245.5731474
#23347,Paz-Soldan 2012,Malawi Pregancy and STI Risk Perception and Avoidance Study,June,2000,December,2000,2012,2000,Malawi,EA,EA,Rural,Mangochi,Cohort,Random,Female,Population-representative survey participants,Men and women living in households in three traditional areas in Mangochi,Adult,Y,15-34,15,34,NA,NA,NA,Mixed,NA,NA,NR,CT,23,451,0.051,urine,NAAT,87,99.8,0.058522282,0.011883315,0.037304425,0.083542608,22.83375311,390.1719559
#23347,Paz-Soldan 2012,Malawi Pregancy and STI Risk Perception and Avoidance Study,June,2000,December,2000,2012,2000,Malawi,EA,EA,Rural,Mangochi,Cohort,Random,Female,Population-representative survey participants,Men and women living in households in three traditional areas in Mangochi,Adult,Y,15-34,15,34,NA,NA,NA,Mixed,NA,NA,NR,NG,15,453,0.033,urine,NAAT,91.6,100,0.038342351,0.009516758,0.022049698,0.059270788,15.60989327,407.1188378
#23347,Paz-Soldan 2012,Malawi Pregancy and STI Risk Perception and Avoidance Study,June,2000,December,2000,2012,2000,Malawi,EA,EA,Rural,Mangochi,Cohort,Random,Male,Population-representative survey participants,Men and women living in households in three Traditional Areas in Mangochi,Adult,Y,20-44,20,44,NA,NA,NA,Mixed,NA,NA,NR,CT,17,247,0.069,urine,NAAT,87.8,99.3,0.075025486,0.018910252,0.041596548,0.116139465,14.55971132,194.0635396
#23347,Paz-Soldan 2012,Malawi Pregancy and STI Risk Perception and Avoidance Study,June,2000,December,2000,2012,2000,Malawi,EA,EA,Rural,Mangochi,Cohort,Random,Male,Population-representative survey participants,Men and women living in households in three Traditional Areas in Mangochi,Adult,Y,20-44,20,44,NA,NA,NA,Mixed,NA,NA,NR,NG,18,247,0.073,urine,NAAT,80.9,99.9,0.093531958,0.021013606,0.057300226,0.138731115,17.95855433,192.0044733
#21676,Black 2008,NA,October,2004,September,2006,2008,2005,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Convenience,Male,PHC/OPD attendees,HIV voluntary counselling and testing clients at PHC,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,13,158,0.082,urine,NAAT,87.8,99.3,0.091891096,0.0254976,0.047841833,0.148333804,11.79468095,128.3549928
#21676,Black 2008,NA,October,2004,September,2006,2008,2005,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Convenience,Male,PHC/OPD attendees,HIV voluntary counselling and testing clients at PHC,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,5,158,0.032,urine,culture or NAAT,80.9,99.9,0.045230194,0.018451542,0.015980654,0.08624085,5.737071261,126.841624
#21676,Black 2008,NA,October,2004,September,2006,2008,2005,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Convenience,Male,PHC/OPD attendees,HIV voluntary counselling and testing clients at PHC,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,6,158,0.038,urine,culture or NAAT,87.6,97.7,0.026607342,0.017176645,0.001977938,0.065869693,2.335685545,87.78349737
#22521,Kaydos-Daniels 2003,NA,January,2000,June,2001,2003,2000,Malawi,EA,EA,Urban,Lilongwe,Cross sectional,Convenience,Male,PHC/OPD attendees,Men attending dermatology outpatient clinics,Adult,U,18+,18,NR,NA,NA,NA,Mixed,431,119,0.276,TV,14,432,0.032,genital fluid or urine,culture,87.6,100,0.039636452,0.010179029,0.021513863,0.062590435,14.56171328,367.381855
#21391,Abbai-Shaik 2016,NA,June,2015,July,2015,2016,2015,South Africa,SA,SA,Urban,Durban,Cross sectional,Consecutive,Male,PHC/OPD attendees,Men recruited from general population who attended clinic at HPRU research facility,Adult,Y,18+,18,NR,NA,31,23-38,Mixed,NA,NA,NR,CT,10,100,0.1,urine,NAAT,87.8,99.3,0.116425239,0.034944763,0.057164031,0.192042771,9.807840303,84.24153003
#32101,Adejuwon 2005,NA,NR,NR,NR,NR,2005,2002,Nigeria,WA,WA,Urban,Ibadan,Cross sectional,Convenience,Female,FP attendees,"Patients at the family planning unit of University College Hospital, Ibadan. Data extracted for women who had used intra-uterine contraceptive devices for at least two months without experiencing vaginal discharge (n = 14) and a further two women who were not on contraception.",Adult,NR,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,0,16,0,genital fluid,culture,75.7,100,0.073512025,0.07064567,0.002064305,0.265992012,1.003195215,13.64668191
#32101,Adejuwon 2005,NA,NR,NR,NR,NR,2005,2002,Nigeria,WA,WA,Urban,Ibadan,Cross sectional,Convenience,Female,FP attendees,"Patients at the family planning unit of University College Hospital, Ibadan. Data extracted for women who had used intra-uterine contraceptive devices for at least two months without experiencing vaginal discharge (n = 14) and a further two women who were not on contraception.",Adult,NR,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,0,16,0,genital fluid,WM,52,100,0.105547822,0.101642664,0.003023977,0.375440096,0.964503051,9.138066804
#23289,Omoregie 2009,NA,NR,NR,NR,NR,2009,2006,Nigeria,WA,WA,Urban,Benin City,Cross sectional,NR,Female,PHC/OPD attendees,Apparently health HIV-negative individuals attending hospital,Adult,NR,NR,NR,NR,NA,NA,NA,HIV negative,56,0,0,TV,0,56,0,urine,WM,52,100,0.033022308,0.031459479,0.001136363,0.119571438,1.06543816,32.26419426
#23289,Omoregie 2009,NA,NR,NR,NR,NR,2009,2006,Nigeria,WA,WA,Urban,Benin City,Cross sectional,NR,Male,PHC/OPD attendees,Apparently health HIV-negative individuals attending hospital,Adult,NR,NR,NR,NR,NA,NA,NA,HIV negative,48,0,0,TV,0,48,0,urine,WM,44,100,0.045115219,0.044045162,0.001121534,0.166009616,1.001845367,22.20637257
#22715,Le Roux 2017,NA,NR,NR,NR,NR,2017,2014,South Africa,SA,SA,Urban,Pretoria,Cross sectional,Consecutive,Male,PHC/OPD attendees,Patients visiting a family practitioner without urethritis signs and symptom,Adult,Y,17 to 65,17,65,36.5,NA,NA,Mixed,NA,NA,NR,CT,4,75,0.051,urine,NAAT,87.8,99.3,0.065842848,0.03128971,0.017892685,0.13771785,4.136510047,62.82398414
#22715,Le Roux 2017,NA,NR,NR,NR,NR,2017,2014,South Africa,SA,SA,Urban,Pretoria,Cross sectional,Consecutive,Male,PHC/OPD attendees,Patients visiting a family practitioner without urethritis signs and symptom,Adult,Y,17 to 65,17,65,36.5,NA,NA,Mixed,NA,NA,NR,NG,2,75,0.026,urine,NAAT,80.9,99.9,0.048076349,0.027831699,0.008710264,0.118335577,2.84044021,59.0818615
#22715,Le Roux 2017,NA,NR,NR,NR,NR,2017,2014,South Africa,SA,SA,Urban,Pretoria,Cross sectional,Consecutive,Male,PHC/OPD attendees,Patients visiting a family practitioner without urethritis signs and symptom,Adult,Y,17 to 65,17,65,36.5,NA,NA,Mixed,NA,NA,NR,TV,1,75,0.013,urine,NAAT,96,97.7,0.018667395,0.01687819,0.00057929,0.060786652,1.200416451,64.30551443
#22069,Ezeanya 2019,NA,NR,NR,NR,NR,2019,2016,Nigeria,WA,WA,Urban,Benin City,Cross sectional,Random,Female,Students,"Apparently healthy, non-menstruating female students",Adult,Y,15 to 39,15,39,26.2,NA,NA,Mixed,NA,NA,NR,CT,13,133,0.097,genital fluid,NAAT,88.6,99.6,0.113177829,0.029425486,0.061317263,0.177182895,13.11933949,115.9179288
#22069,Ezeanya 2019,NA,NR,NR,NR,NR,2019,2016,Nigeria,WA,WA,Urban,Benin City,Cross sectional,Random,Female,Students,"Apparently healthy, non-menstruating female students",Adult,Y,15 to 39,15,39,26.2,NA,NA,Mixed,NA,NA,NR,TV,94,133,0.71,genital fluid,NAAT,95,98,0.734600171,0.042455747,0.650242745,0.815218085,79.45655127,108.1629904
#21539,Arinze 2014,NA,NR,NR,NR,NR,2014,2011,Nigeria,WA,WA,Urban,Port Harcourt,Cross sectional,Random,Female,Students,Female undergraduates of University of Port Harcourt,Adult,Y,15 to 30,15,30,NA,NA,NA,Mixed,NA,NA,NR,CT,107,354,0.302,genital fluid,rapid antigen test,56,99,0.533473586,0.044857792,0.447669333,0.622613394,65.98212454,123.6839578
#24159,Adesiji 2015,NA,NR,NR,NR,NR,2015,2012,Nigeria,WA,WA,Mixed,Osun State,Cross sectional,Convenience,Female,FP and GYN attendees,Patients attending family planning and obstetrics and gynaecology clinics from selected hospitals in southern part of Nigeria.,Adult,Y,20+,20,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,1,140,0.007,genital fluid,rapid antigen test,56,99,0.017787607,0.015857814,0.000622236,0.058551323,1.235815977,69.47623712
#21877,Crucitti 2010,NA,NR,NR,NR,NR,2010,2007,Zambia,EA,EA,Urban,Ndola,Cross sectional,Convenience,Female,Students,Adolescent school girls,Youth,Y,13 to 16,13,16,14.25968109,14,NA,Mixed,NA,NA,NR,TV,108,439,0.246,genital fluid,NAAT,95,98,0.24408007,0.022454661,0.202236214,0.288653996,89.3156214,365.9275474
#32523,Franceschi 2016,F,April,2013,May,2014,2016,2014,Rwanda,EA,EA,Urban,"Nyarugenge, Kigali",Cross sectional,Convenience,Female,Students,Secondary school students,Youth,Y,18 to 20,18,20,NA,NA,NA,Mixed,NA,NA,NR,CT,20,912,0.021929825,urine,NAAT,87,99.8,0.024166567,0.005820336,0.014057282,0.036694765,16.82323239,696.1366262
#24946,Baussano 2021,F,March,2017,November,2017,2021,2017,Rwanda,EA,EA,Urban,"Nyarugenge, Kigali",Cross sectional,Convenience,Female,Students,Secondary school students,Youth,Y,17 to 21,17,21,NA,NA,NA,Mixed,NA,NA,NR,CT,40,1087,0.037,urine,NAAT,87,99.8,0.040909555,0.006682136,0.028639945,0.054917999,35.94830235,878.7263152
#22957,Mensch 2008,Malawi Diffusion and Ideational Change Project (MDICP),June,2004,July,2004,2008,2004,Malawi,EA,EA,Rural,Balaka District,Cross sectional,NR,Female,Population-representative survey participants,Unmarried female adolescents,Youth,Y,15 to 21,15,21,NA,NA,NA,Mixed,423,25,0.06,CT,4,387,0.01,genital fluid,NAAT,88.6,99.6,0.010281169,0.006359453,0.001102738,0.025245076,2.586766566,251.602384
#22957,Mensch 2008,Malawi Diffusion and Ideational Change Project (MDICP),June,2004,July,2004,2008,2004,Malawi,EA,EA,Rural,Balaka District,Cross sectional,NR,Female,Population-representative survey participants,Unmarried female adolescents,Youth,Y,15 to 21,15,21,NA,NA,NA,Mixed,423,25,0.06,NG,23,387,0.06,genital fluid,NAAT,93.3,99.2,0.058039206,0.013132284,0.034635878,0.086108313,18.39904113,317.010561
#22957,Mensch 2008,Malawi Diffusion and Ideational Change Project (MDICP),June,2004,July,2004,2008,2004,Malawi,EA,EA,Rural,Balaka District,Cross sectional,NR,Female,Population-representative survey participants,Unmarried female adolescents,Youth,Y,15 to 21,15,21,NA,NA,NA,Mixed,423,25,0.06,TV,8,401,0.02,genital fluid,NAAT,95,98,0.007553425,0.006072057,0.00021808,0.022004247,1.535760109,203.3196949
#23369,Pettifor 2005,NA,NR,2002,NR,2002,2005,2002,South Africa,SA,SA,Mixed,National,Cross sectional,Random,Male,PHC/OPD attendees,Attendees of youth clinics and government clinics in all 9 provinces,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,3844,554,0.144,CT,230,3844,0.05998179,urine,NAAT,87.8,99.3,0.06092775,0.004465384,0.052316647,0.07004985,174.8282685,2869.435805
#23369,Pettifor 2005,NA,NR,2002,NR,2002,2005,2002,South Africa,SA,SA,Mixed,National,Cross sectional,Random,Male,PHC/OPD attendees,Attendees of youth clinics and government clinics in all 9 provinces,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,3844,554,0.144,NG,72,3844,0.018948751,urine,NAAT,80.9,99.9,0.022243053,0.002732003,0.017234794,0.027851153,64.81229151,2913.821735
#23369,Pettifor 2005,NA,NR,2002,NR,2002,2005,2002,South Africa,SA,SA,Mixed,National,Cross sectional,Random,Female,PHC/OPD attendees,Attendees of youth clinics and government clinics in all 9 provinces,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,4626,1123,0.2,CT,455,4626,0.098357112,urine,NAAT,87,99.8,0.111268789,0.005070892,0.10154954,0.121334472,427.9061334,3845.697755
#23369,Pettifor 2005,NA,NR,2002,NR,2002,2005,2002,South Africa,SA,SA,Mixed,National,Cross sectional,Random,Female,PHC/OPD attendees,Attendees of youth clinics and government clinics in all 9 provinces,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,4626,1123,0.2,NG,162,4626,0.035,urine,NAAT,91.6,100,0.038462155,0.003022999,0.032964832,0.044368351,155.653084,4046.915322
#22332,Hawken 2002,NA,April,2000,July,2000,2002,2000,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Random,Female,Population-representative survey participants,Community members identified in randomly selected households,Adult,Y,15 to 49,15,49,27.1,NA,NA,Mixed,416,57,0.137,CT,11,579,0.019,urine,NAAT,87,99.8,0.021298112,0.00671065,0.010105697,0.036205063,9.858331639,462.8734995
#22332,Hawken 2002,NA,April,2000,July,2000,2002,2000,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Random,Female,Population-representative survey participants,Community members identified in randomly selected households,Adult,Y,15 to 49,15,49,27.1,NA,NA,Mixed,416,57,0.137,NG,4,571,0.007,urine,NAAT,91.6,100,0.009468777,0.004245371,0.003198759,0.019427468,4.927478371,520.3922562
#22332,Hawken 2002,NA,April,2000,July,2000,2002,2000,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Random,Male,Population-representative survey participants,Community members identified in randomly selected households,Adult,Y,15 to 49,15,49,28.5,NA,NA,Mixed,425,34,0.08,CT,6,546,0.011,urine,NAAT,87.8,99.3,0.007473493,0.005219538,0.000481426,0.019793363,2.034816818,272.2711894
#22332,Hawken 2002,NA,April,2000,July,2000,2002,2000,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Random,Male,Population-representative survey participants,Community members identified in randomly selected households,Adult,Y,15 to 49,15,49,28.5,NA,NA,Mixed,425,34,0.08,NG,7,583,0.012,urine,NAAT,80.9,99.9,0.015636774,0.005967269,0.005902704,0.028894647,6.759249743,432.2662632
#23344,Payne 2020,NA,NR,2018,NR,2018,2020,2018,Cameroon,CA,CA,Urban,Dschang,Cross sectional,NR,Female,PHC/OPD attendees,Women attending district hospital for consultation (reason not reported),Adult,Y,15 to 55,15,55,NA,NA,NA,Mixed,NA,NA,NR,TV,3,1001,0.002997003,genital fluid,WM,52,100,0.007678818,0.003808953,0.002152362,0.016802102,4.033015565,525.213054
#25593,Fayemiwo 2018,NA,March,2006,December,2006,2018,2006,Nigeria,WA,WA,Urban,Ibadan,Cross sectional,Consecutive,Female,FP attendees,"Child-bearing age women using different types of hormonal contraceptive methods and attending the family planning clinic, University College Hospital",Adult,Y,19 to 54,19,54,28.7,NA,NA,Mixed,116,14,0.121,CT,9,116,0.078,genital fluid,rapid antigen test,56,99,0.136070815,0.045929988,0.059126359,0.23767326,7.582552841,55.72504904
#25593,Fayemiwo 2018,NA,March,2006,December,2006,2018,2006,Nigeria,WA,WA,Urban,Ibadan,Cross sectional,Consecutive,Female,FP attendees,"Child-bearing age women using different types of hormonal contraceptive methods and attending the family planning clinic, University College Hospital",Adult,Y,19 to 54,19,54,28.7,NA,NA,Mixed,116,14,0.121,NG,3,116,0.026,genital fluid,culture,75.7,100,0.044802128,0.021844282,0.013262244,0.096553653,4.018047445,89.68429975
#25593,Fayemiwo 2018,NA,March,2006,December,2006,2018,2006,Nigeria,WA,WA,Urban,Ibadan,Cross sectional,Consecutive,Female,FP attendees,"Child-bearing age women using different types of hormonal contraceptive methods and attending the family planning clinic, University College Hospital",Adult,Y,19 to 54,19,54,28.7,NA,NA,Mixed,116,14,0.121,TV,12,116,0.103,genital fluid,WM,52,100,0.21246106,0.054957793,0.119243878,0.328312596,11.7698834,55.39783811
#22189,Ghebremichael 2011,Moshi Infertility survey,November,2002,March,2003,2011,2003,Tanzania,EA,EA,Urban,Moshi,Cross sectional,Random,Male,Community members,Community-based infertility study partners,Adult,Y,20+,20,NR,37,NA,NA,Mixed,566,37,6.50E-02,CT,4,588,0.007,urine,NAAT,87.8,99.3,0.004175056,0.003448157,0.000149337,0.012700628,1.459935097,349.6803537
#22189,Ghebremichael 2011,Moshi Infertility survey,November,2002,March,2003,2011,2003,Tanzania,EA,EA,Urban,Moshi,Cross sectional,Random,Male,Community members,Community-based infertility study partners,Adult,Y,20+,20,NR,37,NA,NA,Mixed,566,37,6.50E-02,TV,38,588,0.064,urine,NAAT,96,97.7,0.046195799,0.010993956,0.02677881,0.06860875,16.84054744,364.547165
#32005,Odendaal 2006,NA,February,2002,November,2003,2006,2003,South Africa,SA,SA,Urban,Tygerberg,Cohort,Consecutive,Female,ANC attendees,Pregnant women between 16 and 23 weeks’ gestation at low risk (no previous or present pregnancy complications),Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,30,343,0.087463557,genital fluid,NAAT,88.6,99.6,0.097460225,0.017180975,0.066666382,0.133274188,29.04193578,297.9875715
#32005,Odendaal 2006,NA,February,2002,November,2003,2006,2003,South Africa,SA,SA,Urban,Tygerberg,Cohort,Consecutive,Female,ANC attendees,Pregnant women between 16 and 23 weeks’ gestation at low risk (no previous or present pregnancy complications),Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,3,343,0.008746356,genital fluid,culture,75.7,100,0.015169405,0.007771533,0.004011356,0.033531359,3.752193923,247.3527449
#23096,Munjoma 2010,NA,April,2002,September,2002,2010,2002,Zimbabwe,EA,EA,Peri-urban,Harare,Cohort,Consecutive,Female,ANC attendees,"Women seeking routine ANC from PHCs, around 36 weeks gestation",Adult,Y,NR,NR,NR,NA,23,20-28,Mixed,340,84,0.247,TV,38,334,0.113772455,genital fluid,WM,52,100,0.223375843,0.033200709,0.160685659,0.289903441,35.15512104,157.3810333
#31585,Sebitloane 2011,NA,February,2003,May,2005,2011,2004,South Africa,SA,SA,Urban,Durban,RCT,NR,Female,ANC attendees,Women >= 36 weeks gestation with vaginal delivery anticipated,Adult,Y,18+,18,NR,NA,NA,NA,HIV negative,383,0,0,TV,30,383,0.078,genital fluid,culture,68.8,100,0.117474217,0.020394243,0.080446611,0.159966203,29.28177156,249.2612607
#22907,Mbu 2008,NA,January,2006,December,2006,2008,2006,Cameroon,CA,CA,Urban,Yaounde,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending antenatal visit,Adult,Y,NR,NR,NR,28,NA,NA,Mixed,2008,198,9.86E-02,CT,204,2008,0.101593625,genital fluid,DFA,82,98.5,0.108137292,0.008392795,0.092059982,0.124877474,148.0593125,1369.179025
#22907,Mbu 2008,NA,January,2006,December,2006,2008,2006,Cameroon,CA,CA,Urban,Yaounde,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending antenatal visit,Adult,Y,NR,NR,NR,28,NA,NA,Mixed,2008,198,9.86E-02,NG,66,2008,0.032868526,genital fluid,culture,75.7,100,0.044044263,0.005217116,0.034168278,0.0545596,68.13268614,1546.913996
#22907,Mbu 2008,NA,January,2006,December,2006,2008,2006,Cameroon,CA,CA,Urban,Yaounde,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending antenatal visit,Adult,Y,NR,NR,NR,28,NA,NA,Mixed,2008,198,9.86E-02,TV,234,2008,0.116533865,genital fluid,WM,52,100,0.224631856,0.013879625,0.198433391,0.252672499,203.0931148,904.1153767
#23709,Sturm 2004,NA,NR,NR,NR,NR,2004,2001,South Africa,SA,SA,Rural,"Kwamsane, KwaZulu-Natal",Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending first ANC visit,Adult,Y,NR,NR,NR,25,NA,NA,Mixed,NA,NA,NR,CT,25,185,0.14,genital fluid or urine,NAAT,87,99.6,0.156550497,0.029519368,0.102557309,0.218922833,23.72214046,151.5302785
#23709,Sturm 2004,NA,NR,NR,NR,NR,2004,2001,South Africa,SA,SA,Rural,"Kwamsane, KwaZulu-Natal",Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending first ANC visit,Adult,Y,NR,NR,NR,25,NA,NA,Mixed,NA,NA,NR,NG,14,185,0.08,genital fluid or urine,culture or NAAT,75.7,99.2,0.096473759,0.026338051,0.051099388,0.153023809,12.12249222,125.6558505
#23709,Sturm 2004,NA,NR,NR,NR,NR,2004,2001,South Africa,SA,SA,Rural,"Kwamsane, KwaZulu-Natal",Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending first ANC visit,Adult,Y,NR,NR,NR,25,NA,NA,Mixed,NA,NA,NR,TV,68,185,0.37,genital fluid or urine,culture or NAAT,66.9,98,0.537650766,0.054083244,0.435526428,0.644252076,45.69253136,84.98552265
#23000,Mocumbi 2017,MDP,September,2007,August,2009,2017,2008,Mozambique,EA,EA,Rural and peri-urban,Manhica District and Mavalane (Maputo City),Cohort,Convenience,Female,HIV/STI prevention trial participants,"Women who were HIV negative, not pregnant, sexually active in the last month",Adult,N,17 to 59,17,59,29.3,NA,NA,HIV negative,505,0,0,CT,18,470,0.04,genital fluid,NAAT,88.6,99.6,0.040913546,0.010488198,0.022574239,0.063863107,14.59453349,356.7164186
#23000,Mocumbi 2017,MDP,September,2007,August,2009,2017,2008,Mozambique,EA,EA,Rural and peri-urban,Manhica District and Mavalane (Maputo City),Cohort,Convenience,Female,HIV/STI prevention trial participants,"Women who were HIV negative, not pregnant, sexually active in the last month",Adult,N,17 to 59,17,59,29.3,NA,NA,HIV negative,505,0,0,NG,10,470,0.02,genital fluid,NAAT,93.3,99.2,0.016592481,0.007402474,0.004283519,0.033101376,4.940857647,297.7769107
#23000,Mocumbi 2017,MDP,September,2007,August,2009,2017,2008,Mozambique,EA,EA,Rural and peri-urban,Manhica District and Mavalane (Maputo City),Cohort,Convenience,Female,HIV/STI prevention trial participants,"Women who were HIV negative, not pregnant, sexually active in the last month",Adult,N,17 to 59,17,59,29.3,NA,NA,HIV negative,505,0,0,TV,37,456,0.08,genital fluid,culture,68.8,100,0.120782429,0.018356917,0.086786266,0.159509881,38.06312005,315.137892
#21497,Alexandre 2015,NA,December,2011,November,2012,2015,2012,Angola,CA,CA,Urban,Luanda,RCT,Convenience,Female,PHC/OPD attendees,Women attending maternal and newborn check-ups,Adult,Y,14 to 52,14,52,25,NA,NA,Mixed,NA,NA,NR,CT,8,311,0.025723473,genital fluid,NAAT,88.6,99.6,0.028041603,0.010608445,0.010583954,0.051410685,6.791253111,242.1849143
#21497,Alexandre 2015,NA,December,2011,November,2012,2015,2012,Angola,CA,CA,Urban,Luanda,RCT,Convenience,Female,PHC/OPD attendees,Women attending maternal and newborn check-ups,Adult,Y,14 to 52,14,52,25,NA,NA,Mixed,NA,NA,NR,NG,2,311,0.006430868,genital fluid,NAAT,93.3,99.2,0.005643019,0.005165287,0.0001233,0.018771095,1.186796749,210.3123856
#26567,Downs 2012,NA,January,2010,August,2011,2012,2010,Tanzania,EA,EA,Rural,Lake Victoria,Cross sectional,Consecutive,Female,PHC/OPD attendees,"Women seeking routine pre-natal, post-natal, or pediatric care for themselves or newborn children",Adult,Y,18 to 50,18,50,NA,30,24-36,Mixed,345,21,6.09E-02,CT,15,345,0.043478261,genital fluid,NAAT,88.6,99.6,0.047981704,0.01306882,0.02561519,0.075470253,12.83287233,267.4534512
#26567,Downs 2012,NA,January,2010,August,2011,2012,2010,Tanzania,EA,EA,Rural,Lake Victoria,Cross sectional,Consecutive,Female,PHC/OPD attendees,"Women seeking routine pre-natal, post-natal, or pediatric care for themselves or newborn children",Adult,Y,18 to 50,18,50,NA,30,24-36,Mixed,345,21,6.09E-02,NG,1,345,0.002898551,genital fluid,NAAT,93.3,99.2,0.003872885,0.003870495,8.62E-05,0.014465689,0.997357257,257.5231006
#23881,Venkatesh 2011,Methods for Improving Reproductive Health in Africa (MIRA),September,2003,September,2005,2011,2004,South Africa,SA,SA,Urban,"Durban, Johannesburg",RCT,Convenience,Female,HIV/STI prevention trial participants,"Women recruited from general community, family planning clinics and general health clinics. Sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,2493,0,0,CT,146,2493,0.058563979,urine,NAAT,87,99.8,0.065571713,0.005426999,0.055405152,0.07660417,136.4142175,2080.382077
#23881,Venkatesh 2011,Methods for Improving Reproductive Health in Africa (MIRA),September,2003,September,2005,2011,2004,South Africa,SA,SA,Urban,"Durban, Johannesburg",RCT,Convenience,Female,HIV/STI prevention trial participants,"Women recruited from general community, family planning clinics and general health clinics. Sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,2493,0,0,NG,18,2493,0.007220217,urine,NAAT,91.6,100,0.008323839,0.001904093,0.005075099,0.012425654,18.95138632,2276.760328
#23881,Venkatesh 2011,Methods for Improving Reproductive Health in Africa (MIRA),September,2003,September,2005,2011,2004,South Africa,SA,SA,Urban,"Durban, Johannesburg",RCT,Convenience,Female,HIV/STI prevention trial participants,"Women recruited from general community, family planning clinics and general health clinics. Sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,2493,0,0,TV,86,2493,0.03449659,urine,NAAT,66.9,98.3,0.027299092,0.005718737,0.01729538,0.039090631,22.16539248,811.9461497
#23881,Venkatesh 2011,Methods for Improving Reproductive Health in Africa (MIRA),September,2003,September,2005,2011,2004,Zimbabwe,EA,EA,Urban,Harare,RCT,Convenience,Female,HIV/STI prevention trial participants,"Women recruited from general community, family planning clinics and general health clinics. Sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,2455,0,0,CT,37,2455,0.015,urine,NAAT,87,99.8,0.015481502,0.002874514,0.010238043,0.021629112,28.55756104,1844.624665
#23881,Venkatesh 2011,Methods for Improving Reproductive Health in Africa (MIRA),September,2003,September,2005,2011,2004,Zimbabwe,EA,EA,Urban,Harare,RCT,Convenience,Female,HIV/STI prevention trial participants,"Women recruited from general community, family planning clinics and general health clinics. Sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,2455,0,0,NG,5,2455,0.002,urine,NAAT,91.6,100,0.002660196,0.001091312,0.000948163,0.005210071,5.926152798,2227.712921
#23881,Venkatesh 2011,Methods for Improving Reproductive Health in Africa (MIRA),September,2003,September,2005,2011,2004,Zimbabwe,EA,EA,Urban,Harare,RCT,Convenience,Female,HIV/STI prevention trial participants,"Women recruited from general community, family planning clinics and general health clinics. Sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,2455,0,0,TV,64,2455,0.026,urine,NAAT,66.9,98.3,0.014546527,0.00498673,0.00531621,0.024839951,8.385385338,576.4527224
#22441,Jewanraj 2021,CAPRISA 008,November,2012,October,2014,2021,2013,South Africa,SA,SA,Mixed,"eThekwini and Vulindlela, KwaZulu Natal",RCT,Consecutive,Female,HIV/STI prevention trial participants,Women who previously participated in an ARV prevention study,Adult,Y,20 to 44,20,44,NA,28,25-33,HIV negative,137,0,0,CT,10,135,0.074074074,genital fluid,NAAT,88.6,99.6,0.08673373,0.025984764,0.043351743,0.143779412,10.17503528,117.3134755
#22441,Jewanraj 2021,CAPRISA 008,November,2012,October,2014,2021,2013,South Africa,SA,SA,Mixed,"eThekwini and Vulindlela, KwaZulu Natal",RCT,Consecutive,Female,HIV/STI prevention trial participants,Women who previously participated in an ARV prevention study,Adult,Y,20 to 44,20,44,NA,28,25-33,HIV negative,137,0,0,NG,5,137,0.03649635,genital fluid,NAAT,93.3,99.2,0.038633253,0.018419582,0.009814491,0.080232917,4.229140481,109.4689198
#22441,Jewanraj 2021,CAPRISA 008,November,2012,October,2014,2021,2013,South Africa,SA,SA,Mixed,"eThekwini and Vulindlela, KwaZulu Natal",RCT,Consecutive,Female,HIV/STI prevention trial participants,Women who previously participated in an ARV prevention study,Adult,Y,20 to 44,20,44,NA,28,25-33,HIV negative,137,0,0,TV,6,135,0.044444444,genital fluid,NAAT,95,98,0.033896694,0.019311866,0.004491422,0.07797354,2.976389653,87.8076678
#23067,Msuya 2009,NA,June,2002,March,2004,2009,2003,Tanzania,EA,EA,Urban,Moshi,Cohort,Consecutive,Female,ANC attendees,Pregnant women in their third trimester,Adult,Y,14 to 43,14,43,NA,24,NA,Mixed,2654,184,6.93E-02,NG,13,2555,0.005088063,genital fluid,culture,75.7,100,0.007242692,0.001931865,0.003889369,0.011465699,13.95370537,1926.591017
#23067,Msuya 2009,NA,June,2002,March,2004,2009,2003,Tanzania,EA,EA,Urban,Moshi,Cohort,Consecutive,Female,ANC attendees,Pregnant women in their third trimester,Adult,Y,14 to 43,14,43,NA,24,NA,Mixed,2654,184,6.93E-02,TV,129,2555,0.050489237,genital fluid,WM,52,100,0.097789289,0.008282264,0.082397841,0.114647544,125.7744439,1286.178119
#25839,Ebhodaghe 2017,NA,November,2014,April,2016,2017,2015,Nigeria,WA,WA,Mixed,"Akure and Ifedore, Ondo State",Cross sectional,Convenience,Female,ANC attendees,Pregnant women who attended the antenatal clinics of selected study centres,Adult,Y,19 to 43,19,43,29.05,NA,NA,HIV negative,126,0,0,CT,4,126,0.031746032,genital fluid,ELISA,65,100,0.059994261,0.026677874,0.019582173,0.122764696,4.753872194,79.23878208
#25839,Ebhodaghe 2017,NA,November,2014,April,2016,2017,2015,Nigeria,WA,WA,Mixed,"Akure and Ifedore, Ondo State",Cross sectional,Convenience,Female,ANC attendees,Pregnant women who attended the antenatal clinics of selected study centres,Adult,Y,19 to 43,19,43,29.05,NA,NA,HIV negative,126,0,0,NG,2,126,0.015873016,genital fluid,culture,75.7,100,0.030708696,0.017679887,0.005979271,0.074586772,2.924274137,95.22625569
#25839,Ebhodaghe 2017,NA,November,2014,April,2016,2017,2015,Nigeria,WA,WA,Mixed,"Akure and Ifedore, Ondo State",Cross sectional,Convenience,Female,ANC attendees,Pregnant women who attended the antenatal clinics of selected study centres,Adult,Y,19 to 43,19,43,29.05,NA,NA,HIV negative,126,0,0,TV,4,126,0.031746032,genital fluid,WM,52,100,0.075066047,0.032772501,0.02481231,0.152356515,4.852646267,64.64502228
#23844,van de Wijgert 2009,Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV),November,1999,January,2004,2009,2002,Uganda,EA,EA,Urban,Kampala,Cohort,Convenience,Female,FP attendees,"Women seeking reproductive and general healthcare services from familt planning clinics and mother-child clinics, and smaller high risk group (~10% of sample) from STI or primary healthcare clinics (women with STI symptoms), sex worker networks, or military bases.",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,2199,0,0,CT,64,2199,0.029,genital fluid,NAAT,88.6,99.6,0.028988217,0.004134464,0.021369596,0.037482875,47.73414933,1646.67419
#23844,van de Wijgert 2009,Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV),November,1999,January,2004,2009,2002,Uganda,EA,EA,Urban,Kampala,Cohort,Convenience,Female,FP attendees,"Women seeking reproductive and general healthcare services from familt planning clinics and mother-child clinics, and smaller high risk group (~10% of sample) from STI or primary healthcare clinics (women with STI symptoms), sex worker networks, or military bases.",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,2199,0,0,NG,40,2199,0.018,genital fluid,NAAT,93.3,99.2,0.011488906,0.003031736,0.005920165,0.017762529,14.19567866,1235.598839
#23844,van de Wijgert 2009,Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV),November,1999,January,2004,2009,2002,Uganda,EA,EA,Urban,Kampala,Cohort,Convenience,Female,FP attendees,"Women seeking reproductive and general healthcare services from familt planning clinics and mother-child clinics, and smaller high risk group (~10% of sample) from STI or primary healthcare clinics (women with STI symptoms), sex worker networks, or military bases.",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,2199,0,0,TV,57,2199,0.026,genital fluid,WM,52,100,0.050607264,0.006595433,0.038694199,0.06426824,55.89655426,1104.516416
#23844,van de Wijgert 2009,Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV),November,1999,January,2004,2009,2002,Zimbabwe,EA,EA,Urban and peri-urban,Harare and Chitungwiza,Cohort,Convenience,Female,FP attendees,Women seeking reproductive and general healthcare services from family planning clinics and mother-child clinics,Adult,Y,18 to 35,18,35,26,NA,NA,HIV negative,2240,0,0,CT,67,2240,0.03,genital fluid,NAAT,88.6,99.6,0.029911732,0.004036281,0.02272134,0.03805248,53.27600233,1781.107247
#23844,van de Wijgert 2009,Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV),November,1999,January,2004,2009,2002,Zimbabwe,EA,EA,Urban and peri-urban,Harare and Chitungwiza,Cohort,Convenience,Female,FP attendees,Women seeking reproductive and general healthcare services from family planning clinics and mother-child clinics,Adult,Y,18 to 35,18,35,26,NA,NA,HIV negative,2240,0,0,NG,49,2240,0.022,genital fluid,NAAT,93.3,99.2,0.015527023,0.00328611,0.009508526,0.022174179,21.97940483,1415.558176
#23844,van de Wijgert 2009,Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV),November,1999,January,2004,2009,2002,Zimbabwe,EA,EA,Urban and peri-urban,Harare and Chitungwiza,Cohort,Convenience,Female,FP attendees,Women seeking reproductive and general healthcare services from family planning clinics and mother-child clinics,Adult,Y,18 to 35,18,35,26,NA,NA,HIV negative,2240,0,0,TV,92,2240,0.041,genital fluid,WM,52,100,0.079677474,0.008114145,0.064762714,0.096326315,88.74126935,1113.756063
#22619,Kleppa 2015,NA,NR,2010,NR,2012,2015,2011,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Convenience,Female,Students,Sexually active women in final years of high school,Adult,Y,15 to 31,15,31,19.1,NA,NA,Mixed,572,159,0.277972028,CT,144,569,0.253075571,genital fluid,NAAT,88.6,99.6,0.283490118,0.020965727,0.242864133,0.326264964,131.0020725,462.104547
#22619,Kleppa 2015,NA,NR,2010,NR,2012,2015,2011,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Convenience,Female,Students,Sexually active women in final years of high school,Adult,Y,15 to 31,15,31,19.1,NA,NA,Mixed,572,159,0.277972028,NG,108,568,0.190140845,genital fluid,NAAT,93.3,99.2,0.197991579,0.017893639,0.164526203,0.233604932,98.19175988,495.9390723
#22619,Kleppa 2015,NA,NR,2010,NR,2012,2015,2011,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Convenience,Female,Students,Sexually active women in final years of high school,Adult,Y,15 to 31,15,31,19.1,NA,NA,Mixed,572,159,0.277972028,TV,127,594,0.213804714,genital fluid,NAAT,95,98,0.209394424,0.017636337,0.175883655,0.245982897,111.4482732,532.2408842
#32533,Bailey 2007,MMC Trial 1,February,2002,September,2005,2007,2003,Kenya,EA,EA,Urban,Kisumu,RCT,Convenience,Male,HIV/STI prevention trial participants,Uncircumcised men recruited from community and public/private clinics,Youth,Y,18 to 24,18,24,NA,20,19-22,HIV negative,2784,0,0,CT,128,2753,0.05,urine,NAAT,87.8,99.3,0.045734787,0.004547032,0.037260349,0.055117448,96.53981321,2110.861771
#32533,Bailey 2007,MMC Trial 1,February,2002,September,2005,2007,2003,Kenya,EA,EA,Urban,Kisumu,RCT,Convenience,Male,HIV/STI prevention trial participants,Uncircumcised men recruited from community and public/private clinics,Youth,Y,18 to 24,18,24,NA,20,19-22,HIV negative,2784,0,0,NG,57,2754,0.02,urine,NAAT,80.9,99.9,0.024767122,0.003417378,0.018490321,0.031774299,51.22398117,2068.225006
#32533,Bailey 2007,MMC Trial 1,February,2002,September,2005,2007,2003,Kenya,EA,EA,Urban,Kisumu,RCT,Convenience,Male,HIV/STI prevention trial participants,Uncircumcised men recruited from community and public/private clinics,Youth,Y,18 to 24,18,24,NA,20,19-22,HIV negative,2784,0,0,TV,58,2759,0.02,urine,culture,87.6,100,0.024423554,0.003128906,0.018683669,0.030964531,59.44208078,2433.801467
#23630,Shukla 2023,NA,NR,2011,NR,2013,2023,2012,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Convenience,Female,Students,"Sexually active, school-attending women from randomly selected secondary schools",Youth,Y,16 to 22,16,22,18.7,NA,NA,Mixed,NA,NA,NR,CT,181,638,0.284,genital fluid,NAAT,88.6,99.6,0.317950161,0.019977772,0.278926277,0.357316984,172.7587684,543.3517246
#23630,Shukla 2023,NA,NR,2011,NR,2013,2023,2012,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Convenience,Female,Students,"Sexually active, school-attending women from randomly selected secondary schools",Youth,Y,16 to 22,16,22,18.7,NA,NA,Mixed,NA,NA,NR,NG,76,638,0.119,genital fluid,NAAT,93.3,99.2,0.121476518,0.013890439,0.096354455,0.149405222,67.19022727,553.1128853
#23630,Shukla 2023,NA,NR,2011,NR,2013,2023,2012,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Convenience,Female,Students,"Sexually active, school-attending women from randomly selected secondary schools",Youth,Y,16 to 22,16,22,18.7,NA,NA,Mixed,NA,NA,NR,TV,113,632,0.181,genital fluid,NAAT,95,98,0.171663775,0.016443075,0.140590468,0.205309771,90.28132238,525.9194732
#23401,Price 2024,NA,January,2018,August,2019,2024,2018,South Africa,SA,SA,Urban,"Rustenberg, North West",Cross sectional,Convenience,Female,Community members,"HIV-negative, non-pregnant female and male adolescents recruited from community",Youth,Y,12 to 19,12,19,NA,18,14-18,HIV negative,78,0,0,CT,18,78,0.231,genital fluid,NAAT,88.6,99.6,0.265006638,0.052756667,0.168145699,0.377030977,18.54565712,69.9818589
#23401,Price 2024,NA,January,2018,August,2019,2024,2018,South Africa,SA,SA,Urban,"Rustenberg, North West",Cross sectional,Convenience,Female,Community members,"HIV-negative, non-pregnant female and male adolescents recruited from community",Youth,Y,12 to 19,12,19,NA,18,14-18,HIV negative,78,0,0,NG,5,78,0.064,genital fluid,NAAT,93.3,99.2,0.071708094,0.031489981,0.021495663,0.143109251,4.813667998,67.12865639
#23401,Price 2024,NA,January,2018,August,2019,2024,2018,South Africa,SA,SA,Urban,"Rustenberg, North West",Cross sectional,Convenience,Male,Community members,"HIV-negative, non-pregnant female and male adolescents recruited from community",Youth,Y,12 to 19,12,19,NA,16,14-19,HIV negative,41,0,0,CT,4,41,0.098,urine,NAAT,87.8,99.3,0.124029169,0.054665892,0.03646174,0.24742474,4.509251283,36.35637748
#23401,Price 2024,NA,January,2018,August,2019,2024,2018,South Africa,SA,SA,Urban,"Rustenberg, North West",Cross sectional,Convenience,Male,Community members,"HIV-negative, non-pregnant female and male adolescents recruited from community",Youth,Y,12 to 19,12,19,NA,16,14-19,HIV negative,41,0,0,NG,1,41,0.024,urine,NAAT,80.9,99.9,0.056395524,0.039222518,0.006844596,0.155644071,1.950780132,34.59104518
#21532,Apea-Kubi 2004,Apea,November,2000,December,2001,2004,2001,Ghana,WA,WA,Urban,Accra,Cross sectional,NR,Female,ANC attendees,Pregnant women newly registered for ANC,Adult,Y,16+,16,NR,29.6,NA,NA,Mixed,NA,NA,NR,CT,9,261,0.034482759,genital fluid,NAAT,88.6,99.6,0.03858073,0.01343221,0.016259394,0.06753245,7.931562766,205.5835344
#21532,Apea-Kubi 2004,Apea,November,2000,December,2001,2004,2001,Ghana,WA,WA,Urban,Accra,Cross sectional,NR,Female,ANC attendees,Pregnant women newly registered for ANC,Adult,Y,16+,16,NR,29.6,NA,NA,Mixed,NA,NA,NR,NG,1,261,0.003831418,genital fluid,NAAT,93.3,99.2,0.005362461,0.004969042,0.000180985,0.018563565,1.15837109,216.0148477
#32490,Apea-Kubi 2005,Apea,November,2001,December,2002,2005,2002,Ghana,WA,WA,Urban,Accra,Cross sectional,NR,Female,ANC attendees,Pregnant women newly registered for ANC,Adult,Y,16+,16,NR,29.6,NA,NA,Mixed,NA,NA,NR,TV,10,294,0.034,genital fluid,WM,52,100,0.071614394,0.021846707,0.034310618,0.120792837,9.976014138,139.3018025
#22590,Kiene 2017,NA,April,2010,October,2011,2017,2011,Uganda,EA,EA,Rural,Butambala,Cross sectional,Convenience,Female,PHC/OPD attendees,Attendees of hospital outpatient for HIV counselling and testing,Adult,Y,18+,18,NR,32.21,NA,NA,Mixed,165,21,0.127,CT,4,165,0.025,urine,NAAT,87,99.8,0.032222087,0.015024135,0.009495287,0.067092208,4.451476276,138.149843
#22590,Kiene 2017,NA,April,2010,October,2011,2017,2011,Uganda,EA,EA,Rural,Butambala,Cross sectional,Convenience,Female,PHC/OPD attendees,Attendees of hospital outpatient for HIV counselling and testing,Adult,Y,18+,18,NR,32.21,NA,NA,Mixed,165,21,0.127,NG,6,165,0.037,urine,NAAT,91.6,100,0.046077355,0.016636622,0.018849203,0.082629703,7.317419461,158.8072826
#22590,Kiene 2017,NA,April,2010,October,2011,2017,2011,Uganda,EA,EA,Rural,Butambala,Cross sectional,Convenience,Male,PHC/OPD attendees,Attendees of hospital outpatient for HIV counselling and testing,Adult,Y,18+,18,NR,34.93,NA,NA,Mixed,160,11,6.90E-02,CT,3,160,0.019,urine,NAAT,87.8,99.3,0.021004026,0.013620839,0.001813656,0.054199412,2.327974664,110.8346895
#22590,Kiene 2017,NA,April,2010,October,2011,2017,2011,Uganda,EA,EA,Rural,Butambala,Cross sectional,Convenience,Male,PHC/OPD attendees,Attendees of hospital outpatient for HIV counselling and testing,Adult,Y,18+,18,NR,34.93,NA,NA,Mixed,160,11,6.90E-02,NG,3,160,0.019,urine,NAAT,80.9,99.9,0.028819054,0.015286748,0.006192178,0.065029511,3.451671233,119.7704538
#32462,Kengne 2010,NA,NR,NR,NR,NR,2010,2007,Cote d'Ivoire,WA,WA,Urban,Institut Pasteur,Cross sectional,NR,Female,ANC attendees,Pregnant women at the Instiut Pasteur,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,25,200,0.125,genital fluid,ELISA,65,100,0.19854649,0.035476056,0.135872384,0.274365171,25.10337461,126.4357515
#32462,Kengne 2010,NA,NR,NR,NR,NR,2010,2007,Cote d'Ivoire,WA,WA,Urban,Institut Pasteur,Cross sectional,NR,Female,ANC attendees,Pregnant women at the Instiut Pasteur,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,4,200,0.02,genital fluid,culture,75.7,100,0.032884457,0.014126334,0.01103537,0.06434744,5.240838431,159.3712909
#32462,Kengne 2010,NA,NR,NR,NR,NR,2010,2007,Cote d'Ivoire,WA,WA,Urban,Institut Pasteur,Cross sectional,NR,Female,ANC attendees,Pregnant women at the Instiut Pasteur,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,40,200,0.2,genital fluid,NAAT,95,98,0.19654146,0.031255853,0.138680697,0.260499533,31.76940798,161.6422709
#23255,Ogilvie 2013,NA,September,2011,October,2011,2013,2011,Uganda,EA,EA,Urban,"Kisenyi, Kampala",Cross sectional,Consecutive,Female,Community members,"Women approached from community, their homes, places of community gathering",Adult,N,26 to 69,26,69,NA,37,32-46,Mixed,199,19,9.55E-02,CT,27,199,0.136,genital fluid,NAAT,88.6,99.6,0.152470567,0.027200119,0.104102606,0.21066568,26.63086065,174.662305
#23255,Ogilvie 2013,NA,September,2011,October,2011,2013,2011,Uganda,EA,EA,Urban,"Kisenyi, Kampala",Cross sectional,Consecutive,Female,Community members,"Women approached from community, their homes, places of community gathering",Adult,N,26 to 69,26,69,NA,37,32-46,Mixed,199,19,9.55E-02,NG,3,199,0.015,genital fluid,NAAT,93.3,99.2,0.014119103,0.009882958,0.001109746,0.038654686,2.012170184,142.5140271
#27382,Chigbu 2006,NA,NR,NR,MR,NR,2006,2003,Nigeria,WA,WA,Urban,Ogbor Hill (Aba),Cross sectional,Random,Female,ANC attendees,Women attending the antenatal clinic,Adult,Y,15 to 65,15,65,NA,NA,NA,Mixed,NA,NA,NR,NG,1,102,0.0098,genital fluid,culture,75.7,100,0.025566848,0.01772306,0.00287552,0.069263025,2.02781816,79.31435849
#27382,Chigbu 2006,NA,NR,NR,MR,NR,2006,2003,Nigeria,WA,WA,Urban,Ogbor Hill (Aba),Cross sectional,Random,Female,ANC attendees,Women attending the antenatal clinic,Adult,Y,15 to 65,15,65,NA,NA,NA,Mixed,NA,NA,NR,TV,5,102,0.049,genital fluid,WM,52,100,0.111161718,0.04441981,0.040892748,0.21185205,5.566469773,50.07542071
#31143,Wokem 2015,NA,NR,2014,NR,2014,2015,2014,Nigeria,WA,WA,Urban,Port Harcourt,Cross sectional,Convenience,Female,ANC attendees,Pregnant women attending two hospitals,Adult,N,11 to 60,11,60,NA,NA,NA,Mixed,NA,NA,NR,TV,14,100,0.14,genital fluid,WM,52,100,0.282637107,0.065825013,0.165854079,0.421637641,13.22559942,46.79357066
#25518,Alexander 2018,NA,NR,2015,NR,2015,2018,2015,Nigeria,WA,WA,Urban,"Ifako Ijaiye, Agege,Shomolu",Cross sectional,Random,Female,ANC attendees,pregnant women attending ANC,Adult,Y,15 to 60,15,60,NA,NA,NA,Mixed,NA,NA,NR,TV,34,300,0.113,genital fluid,WM,52,100,0.222158253,0.035017359,0.158560338,0.293095962,31.30757152,140.9246388
#31154,Samuel 2015,NA,NR,NR,NR,NR,2015,2012,Nigeria,WA,WA,Urban,"Ilorin, Kwara State",Cross sectional,Random,Female,ANC attendees,Pregnant women attending ANC in 5 health facilities,Adult,Y,21 to 50,21,50,NA,NA,NA,Mixed,NA,NA,NR,TV,50,250,0.2,genital fluid,culture and WM,52,100,0.389109413,0.048384212,0.299673302,0.489694572,39.50932074,101.537818
#25314,Ukatu 2019,NA,April,NR,September,NR,2019,2016,Nigeria,WA,WA,Urban,Sokoto metropolis,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending routine ANC,Adult,Y,18 to 45,18,45,NA,NA,NA,Mixed,NA,NA,NR,TV,17,100,0.17,genital fluid or urine,WM,52,100,0.337856002,0.072495019,0.204250845,0.491618389,14.38134113,42.56648113
#21877,Crucitti 2010,NA,NR,NR,NR,NR,2010,2007,Zambia,EA,EA,Urban,Ndola,Cross sectional,Convenience,Female,ANC attendees,Pregnant women attending ANC,Adult,Y,15 to 42,15,42,NA,NA,NA,Mixed,NA,NA,NR,TV,99,307,0.322,genital fluid,NAAT,95,98,0.326116047,0.029324895,0.270714115,0.38327002,83.34058353,255.5549909
#22617,Kleinschmidt 2007,NA,August,1999,May,2001,2007,2000,South Africa,SA,SA,Peri-urban,Orange Farm,Cohort,NR,Female,FP attendees,Women attending famliy planning who were sexually active in past 3 months,Adult,Y,18 to 40,18,40,27.7,NA,NA,HIV negative,554,0,0,NG,21,539,0.039,urine,NAAT,91.6,100,0.044127082,0.009316821,0.027704414,0.06437129,21.442483,485.9256997
#22617,Kleinschmidt 2007,NA,August,1999,May,2001,2007,2000,South Africa,SA,SA,Peri-urban,Orange Farm,Cohort,NR,Female,FP attendees,Women attending famliy planning who were sexually active in past 3 months,Adult,Y,18 to 40,18,40,27.7,NA,NA,HIV negative,554,0,0,TV,41,545,0.075,genital fluid,culture,68.8,100,0.111334632,0.01633547,0.080950867,0.145203683,41.27960646,370.770583
#26665,Thigpen 2012,"TDF-1, TDF-2",February,2007,October,2009,2012,2008,Botswana,SA,SA,Urban,Francistown and Gabarone,RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-seronegative, sexually active adults, recuruited from community venues",Adult,Y,18 to 39,18,39,NA,NA,NA,HIV negative,557,0,0,TV,33,504,0.0655,genital fluid,culture and WM,52,100,0.129071125,0.021121774,0.090972376,0.171883948,32.52221363,251.9712572
#26665,Thigpen 2012,"TDF-1, TDF-2",February,2007,October,2009,2012,2008,Botswana,SA,SA,Urban,Francistown and Gabarone,RCT,Convenience,Both sexes,HIV/STI prevention trial participants,"HIV-seronegative, sexually active adults, recuruited from community venues",Adult,Y,18 to 39,18,39,NA,NA,NA,HIV negative,1219,0,0,CT,97,1144,0.085,"genital fluid (women), urine (men)",NAAT,88.2,99.45,0.091334278,0.00951827,0.073476229,0.110183421,83.66728763,916.0557191
#26665,Thigpen 2012,"TDF-1, TDF-2",February,2007,October,2009,2012,2008,Botswana,SA,SA,Urban,Francistown and Gabarone,RCT,Convenience,Both sexes,HIV/STI prevention trial participants,"HIV-seronegative, sexually active adults, recuruited from community venues",Adult,Y,18 to 39,18,39,NA,NA,NA,HIV negative,1219,0,0,NG,24,1143,0.021,"genital fluid (women), urine (men)",NAAT,87.1,99.55,0.020007926,0.004959441,0.011427694,0.030525896,15.95002134,797.1851563
#21922,De Jongh 2010,NA,NR,NR,NR,NR,2010,2007,South Africa,SA,SA,Peri-urban,Pretoria,Cross sectional,NR,Female,GYN attendees,Women presenting for termination of pregnancy,Adult,Y,13 to 41,13,41,27,NA,NA,Mixed,NA,NA,NR,CT,28,200,0.14,genital fluid,NAAT,88.6,99.6,0.158177632,0.027625872,0.107703772,0.213217679,27.59806407,174.4751378
#21922,De Jongh 2010,NA,NR,NR,NR,NR,2010,2007,South Africa,SA,SA,Peri-urban,Pretoria,Cross sectional,NR,Female,GYN attendees,Women presenting for termination of pregnancy,Adult,Y,13 to 41,13,41,27,NA,NA,Mixed,NA,NA,NR,NG,9,200,0.045,genital fluid,NAAT,93.3,99.2,0.045054881,0.016367546,0.017508175,0.081123713,7.235940423,160.6028094
#21922,De Jongh 2010,NA,NR,NR,NR,NR,2010,2007,South Africa,SA,SA,Peri-urban,Pretoria,Cross sectional,NR,Female,GYN attendees,Women presenting for termination of pregnancy,Adult,Y,13 to 41,13,41,27,NA,NA,Mixed,NA,NA,NR,TV,25,200,0.125,genital fluid,NAAT,95,98,0.116951268,0.025172336,0.071000928,0.170421373,19.06107932,162.9830931
#25517,Kashibu 2018,NA,July,2017,September,2017,2018,2017,Nigeria,WA,WA,Urban,"Jalingo, Taraba State",Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending first ANC,Adult,Y,15 to 39,15,39,27,NA,NA,Mixed,NA,NA,NR,TV,4,90,0.044,genital fluid,WM,52,100,0.104732803,0.044195862,0.035187746,0.209503383,5.027532888,48.0034213
#23134,Nakubulwa 2015,NA,June,2013,November,2013,2015,2013,Uganda,EA,EA,Urban,Kampala,Case control,Consecutive,Female,ANC attendees,women >= 28 weeks gestation,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,174,24,0.138,CT,6,174,0.034482759,genital fluid,rapid antigen test,56,99,0.054003365,0.027859734,0.011453862,0.117372176,3.554490102,65.81978899
#23134,Nakubulwa 2015,NA,June,2013,November,2013,2015,2013,Uganda,EA,EA,Urban,Kampala,Case control,Consecutive,Female,ANC attendees,women >= 28 weeks gestation,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,174,24,0.138,TV,25,174,0.143678161,genital fluid,NAAT and WM,52,100,0.28304378,0.051036888,0.188986381,0.388147863,22.05116324,77.90725255
#22243,Gray 2009,MMC Trial 2,NR,2004,December,2006,2009,2005,Uganda,EA,EA,Rural,Rakai,RCT,Convenience,Female,Community members,"Women married to men participating as uncircumcised controls in MMC trial, one year after trial enrolment",Adult,Y,15 to 49,15,49,NA,NA,NA,HIV negative,402,0,0,TV,45,402,0.112,genital fluid,culture,68.8,100,0.165379279,0.022683413,0.123586631,0.211743296,44.36439247,268.2584703
#23358,Peters 2014,NA,November,2011,February,2012,2014,2011,South Africa,SA,SA,Rural,"Mopani District, Limpopo Province",Cross sectional,Consecutive,Female,PHC/OPD attendees,"Women sexually active during the last 6 months, regardless of reason for visiting PHC",Adult,Y,18 to 49,18,49,NA,30,NA,Mixed,461,187,0.41,CT,100,603,0.16,genital fluid,NAAT,88.6,99.6,0.184482729,0.0176143,0.150506874,0.220288893,89.45689066,484.906587
#23358,Peters 2014,NA,November,2011,February,2012,2014,2011,South Africa,SA,SA,Rural,"Mopani District, Limpopo Province",Cross sectional,Consecutive,Female,PHC/OPD attendees,"Women sexually active during the last 6 months, regardless of reason for visiting PHC",Adult,Y,18 to 49,18,49,NA,30,NA,Mixed,461,187,0.41,NG,60,603,0.1,genital fluid,NAAT,93.3,99.2,0.100315297,0.013448407,0.076045521,0.128302102,50.05909635,499.0175761
#21956,Dessai 2020,NA,November,2017,June,2018,2020,2018,South Africa,SA,SA,Urban,Durban,Cross sectional,Convenience,Female,ANC attendees,Women presenting for ANC,Adult,Y,18 to 43,18,43,28.5,28,24-33,Mixed,142,59,0.415492958,TV,28,271,0.103321033,genital fluid,NAAT,95,98,0.092704178,0.019766691,0.056741135,0.134689799,19.95627883,215.2683859
#23846,van de Wijgert 2006,NA,January,2002,August,2002,2006,2002,South Africa,SA,SA,Peri-urban,"Gugulethu, Cape Town",Cross sectional,Convenience,Female,PHC/OPD attendees,"Sexually active, non-pregnant attendees of community health centre for reasons other than to seek care for an STI or vaginal infection",Adult,N,18 to 69,18,69,30.6,NA,NA,Mixed,NA,NA,NR,CT,28,300,0.092,genital fluid,NAAT,88.6,99.6,0.10450551,0.019335443,0.069219762,0.144850376,26.15971713,250.3190225
#23846,van de Wijgert 2006,NA,January,2002,August,2002,2006,2002,South Africa,SA,SA,Peri-urban,"Gugulethu, Cape Town",Cross sectional,Convenience,Female,PHC/OPD attendees,"Sexually active, non-pregnant attendees of community health centre for reasons other than to seek care for an STI or vaginal infection",Adult,N,18 to 69,18,69,30.6,NA,NA,Mixed,NA,NA,NR,NG,17,300,0.055,genital fluid,NAAT,93.3,99.2,0.055853832,0.014820231,0.029759098,0.087762114,13.41019883,240.0945171
#23846,van de Wijgert 2006,NA,January,2002,August,2002,2006,2002,South Africa,SA,SA,Peri-urban,"Gugulethu, Cape Town",Cross sectional,Convenience,Female,PHC/OPD attendees,"Sexually active, non-pregnant attendees of community health centre for reasons other than to seek care for an STI or vaginal infection",Adult,N,18 to 69,18,69,30.6,NA,NA,Mixed,NA,NA,NR,TV,33,300,0.11,genital fluid,culture,68.8,100,0.163966682,0.026004018,0.116566629,0.219217001,33.23945332,202.7207777
#23576,Schonfeld 2018,NA,May,2014,September,2015,2018,2014,Ethiopia,EA,EA,Mixed,"Asella, Central Ethiopia",Cohort,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,NR,NR,NR,25.8,NA,NA,Mixed,580,12,2.10E-02,CT,57,580,0.098275862,genital fluid,rapid antigen test,56,99,0.162777968,0.022472477,0.121190036,0.208333423,43.9268452,269.8574375
#23576,Schonfeld 2018,NA,May,2014,September,2015,2018,2014,Ethiopia,EA,EA,Mixed,"Asella, Central Ethiopia",Cohort,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,NR,NR,NR,25.8,NA,NA,Mixed,580,12,2.10E-02,NG,25,580,0.043103448,genital fluid,rapid antigen test,70,96,0.013528247,0.010163421,0.000618163,0.038189429,1.747784442,129.1951891
#23576,Schonfeld 2018,NA,May,2014,September,2015,2018,2014,Ethiopia,EA,EA,Mixed,"Asella, Central Ethiopia",Cohort,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,NR,NR,NR,25.8,NA,NA,Mixed,580,12,2.10E-02,TV,31,580,0.053448276,genital fluid,rapid antigen test,83.3,98.8,0.05255934,0.011414632,0.031630034,0.076366337,20.08759694,382.188909
#22188,Ghebremichael 2009,Moshi Infertility survey,November,2002,March,2003,2009,2003,Tanzania,EA,EA,Urban,Moshi,Cross sectional,Random,Female,Community members,Community-based infertility study,Adult,Y,20 to 44,20,44,NA,NA,NA,Mixed,1418,164,0.116,CT,22,1440,0.015,urine,NAAT,87,99.8,0.016099185,0.003823153,0.00938515,0.024025522,17.44679897,1083.70698
#22188,Ghebremichael 2009,Moshi Infertility survey,November,2002,March,2003,2009,2003,Tanzania,EA,EA,Urban,Moshi,Cross sectional,Random,Female,Community members,Community-based infertility study,Adult,Y,20 to 44,20,44,NA,NA,NA,Mixed,1418,164,0.116,NG,3,1440,0.002,urine,NAAT,91.6,100,0.003046779,0.001556515,0.000832846,0.006652074,3.81988459,1253.745145
#22188,Ghebremichael 2009,Moshi Infertility survey,November,2002,March,2003,2009,2003,Tanzania,EA,EA,Urban,Moshi,Cross sectional,Random,Female,Community members,Community-based infertility study,Adult,Y,20 to 44,20,44,NA,NA,NA,Mixed,1418,164,0.116,TV,156,1440,0.108,urine,NAAT,66.9,98.3,0.140733528,0.012506856,0.11727802,0.165453014,108.7994459,773.0883143
#21805,Chersich 2009,NA,March,2006,August,2006,2009,2006,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,PHC/OPD attendees,"Postpartum women bringing infant for immunization and well-child services or for acute paediatric care,  4 weeks to 1 year after childbirth",Adult,Y,16 to 45,16,45,25.5,NA,NA,Mixed,496,54,0.11,TV,35,454,0.077092511,genital fluid,WM,52,100,0.151573807,0.024902951,0.107105509,0.204151657,31.43118465,207.3655425
#22061,Enwuru 2024,NA,April,2019,September,2020,2024,2020,Nigeria,WA,WA,Urban,Lagos,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women attending ANC,Adult,Y,15+,15,NR,28.11,NA,NA,HIV negative,232,0,0,TV,48,232,0.206896552,genital fluid,WM,52,100,0.402294672,0.05079123,0.305057211,0.506545542,37.49714752,93.20816331
#22474,Kaida 2018,AYAZAZI,November,2014,April,2016,2018,2015,South Africa,SA,SA,Urban,Durban and Soweto,Cohort,Convenience,Female,Community members,Adolescents from community,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,198,10,5.10E-02,CT,36,198,0.182,genital fluid,NAAT,88.6,99.6,0.20518187,0.030390913,0.148638184,0.267141058,36.22915777,176.5709505
#22474,Kaida 2018,AYAZAZI,November,2014,April,2016,2018,2015,South Africa,SA,SA,Urban,Durban and Soweto,Cohort,Convenience,Female,Community members,Adolescents from community,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,198,10,5.10E-02,NG,14,198,0.071,genital fluid,NAAT,93.3,99.2,0.072474753,0.020301158,0.03802402,0.116231643,11.82109244,163.1063513
#22474,Kaida 2018,AYAZAZI,November,2014,April,2016,2018,2015,South Africa,SA,SA,Urban,Durban and Soweto,Cohort,Convenience,Female,Community members,Adolescents from community,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,198,10,5.10E-02,TV,16,198,0.081,genital fluid,NAAT,95,98,0.069932563,0.021097674,0.033366668,0.115035496,10.21890083,146.1250725
#23849,van der Veer 2024,NA,August,2021,March,2022,2024,2021,Malawi,EA,EA,Urban,Blantyre,Case control,Consecutive,Female,ANC and GYN attendees,"All women who delivered at or presented to QECH [Queen Elixabeth Central Hospital, Blantyre] within 48 hours after birth",Adult,Y,NR,NR,NR,NA,24,19.5-30,Mixed,510,84,0.164,CT,14,507,0.027,genital fluid,NAAT,88.6,99.6,0.028831996,0.008340489,0.014162484,0.046799169,11.60541727,402.518689
#23849,van der Veer 2024,NA,August,2021,March,2022,2024,2021,Malawi,EA,EA,Urban,Blantyre,Case control,Consecutive,Female,ANC and GYN attendees,"All women who delivered at or presented to QECH [Queen Elixabeth Central Hospital, Blantyre] within 48 hours after birth",Adult,Y,NR,NR,NR,NA,24,19.5-30,Mixed,510,84,0.164,NG,16,507,0.031,genital fluid,NAAT,93.3,99.2,0.027478639,0.008551817,0.012931287,0.045974483,10.04090445,365.4076294
#23849,van der Veer 2024,NA,August,2021,March,2022,2024,2021,Malawi,EA,EA,Urban,Blantyre,Case control,Consecutive,Female,ANC and GYN attendees,"All women who delivered at or presented to QECH [Queen Elixabeth Central Hospital, Blantyre] within 48 hours after birth",Adult,Y,NR,NR,NR,NA,24,19.5-30,Mixed,510,84,0.164,TV,87,507,0.171,genital fluid,NAAT,95,98,0.164257971,0.018224545,0.130903406,0.202138573,67.89093214,413.3189495
#22755,Lingappa 2009,Partners HSV-2/HIV Transmission Study (Partners Study),November,2004,April,2007,2009,2006,"Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia",EA,EA,Mixed,14 sites,RCT,Convenience,Female,HIV/STI prevention trial participants,HIV-negative partner in HIV-1 serodiscordant couple,Adult,Y,18+,18,NR,NA,31,25-38,HIV negative,1120,0,0,CT,19,1120,0.02,genital fluid,NAAT,88.6,99.6,0.01557881,0.00454813,0.007815378,0.025248169,11.55004779,741.3947251
#22755,Lingappa 2009,Partners HSV-2/HIV Transmission Study (Partners Study),November,2004,April,2007,2009,2006,"Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia",EA,EA,Mixed,14 sites,RCT,Convenience,Female,HIV/STI prevention trial participants,HIV-negative partner in HIV-1 serodiscordant couple,Adult,Y,18+,18,NR,NA,31,25-38,HIV negative,1120,0,0,NG,12,1120,0.01,genital fluid,NAAT,93.3,99.2,0.004573544,0.00311071,0.00031183,0.011960596,2.151770393,470.482012
#22755,Lingappa 2009,Partners HSV-2/HIV Transmission Study (Partners Study),November,2004,April,2007,2009,2006,"Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia",EA,EA,Mixed,14 sites,RCT,Convenience,Female,HIV/STI prevention trial participants,HIV-negative partner in HIV-1 serodiscordant couple,Adult,Y,18+,18,NR,NA,31,25-38,HIV negative,1120,0,0,TV,123,1120,0.11,genital fluid,NAAT,95,98,0.09718655,0.009834825,0.078139056,0.11662479,88.16111353,907.1328695
#23168,Ngandjio 2003,NA,May,2001,July,2001,2003,2001,Cameroon,CA,CA,Urban,Yaounde,Cross sectional,Convenience,Female,Students,Volunteer students,Youth,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,24,605,0.0396,genital fluid,DFA and NAAT,82,99.6,0.045579228,0.009638687,0.028269142,0.066405762,21.34214653,468.2428236
#23168,Ngandjio 2003,NA,May,2001,July,2001,2003,2001,Cameroon,CA,CA,Urban,Yaounde,Cross sectional,Convenience,Male,Students,Volunteer students,Youth,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,24,662,0.0362,genital fluid,DFA and NAAT,82,99.2,0.036639429,0.009112441,0.020245246,0.056184789,15.57459624,425.0774869
#22755,Lingappa 2009,Partners HSV-2/HIV Transmission Study (Partners Study),November,2004,April,2007,2009,2006,"Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia",EA,EA,Mixed,14 sites,RCT,Convenience,Male,HIV/STI prevention trial participants,HIV-negative partner in HIV-1 serodiscordant couple,Adult,Y,18+,18,NR,NA,35,30-42,HIV negative,2304,0,0,CT,64,2304,0.03,urine,NAAT,87.8,99.3,0.024421982,0.004010605,0.017037398,0.032815629,36.17463179,1481.232459
#22755,Lingappa 2009,Partners HSV-2/HIV Transmission Study (Partners Study),November,2004,April,2007,2009,2006,"Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia",EA,EA,Mixed,14 sites,RCT,Convenience,Male,HIV/STI prevention trial participants,HIV-negative partner in HIV-1 serodiscordant couple,Adult,Y,18+,18,NR,NA,35,30-42,HIV negative,2304,0,0,NG,11,2304,0.01,urine,NAAT,80.9,99.9,0.005224212,0.001906249,0.002079156,0.009477608,7.471497229,1430.167302
#22755,Lingappa 2009,Partners HSV-2/HIV Transmission Study (Partners Study),November,2004,April,2007,2009,2006,"Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda, Zambia",EA,EA,Mixed,14 sites,RCT,Convenience,Male,HIV/STI prevention trial participants,HIV-negative partner in HIV-1 serodiscordant couple,Adult,Y,18+,18,NR,NA,35,30-42,HIV negative,2304,0,0,TV,157,2304,0.07,urine,NAAT,96,97.7,0.048436826,0.005562984,0.037911316,0.059750914,72.13953371,1489.353032
#22474,Kaida 2018,AYAZAZI,November,2014,April,2016,2018,2015,South Africa,SA,SA,Urban,Durban and Soweto,Cohort,Convenience,Male,Community members,Adolescents from community,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,154,3,0.02,CT,12,154,0.078,urine,NAAT,87.8,99.3,0.087312702,0.024861221,0.045746262,0.142426254,11.25724124,128.9301661
#22474,Kaida 2018,AYAZAZI,November,2014,April,2016,2018,2015,South Africa,SA,SA,Urban,Durban and Soweto,Cohort,Convenience,Male,Community members,Adolescents from community,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,154,3,0.02,NG,2,154,0.013,urine,NAAT,80.9,99.9,0.022503318,0.013524915,0.003674543,0.055848203,2.70607186,120.252127
#22474,Kaida 2018,AYAZAZI,November,2014,April,2016,2018,2015,South Africa,SA,SA,Urban,Durban and Soweto,Cohort,Convenience,Male,Community members,Adolescents from community,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,154,3,0.02,TV,1,154,0.007,urine,NAAT,96,97.7,0.00802053,0.007615118,0.00025832,0.027844513,1.100412669,137.1994948
#32535,Ramjee 2008,HPTN 055,June,2003,October,2004,2008,2004,South Africa,SA,SA,Mixed,Durban and Hlabisa,Cohort,Convenience,Female,HIV/STI prevention trial participants,Women recruited from community meetings and door-to-door visits,Adult,NR,18+,18,NR,NA,29.9,NA,Mixed,479,177.733,0.371050104,CT,35,479,0.074045929,urine,NAAT,87,99.8,0.083945239,0.01369376,0.059193727,0.112481283,34.42453835,410.0832713
#32535,Ramjee 2008,HPTN 055,June,2003,October,2004,2008,2004,South Africa,SA,SA,Mixed,Durban and Hlabisa,Cohort,Convenience,Female,HIV/STI prevention trial participants,Women recruited from community meetings and door-to-door visits,Adult,NR,18+,18,NR,NA,29.9,NA,Mixed,479,177.733,0.371050104,NG,31,479,0.06654071,urine,NAAT,91.6,100,0.072572978,0.01254919,0.050004491,0.099667616,31.01689091,427.3889782
#32535,Ramjee 2008,HPTN 055,June,2003,October,2004,2008,2004,South Africa,SA,SA,Mixed,Durban and Hlabisa,Cohort,Convenience,Female,HIV/STI prevention trial participants,Women recruited from community meetings and door-to-door visits,Adult,NR,18+,18,NR,NA,29.9,NA,Mixed,479,177.733,0.371050104,TV,42,479,0.089586639,genital fluid,WM,52,100,0.171296361,0.02488527,0.126229435,0.222085543,39.26547201,229.2253716
#32535,Ramjee 2008,HPTN 055,June,2003,October,2004,2008,2004,Zambia,EA,EA,Urban,Lusaka,Cohort,Convenience,Female,HIV/STI prevention trial participants,Women recruited from lower middle class socioeconomic communities through community meetings and local family planning clinics,Adult,NR,18+,18,NR,NA,27,NA,Mixed,239,92,0.387,CT,6,239,0.027,urine,NAAT,87,99.8,0.03117866,0.012613853,0.01129082,0.060339577,5.919200481,189.8478144
#32535,Ramjee 2008,HPTN 055,June,2003,October,2004,2008,2004,Zambia,EA,EA,Urban,Lusaka,Cohort,Convenience,Female,HIV/STI prevention trial participants,Women recruited from lower middle class socioeconomic communities through community meetings and local family planning clinics,Adult,NR,18+,18,NR,NA,27,NA,Mixed,239,92,0.387,NG,8,239,0.034,urine,NAAT,91.6,100,0.040959901,0.013450604,0.018794658,0.071397788,8.893464684,217.1261255
#32535,Ramjee 2008,HPTN 055,June,2003,October,2004,2008,2004,Zambia,EA,EA,Urban,Lusaka,Cohort,Convenience,Female,HIV/STI prevention trial participants,Women recruited from lower middle class socioeconomic communities through community meetings and local family planning clinics,Adult,NR,18+,18,NR,NA,27,NA,Mixed,239,92,0.387,TV,8,239,0.037,genital fluid,WM,52,100,0.072137809,0.023543381,0.034101728,0.122786239,8.711074561,120.7560173
#27026,Kamali 2010,NA,June,2003,September,2004,2010,2004,Uganda,EA,EA,Urban,Kampala,RCT,NR,Female,HIV/STI prevention trial participants,Women attending hospital; recruited to participate in trial,Adult,Y,18 to 45,18,45,NA,29,25-33.8,Mixed,180,73,0.4,CT,6,180,0.033,genital fluid,NAAT,88.6,99.6,0.038956448,0.016151614,0.012372836,0.077290387,5.590747856,143.5127717
#27026,Kamali 2010,NA,June,2003,September,2004,2010,2004,Uganda,EA,EA,Urban,Kampala,RCT,NR,Female,HIV/STI prevention trial participants,Women attending hospital; recruited to participate in trial,Adult,Y,18 to 45,18,45,NA,29,25-33.8,Mixed,180,73,0.4,NG,2,180,0.011,genital fluid,NAAT,93.3,99.2,0.011705914,0.0094136,0.000540653,0.035246204,1.528218177,130.5509445
#27026,Kamali 2010,NA,June,2003,September,2004,2010,2004,Uganda,EA,EA,Urban,Kampala,RCT,NR,Female,HIV/STI prevention trial participants,Women attending hospital; recruited to participate in trial,Adult,Y,18 to 45,18,45,NA,29,25-33.8,Mixed,180,73,0.4,TV,11,180,0.061,genital fluid,culture,68.8,100,0.095809356,0.026924741,0.051332015,0.156817255,11.44913811,119.4991663
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Malawi,EA,EA,Urban,"Blantrye, Lilongwe",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,24-33,HIV negative,272,0,0,CT,6,272,0.02,urine,NAAT,87,99.8,0.026862243,0.010365818,0.010372422,0.050409777,6.535091742,243.2816877
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Malawi,EA,EA,Urban,"Blantrye, Lilongwe",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,24-33,HIV negative,272,0,0,NG,13,272,0.05,urine,NAAT,91.6,100,0.056011428,0.014691247,0.030583583,0.087787779,13.7215355,244.977428
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Malawi,EA,EA,Urban,"Blantrye, Lilongwe",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,24-33,HIV negative,272,0,0,TV,28,272,0.1,genital fluid,rapid antigen test,83.3,98.8,0.114644133,0.022457648,0.074214894,0.16269343,23.07241284,201.2524512
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,South Africa,SA,SA,Urban,"Cape Town, Durban, Johannesburg",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,24,21-29,HIV negative,1426,0,0,CT,237,1426,0.17,urine,NAAT,87,99.8,0.189601154,0.01133836,0.167410044,0.21276507,226.6106455,1195.196552
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,South Africa,SA,SA,Urban,"Cape Town, Durban, Johannesburg",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,24,21-29,HIV negative,1426,0,0,NG,55,1426,0.04,urine,NAAT,91.6,100,0.042750209,0.005587183,0.03255445,0.054405386,56.04231262,1310.924879
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,South Africa,SA,SA,Urban,"Cape Town, Durban, Johannesburg",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,24,21-29,HIV negative,1426,0,0,TV,88,1426,0.06,genital fluid,rapid antigen test,83.3,98.8,0.061323399,0.007604933,0.047465677,0.076882562,61.03482324,995.2941991
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Uganda,EA,EA,Urban,Kampala,RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,24-33,HIV negative,253,0,0,CT,25,253,0.1,urine,NAAT,87,99.8,0.114707226,0.022172373,0.07537792,0.161236285,23.69431317,206.5633882
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Uganda,EA,EA,Urban,Kampala,RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,24-33,HIV negative,253,0,0,NG,15,253,0.06,urine,NAAT,91.6,100,0.068613819,0.016692022,0.039310296,0.104042988,15.73747577,229.3630651
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Uganda,EA,EA,Urban,Kampala,RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,24-33,HIV negative,253,0,0,TV,13,253,0.05,genital fluid,rapid antigen test,83.3,98.8,0.052336508,0.017412093,0.022503413,0.090905079,8.561733376,163.5900772
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Zimbabwe,EA,EA,Urban,"Chitungwiza, Harare",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,25-33,HIV negative,678,0,0,CT,48,678,0.07,urine,NAAT,87,99.8,0.080565915,0.011316115,0.059905962,0.103746469,46.60457548,578.4651657
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Zimbabwe,EA,EA,Urban,"Chitungwiza, Harare",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,25-33,HIV negative,678,0,0,NG,26,678,0.04,urine,NAAT,91.6,100,0.043318457,0.008430598,0.028431794,0.060785006,25.25786054,583.0738769
#23338,Palanee-Phillips 2015,ASPIRE / MTN-020,August,2012,June,2014,2015,2013,Zimbabwe,EA,EA,Urban,"Chitungwiza, Harare",RCT,Convenience,Female,HIV/STI prevention trial participants,"HIV-negative, recruited from clinics for treatment of STIs, family planning clinics, post-natal clinics, as well as community-based locations",Adult,Y,18 to 45,18,45,NA,28,25-33,HIV negative,678,0,0,TV,51,678,0.08,genital fluid,rapid antigen test,83.3,98.8,0.078549777,0.012337518,0.055623278,0.103364987,37.35134024,475.511728
#21469,Ajani 2022,NA,February,2019,April,2020,2022,2019,Nigeria,WA,WA,Urban,"Babcock University, Ogun State",Cross sectional,Random,Male,Students,Undergraduate’s male and females students of Babcock University who were sexually active and had no STI symptoms,Adult,Y,15 to 30,15,30,NA,NA,NA,Mixed,NA,NA,NR,TV,14,123,0.114,urine,culture,87.6,100,0.136698021,0.033860766,0.077421252,0.209945752,14.0699848,102.9274945
#21469,Ajani 2022,NA,February,2019,April,2020,2022,2019,Nigeria,WA,WA,Urban,"Babcock University, Ogun State",Cross sectional,Random,Female,Students,Undergraduate’s male and females students of Babcock University who were sexually active and had no STI symptoms,Adult,Y,15 to 30,15,30,NA,NA,NA,Mixed,NA,NA,NR,TV,16,123,0.13,urine,culture,68.8,100,0.198407846,0.043389863,0.119065879,0.289212663,16.7607935,84.47646544
#31636,Donbraye 2010,NA,March,2000,August,2000,2010,2000,Nigeria,WA,WA,Urban,Ibadan,Cross sectional,NR,Female,ANC attendees,pregnant women,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,6,100,0.06,genital fluid,WM,52,100,0.131028022,0.047559588,0.054739451,0.238163184,6.595655749,50.33774941
#22843,Mapingure 2010,NA,June,2002,March,2004,2010,2003,Zimbabwe,EA,EA,Peri-urban,Harare,Cross sectional,Consecutive,Female,ANC attendees,pregnant women in 3rd trimester,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,691,177,0.256,TV,80,680,0.117647059,genital fluid,WM,52,100,0.227931522,0.023338187,0.183808231,0.275374144,73.64281638,323.0918462
#32525,Sagay 2005,NA,April,2002,November,2003,2005,2003,Nigeria,WA,WA,Urban,Jos,Cross sectional,Consecutive,Female,ANC attendees,pregnant women,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,2657,217,8.20E-02,TV,41,2657,0.015430937,genital fluid,WM,52,100,0.030379981,0.004633202,0.022031034,0.040273885,41.68829711,1372.229221
#23633,Siemer 2008,NA,November,2002,February,2003,2008,2003,Ghana,WA,WA,Urban,"Komfo Anokye Teaching Hospital, Kumasi, Ghana",Case control,NR,Female,ANC attendees,Pregnant women (controls),Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,6,248,0.024193548,urine,NAAT,87,99.8,0.030257195,0.011575781,0.011515564,0.056321313,6.625418309,218.970009
#23017,Moodley 2015,SAHAPS,May,2008,June,2010,2015,2009,South Africa,SA,SA,Urban,Durban,Cohort,Consecutive,Female,ANC attendees,first ANC visit,Adult,Y,18+,18,NR,25.5,NA,NA,Mixed,1459,471,0.323,CT,259,1459,0.177518849,genital fluid,NAAT,88.6,99.6,0.197137388,0.011088702,0.176092158,0.218292825,253.75689,1287.20834
#23017,Moodley 2015,SAHAPS,May,2008,June,2010,2015,2009,South Africa,SA,SA,Urban,Durban,Cohort,Consecutive,Female,ANC attendees,first ANC visit,Adult,Y,18+,18,NR,25.5,NA,NA,Mixed,1459,471,0.323,NG,93,1459,0.063742289,genital fluid,NAAT,93.3,99.2,0.060912095,0.007057161,0.047614852,0.075131124,69.96055036,1148.54941
#23017,Moodley 2015,SAHAPS,May,2008,June,2010,2015,2009,South Africa,SA,SA,Urban,Durban,Cohort,Consecutive,Female,ANC attendees,first ANC visit,Adult,Y,18+,18,NR,25.5,NA,NA,Mixed,1459,471,0.323,TV,223,1459,0.152844414,genital fluid,NAAT,95,98,0.143439792,0.010156627,0.123916967,0.164334598,170.8433783,1191.045914
#23449,Ravindran 2021,NA,NR,2009,NR,2015,2021,2012,Kenya,EA,EA,Rural and peri-urban,Western Kenya,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,14+,14,NR,NA,22,19-27,HIV negative,1244,0,0,CT,67,1241,0.053988719,genital fluid,NAAT,88.6,99.6,0.057246697,0.007483783,0.04356125,0.072875555,55.1640988,963.6206458
#23449,Ravindran 2021,NA,NR,2009,NR,2015,2021,2012,Kenya,EA,EA,Rural and peri-urban,Western Kenya,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,14+,14,NR,NA,22,19-27,HIV negative,1244,0,0,NG,29,1204,0.024086379,genital fluid,NAAT,93.3,99.2,0.018351053,0.004722705,0.009914989,0.028196182,14.8216519,807.6731185
#23449,Ravindran 2021,NA,NR,2009,NR,2015,2021,2012,Kenya,EA,EA,Rural and peri-urban,Western Kenya,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,14+,14,NR,NA,22,19-27,HIV negative,1244,0,0,TV,129,1244,0.103697749,genital fluid,WM,52,100,0.200671536,0.016497834,0.169473329,0.233310406,118.2613838,589.3281434
#23761,Tchelougou 2013,NA,June,2010,August,2011,2013,2011,Togo,WA,WA,Urban,Sokode,Cohort,NR,Female,ANC attendees,ANC - hospital,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,11,302,0.036423841,genital fluid,WM,52,100,0.076654291,0.022645055,0.038627703,0.127306917,10.58011794,138.0238176
#22609,Kinuthia 2015,Mama Salama Study,May,2011,June,2013,2015,2012,Kenya,EA,EA,Rural,Western Kenya,Cohort,Consecutive,Female,ANC attendees,From HIV incidence study: enrollment data - women who were HIV negative,Adult,Y,14+,14,NR,NA,22,19-27,HIV negative,1276,0,0,CT,70,1276,0.054858934,genital fluid,NAAT,88.6,99.6,0.058594404,0.007138458,0.045163249,0.073202507,63.42789269,1082.490616
#22609,Kinuthia 2015,Mama Salama Study,May,2011,June,2013,2015,2012,Kenya,EA,EA,Rural,Western Kenya,Cohort,Consecutive,Female,ANC attendees,From HIV incidence study: enrollment data - women who were HIV negative,Adult,Y,14+,14,NR,NA,22,19-27,HIV negative,1276,0,0,NG,32,1276,0.02507837,genital fluid,NAAT,93.3,99.2,0.019203788,0.00491057,0.010662579,0.029398243,14.99991504,781.09148
#22609,Kinuthia 2015,Mama Salama Study,May,2011,June,2013,2015,2012,Kenya,EA,EA,Rural,Western Kenya,Cohort,Consecutive,Female,ANC attendees,From HIV incidence study: enrollment data - women who were HIV negative,Adult,Y,14+,14,NR,NA,22,19-27,HIV negative,1276,0,0,TV,81,1278,0.063380282,genital fluid,WM,52,100,0.123308911,0.012949041,0.099433606,0.150985552,79.49874768,644.712107
#23202,Nkhoma 2017,iLiNS-DYAD-M trial,February,2011,August,2012,2017,2012,Malawi,EA,EA,Rural and peri-urban,Mangochi District,RCT,NR,Female,ANC attendees,one week post delivery; subset of trial maternal supplementation trial,Adult,Y,15+,15,NR,25,NA,NA,Mixed,NA,NA,NR,TV,127,1210,0.104958678,genital fluid,WM,52,100,0.203412858,0.016822735,0.171157568,0.23652441,116.4653901,572.5566776
#23696,Stephen 2017,NA,January,2012,April,2012,2017,2012,Zimbabwe,EA,EA,Urban,"Mbare, Harare",Cross sectional,NR,Female,ANC attendees,First ANC. pregnant women attending polyclinic,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,14,242,0.05785124,genital fluid,NAAT,88.6,99.6,0.064527497,0.017847741,0.033528786,0.10271941,12.22796408,189.5000532
#21788,Chaponda 2021,NA,November,2013,April,2014,2021,2014,Zambia,EA,EA,Rural,Nchelenge and Kashikishi,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,NR,NR,NR,25.6,NA,NA,Mixed,NA,NA,NR,CT,56,1084,0.051660517,genital fluid,NAAT,88.6,99.6,0.055037373,0.007543656,0.040935318,0.070567229,50.29979668,913.9207452
#21788,Chaponda 2021,NA,November,2013,April,2014,2021,2014,Zambia,EA,EA,Rural,Nchelenge and Kashikishi,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,NR,NR,NR,25.6,NA,NA,Mixed,NA,NA,NR,NG,34,1084,0.031365314,genital fluid,NAAT,93.3,99.2,0.026387162,0.005756697,0.01623512,0.038316074,20.45620041,775.2330655
#21788,Chaponda 2021,NA,November,2013,April,2014,2021,2014,Zambia,EA,EA,Rural,Nchelenge and Kashikishi,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,NR,NR,NR,25.6,NA,NA,Mixed,NA,NA,NR,TV,269,1084,0.248154982,genital fluid,NAAT,95,98,0.246143625,0.014332328,0.218962327,0.275175158,222.3475363,903.3243749
#23331,Oyeyemi 2016,NA,May,2014,August,2014,2016,2014,Nigeria,WA,WA,Urban,"Agege, Lagos State",Cross sectional,NR,Female,ANC attendees,pregnant women,Adult,Y,21+,21,NR,35.1,NA,NA,Mixed,108,16,0.148,TV,37,198,0.186868687,genital fluid,WM,52,100,0.36467549,0.052235083,0.268539027,0.474000217,30.9659343,84.91367022
#23983,Wynn 2018,NA,July,2015,May,2016,2018,2016,Botswana,SA,SA,Urban,Gaborone,Cohort,Consecutive,Female,ANC attendees,outpatient ANC care at hospital,Adult,Y,18+,18,NR,NA,30,19-45,Mixed,395,90,0.225,CT,31,400,0.0775,genital fluid,NAAT,88.6,99.6,0.085864467,0.014942835,0.058621259,0.117506023,30.18363517,351.5264949
#23983,Wynn 2018,NA,July,2015,May,2016,2018,2016,Botswana,SA,SA,Urban,Gaborone,Cohort,Consecutive,Female,ANC attendees,outpatient ANC care at hospital,Adult,Y,18+,18,NR,NA,30,19-45,Mixed,395,90,0.225,NG,5,400,0.0125,genital fluid,NAAT,93.3,99.2,0.008762389,0.006189698,0.000519605,0.023893939,1.986478677,226.7051463
#23983,Wynn 2018,NA,July,2015,May,2016,2018,2016,Botswana,SA,SA,Urban,Gaborone,Cohort,Consecutive,Female,ANC attendees,outpatient ANC care at hospital,Adult,Y,18+,18,NR,NA,30,19-45,Mixed,395,90,0.225,TV,21,400,0.0525,genital fluid,NAAT,95,98,0.037472014,0.011983801,0.015617321,0.062612942,9.411053775,251.148866
#22139,Gadoth 2019,NA,October,2016,February,2017,2019,2017,Democratic Republic of Congo,CA,CA,Mixed,Ksiantu Health Zone,Cohort,Convenience,Female,ANC attendees,pregnant women,Adult,Y,18+,18,NR,NA,NA,NA,HIV negative,351,0,0,CT,11,351,0.031339031,genital fluid,NAAT,88.6,99.6,0.033694763,0.010970964,0.01556366,0.058414193,9.114850522,270.5123785
#22139,Gadoth 2019,NA,October,2016,February,2017,2019,2017,Democratic Republic of Congo,CA,CA,Mixed,Ksiantu Health Zone,Cohort,Convenience,Female,ANC attendees,pregnant women,Adult,Y,18+,18,NR,NA,NA,NA,HIV negative,351,0,0,NG,5,351,0.014245014,genital fluid,NAAT,93.3,99.2,0.010553554,0.007341143,0.000780892,0.028665016,2.04485455,193.7598053
#22139,Gadoth 2019,NA,October,2016,February,2017,2019,2017,Democratic Republic of Congo,CA,CA,Mixed,Ksiantu Health Zone,Cohort,Convenience,Female,ANC attendees,pregnant women,Adult,Y,18+,18,NR,NA,NA,NA,HIV negative,351,0,0,TV,52,357,0.145658263,genital fluid,NAAT,95,98,0.137023393,0.020549464,0.09834962,0.179220769,38.36961797,280.0223894
#21549,Asmah 2017,NA,April,2016,June,2016,2017,2016,Ghana,WA,WA,Rural,"Sogakope, South Tongu District, Volta Region",Cross sectional,Random,Female,ANC attendees,pregnant women who had been received for antenatal care as well as those visiting the laboratory for routine urine exam,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,20,99,0.202020202,genital fluid,WM,52,100,0.399525977,0.076808443,0.258708803,0.558060936,16.24674441,40.6650515
#22231,Govender 2023,CAP 008,February,2017,March,2018,2023,2018,South Africa,SA,SA,Peri-urban,"Umlazi, KwaZulu-Natal",Cohort,NR,Female,ANC attendees,pregnant women attending first antenatal visit who were enrolled in HIV incidence cohort study,Adult,Y,15+,15,NR,NA,23,20-27,HIV negative,752,0,0,CT,73,752,0.098,genital fluid,NAAT,88.6,99.6,0.106738868,0.012254647,0.08356799,0.132502651,67.76758152,634.8913266
#22231,Govender 2023,CAP 008,February,2017,March,2018,2023,2018,South Africa,SA,SA,Peri-urban,"Umlazi, KwaZulu-Natal",Cohort,NR,Female,ANC attendees,pregnant women attending first antenatal visit who were enrolled in HIV incidence cohort study,Adult,Y,15+,15,NR,NA,23,20-27,HIV negative,752,0,0,NG,43,752,0.057,genital fluid,NAAT,93.3,99.2,0.054205774,0.008979334,0.037812655,0.072631285,34.46668565,635.8489704
#22231,Govender 2023,CAP 008,February,2017,March,2018,2023,2018,South Africa,SA,SA,Peri-urban,"Umlazi, KwaZulu-Natal",Cohort,NR,Female,ANC attendees,pregnant women attending first antenatal visit who were enrolled in HIV incidence cohort study,Adult,Y,15+,15,NR,NA,23,20-27,HIV negative,752,0,0,TV,115,752,0.151,genital fluid,NAAT,95,98,0.143802158,0.01442536,0.116860367,0.173308924,85.0847238,591.679047
#22459,Joseph Davey 2019,NA,November,2017,July,2018,2019,2018,South Africa,SA,SA,Urban,Cape Town,Cross sectional,Convenience,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,NR,NA,29,24-34,Mixed,242,107,0.44,CT,49,242,0.2,genital fluid,NAAT,88.6,99.6,0.227768938,0.029306884,0.170936103,0.286824262,46.64412696,204.7870419
#22459,Joseph Davey 2019,NA,November,2017,July,2018,2019,2018,South Africa,SA,SA,Urban,Cape Town,Cross sectional,Convenience,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,NR,NA,29,24-34,Mixed,242,107,0.44,NG,14,242,0.058,genital fluid,NAAT,93.3,99.2,0.057654389,0.016847618,0.028512594,0.094392251,11.03565027,191.4104119
#22459,Joseph Davey 2019,NA,November,2017,July,2018,2019,2018,South Africa,SA,SA,Urban,Cape Town,Cross sectional,Convenience,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,NR,NA,29,24-34,Mixed,242,107,0.44,TV,37,242,0.15,genital fluid,NAAT,95,98,0.146283795,0.024415438,0.102478208,0.19820269,30.6462206,209.4983975
#23127,Naicker 2021,NA,November,2017,April,2018,2021,2018,South Africa,SA,SA,Urban,Durban,Cross sectional,NR,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,104,40,0.384615385,TV,24,219,0.109589041,genital fluid,NAAT,95,98,0.100044728,0.022689536,0.058785903,0.149323875,17.49677884,174.8895629
#22789,Mabaso 2022,NA,October,2018,April,2021,2022,2020,South Africa,SA,SA,Urban,Durban,Cross sectional,NR,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,NR,NA,29,24-35,Mixed,NA,NA,NR,CT,81,735,0.110204082,genital fluid,NAAT,88.6,99.6,0.121708166,0.013108367,0.097297383,0.148645754,75.71485438,622.1016778
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Kenya,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,474,0,0,CT,99,474,0.208860759,genital fluid,NAAT,88.6,99.6,0.233552217,0.021125234,0.19407156,0.276410391,93.68013138,401.1100073
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Kenya,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,474,0,0,NG,16,474,0.033755274,genital fluid,NAAT,93.3,99.2,0.029851985,0.00915753,0.013948957,0.049310746,10.30926676,345.3461009
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Kenya,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,474,0,0,TV,53,474,0.111814346,genital fluid,culture,68.8,100,0.164946925,0.0208461,0.126319932,0.207586448,52.28208185,316.9630589
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Malawi,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,311,0,0,CT,30,311,0.096463023,genital fluid,NAAT,88.6,99.6,0.107276151,0.019017439,0.073276376,0.146944536,28.40661216,264.7989498
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Malawi,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,311,0,0,NG,10,311,0.032154341,genital fluid,NAAT,93.3,99.2,0.029442211,0.011194383,0.010489231,0.054409345,6.713699485,228.0297326
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Malawi,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,311,0,0,TV,55,311,0.176848875,genital fluid,culture,68.8,100,0.259303935,0.031328606,0.199590179,0.324865852,50.74299779,195.6892705
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Tanzania,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,586,0,0,CT,64,586,0.109215017,genital fluid,NAAT,88.6,99.6,0.120809686,0.013973528,0.09533216,0.149546947,65.71647943,543.9669741
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Tanzania,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,586,0,0,NG,11,586,0.018771331,genital fluid,NAAT,93.3,99.2,0.01356677,0.006335122,0.003087222,0.027703124,4.523875357,333.4526443
#32526,Madanitsa 2023,NA,March,2018,July,2019,2023,2018,Tanzania,EA,EA,Rural,NR,RCT,Convenience,Female,ANC attendees,women with viable singleton pregnancy between 16 weeks and 28 weeks gestation,Adult,Y,NR,NR,NR,NA,NA,NA,HIV negative,586,0,0,TV,92,586,0.156996587,genital fluid,culture,68.8,100,0.229739968,0.021165831,0.189427762,0.273538041,90.74858013,395.0056265
#21808,Chetty 2020,NA,October,2018,April,2019,2020,2019,South Africa,SA,SA,Urban,Durban,Cross sectional,NR,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,NR,NA,27,24-36,Mixed,NA,NA,NR,TV,47,362,0.129834254,genital fluid,NAAT,95,98,0.120239442,0.018459411,0.086148794,0.158640432,37.32696775,310.438631
#30645,Auta 2020,NA,NR,2019,NR,2020,2020,2019,Nigeria,WA,WA,Urban,Kaduna,Cross sectional,NR,Female,ANC attendees,Pregnant women,Adult,Y,15+,15,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,16,405,0.039506173,genital fluid,WM,52,100,0.079762999,0.01893255,0.047320842,0.120782717,16.33369376,204.777828
#21927,de Voux 2023,NA,August,2019,November,2020,2023,2020,South Africa,SA,SA,Urban,Gugulethu,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,16+,16,NR,NA,26,22-31,HIV negative,1194,0,0,CT,285,1194,0.238693467,genital fluid,NAAT,88.6,99.6,0.266664796,0.014133241,0.238739841,0.294836255,261.0660284,979.004475
#21927,de Voux 2023,NA,August,2019,November,2020,2023,2020,South Africa,SA,SA,Urban,Gugulethu,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,16+,16,NR,NA,26,22-31,HIV negative,1194,0,0,NG,97,1194,0.081239531,genital fluid,NAAT,93.3,99.2,0.080080698,0.008613517,0.064329343,0.097032425,79.51415565,992.9253546
#21927,de Voux 2023,NA,August,2019,November,2020,2023,2020,South Africa,SA,SA,Urban,Gugulethu,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,16+,16,NR,NA,26,22-31,HIV negative,1194,0,0,TV,75,1194,0.06281407,genital fluid,NAAT,95,98,0.046838251,0.007531032,0.032489539,0.062183306,36.86879531,787.1514143
#21928,de Voux 2024,STI and PrEP in Pregnancy Study,November,2021,May,2022,2024,2022,South Africa,SA,SA,Peri-urban,Gugulethu,Cohort,Consecutive,Female,ANC attendees,Pregnant women at baseline,Adult,Y,18+,18,NR,NA,27,23-32,Mixed,82,2,0.02,CT,26,133,0.2,genital fluid,NAAT,88.6,99.6,0.221657475,0.038917558,0.151900206,0.302777913,25.24901053,113.9100343
#21928,de Voux 2024,STI and PrEP in Pregnancy Study,November,2021,May,2022,2024,2022,South Africa,SA,SA,Peri-urban,Gugulethu,Cohort,Consecutive,Female,ANC attendees,Pregnant women at baseline,Adult,Y,18+,18,NR,NA,27,23-32,Mixed,82,2,0.02,NG,10,133,0.08,genital fluid,NAAT,93.3,99.2,0.079387897,0.024386661,0.037209198,0.131367206,9.756197694,122.8927583
#21928,de Voux 2024,STI and PrEP in Pregnancy Study,November,2021,May,2022,2024,2022,South Africa,SA,SA,Peri-urban,Gugulethu,Cohort,Consecutive,Female,ANC attendees,Pregnant women at baseline,Adult,Y,18+,18,NR,NA,27,23-32,Mixed,82,2,0.02,TV,14,133,0.11,genital fluid,NAAT,95,98,0.098208766,0.030441237,0.045047185,0.165039642,9.386029507,95.5722174
#23103,Mussa 2023,Maduo,March,2021,March,2022,2023,2022,Botswana,SA,SA,Urban,Gaborone,Cross sectional,NR,Female,ANC attendees,Pregnant women participating in Madua study,Adult,Y,15+,15,NR,NA,27,24-33,Mixed,251,54,0.22,CT,57,251,0.227091633,genital fluid,NAAT,88.6,99.6,0.255161235,0.029354394,0.200480141,0.313219441,56.27887577,220.5620137
#23103,Mussa 2023,Maduo,March,2021,March,2022,2023,2022,Botswana,SA,SA,Urban,Gaborone,Cross sectional,NR,Female,ANC attendees,Pregnant women participating in Madua study,Adult,Y,15+,15,NR,NA,27,24-33,Mixed,251,54,0.22,NG,3,251,0.011952191,genital fluid,NAAT,93.3,99.2,0.010302231,0.007769365,0.000514596,0.029467196,1.740179853,168.9129169
#27361,Jatau 2006,NA,NR,NR,NR,NR,2006,2003,Nigeria,WA,WA,Urban,Zaria,Cross sectional,Random,Female,ANC attendees,Pregnant women,Adult,Y,16+,16,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,56,300,0.186666667,genital fluid,culture,68.8,100,0.274544822,0.032357291,0.212430208,0.341823732,52.22672461,190.2302298
#24699,Maureen 2022,NA,NR,NR,NR,NR,2022,2019,Nigeria,WA,WA,Urban,"Orlu, Imo State",Cross sectional,NR,Female,ANC attendees,Women attending ANC for first time,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,1,200,0.005,genital fluid,NAAT,88.6,99.6,0.008787631,0.007193045,0.00042851,0.027197104,1.479397179,168.3499345
#24699,Maureen 2022,NA,NR,NR,NR,NR,2022,2019,Nigeria,WA,WA,Urban,"Orlu, Imo State",Cross sectional,NR,Female,ANC attendees,Women attending ANC for first time,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,12,200,0.06,genital fluid,NAAT,93.3,99.2,0.060805207,0.018990231,0.028868538,0.101958954,9.628901075,158.356522
#24699,Maureen 2022,NA,NR,NR,NR,NR,2022,2019,Nigeria,WA,WA,Urban,"Orlu, Imo State",Cross sectional,NR,Female,ANC attendees,Women attending ANC for first time,Adult,Y,18+,18,NR,NA,NA,NA,Mixed,NA,NA,NR,TV,8,200,0.04,genital fluid,NAAT,95,98,0.027334966,0.0150256,0.004113504,0.061400607,3.219116689,117.7655285
#22628,Konadu 2019,NA,Sept,2014,March,2015,2019,2015,Ghana,WA,WA,Rural,Kintampo,Cross sectional,Random,Female,ANC attendees,Pregnant women attending ANC,Adult,Y,12 to 54,12,54,27,NA,NA,Mixed,NA,NA,NR,TV,8,589,0.013582343,genital fluid,WM,52,100,0.029191279,0.009713578,0.013100765,0.051040807,8.767614584,300.3504822
#31520,Sam-Wobo 2012,NA,NR,NR,NR,NR,2012,2009,Nigeria,WA,WA,Urban,"Ijaiye, Ogun State",Cross sectional,Consecutive,Female,ANC attendees,pregnant women,Adult,Y,16 to 50,16,50,NA,NA,NA,Mixed,NA,NA,NR,TV,22,200,0.11,genital fluid,WM,52,100,0.219225132,0.041357039,0.147735393,0.303184413,21.93853551,100.0730859
#32532,Kirakoya-Samadoulougou 2008,NA,May,2003,July,2003,2008,2003,Burkina Faso,WA,WA,Rural,"Boulgou, Poni, Seno, and Yatenga Provinces",Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,14 to 49,14,49,25,26,NA,Mixed,2133,53,2.50E-02,TV,32,2133,0.015002344,genital fluid,culture,68.8,100,0.022437823,0.00390993,0.015491295,0.030901415,32.19347539,1434.786031
#26806,Usanga 2011,NA,December,2007,November,2008,2011,2008,Nigeria,WA,WA,Urban,"Calabar, Cross River State",Cohort,NR,Female,ANC attendees,First ANC,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,562,38,6.80E-02,NG,0,562,0,genital fluid,culture,75.7,100,0.002283016,0.002310195,4.53E-05,0.008904008,0.974378959,426.7946642
#26806,Usanga 2011,NA,December,2007,November,2008,2011,2008,Nigeria,WA,WA,Urban,"Calabar, Cross River State",Cohort,NR,Female,ANC attendees,First ANC,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,562,38,6.80E-02,TV,29,562,0.051601423,genital fluid,WM,52,100,0.102072206,0.018098414,0.068878874,0.139894007,28.56112941,279.8129937
#22364,Homsy 2019,NA,February,2013,April,2014,2019,2014,Uganda,EA,EA,Mixed,Kampala and Kitgum,RCT,Consecutive,Female,ANC attendees,pregnant women of any gestational age individually or with their partners when presenting in couples,Adult,Y,18 to 49,18,49,NA,NA,NA,HIV negative,819,0,0,TV,12,819,0.014652015,genital fluid,WM,52,100,0.030453588,0.00824179,0.016261468,0.04854346,13.23739362,434.6743564
#23549,Sangare 2021,NA,February,2015,April,2015,2021,2015,Burkina Faso,WA,WA,Mixed,Bobo-Dioulasso,Cross sectional,Random,Female,ANC attendees,Pregnant women,Adult,Y,15 to 49,15,49,25.9,25,NA,Mixed,278,6,2.16E-02,TV,10,315,0.031746032,genital fluid and urine,WM,52,100,0.06659538,0.019994544,0.032818469,0.111377274,10.35464318,155.4859093
#23214,Nsereko 2020,NA,Sep,2017,October,2017,2020,2017,Rwanda,EA,EA,Urban and peri-urban,"Gasabo District, Kigali Province",Cohort,Convenience,Female,ANC attendees,singleton pregnancy at 9-15 gestational weeks,Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,NA,NA,NR,TV,19,367,0.051771117,genital fluid,WM,52,100,0.104178728,0.022278439,0.065961264,0.153903041,19.58889624,188.0316315
#23899,Volker 2017,NA,October,2011,January,2012,2017,2012,Ghana,WA,WA,Rural,Western Region,Cross sectional,NR,Female,ANC attendees,Hospital (delivery),Adult,Y,14 to 48,14,48,26.3,NA,NA,Mixed,173,1,6.00E-03,CT,3,177,0.016949153,genital fluid,NAAT,88.6,99.6,0.020883651,0.012480506,0.002753477,0.049728439,2.741465735,131.2732949
#23899,Volker 2017,NA,October,2011,January,2012,2017,2012,Ghana,WA,WA,Rural,Western Region,Cross sectional,NR,Female,ANC attendees,Hospital (delivery),Adult,Y,14 to 48,14,48,26.3,NA,NA,Mixed,173,1,6.00E-03,NG,0,180,0,genital fluid,culture,75.7,100,0.007233964,0.007134867,0.00014877,0.027051729,1.020534681,141.0754528
#22462,Juliana 2020,AMANHI,March,2018,January,2019,2020,2019,Tanzania,EA,EA,Rural,Pemba Island,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,16 to 48,16,48,28.3,NA,NA,Mixed,NA,NA,NR,CT,20,439,0.045558087,genital fluid,NAAT,88.6,99.6,0.049470558,0.01176295,0.028901521,0.075150023,16.81228392,339.8442332
#22462,Juliana 2020,AMANHI,March,2018,January,2019,2020,2019,Tanzania,EA,EA,Rural,Pemba Island,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,16 to 48,16,48,28.3,NA,NA,Mixed,NA,NA,NR,NG,0,439,0,genital fluid,NAAT,93.3,99.2,0.002400196,0.002471355,4.75E-05,0.008978762,0.940977415,392.0419788
#22462,Juliana 2020,AMANHI,March,2018,January,2019,2020,2019,Tanzania,EA,EA,Rural,Pemba Island,Cohort,NR,Female,ANC attendees,Pregnant women,Adult,Y,16 to 48,16,48,28.3,NA,NA,Mixed,NA,NA,NR,TV,31,439,0.070615034,genital fluid,NAAT,95,98,0.056677493,0.013232975,0.032711883,0.084671591,17.30479708,305.320437
#32031,Inabo 2006,NA,NR,NR,NR,NR,2006,2003,Nigeria,WA,WA,Urban,Kaduna,Cross sectional,NR,Female,ANC attendees,Pregnant women,Adult,Y,18 to 47,18,47,NA,NA,NA,Mixed,NA,NA,NR,TV,62,350,0.177142857,genital fluid,WM,52,100,0.344494211,0.040193382,0.270187543,0.425210599,48.15387997,139.781391
#25928,Maufi 2016,NA,November,2014,April,2015,2016,2015,Tanzania,EA,EA,Urban and peri-urban,Mwanza,Cross sectional,Consecutive,Female,ANC attendees,ANC (hosp and health centre),Adult,Y,17 to 46,17,46,NA,26,NA,Mixed,325,6,1.85E-02,TV,38,365,0.104109589,genital fluid,WM,52,100,0.204433774,0.03144966,0.146867652,0.27247088,33.61628591,164.4360674
#22898,Mbah 2022,NA,November,2017,December,2018,2022,2018,Cameroon,CA,CA,Peri-urban,"Buea, Limbe Tiko, and Mutengene in Fako Division",Case control,NR,Female,ANC attendees,Control group in infertility study was pregnant women enrolled at ANC,Adult,Y,15 to 46,15,46,NA,27,24-32,Mixed,NA,NA,NR,CT,13,265,0.049056604,genital fluid,NAAT,88.6,99.6,0.054788184,0.015220665,0.028198641,0.0873064,12.24716785,223.536664
#22898,Mbah 2022,NA,November,2017,December,2018,2022,2018,Cameroon,CA,CA,Peri-urban,"Buea, Limbe Tiko, and Mutengene in Fako Division",Case control,NR,Female,ANC attendees,Control group in infertility study was pregnant women enrolled at ANC,Adult,Y,15 to 46,15,46,NA,27,24-32,Mixed,NA,NA,NR,NG,7,265,0.026415094,genital fluid,NAAT,93.3,99.2,0.023932761,0.010836787,0.006230458,0.048334941,4.760627922,198.9167887
#22898,Mbah 2022,NA,November,2017,December,2018,2022,2018,Cameroon,CA,CA,Peri-urban,"Buea, Limbe Tiko, and Mutengene in Fako Division",Case control,NR,Female,ANC attendees,Control group in infertility study was pregnant women enrolled at ANC,Adult,Y,15 to 46,15,46,NA,27,24-32,Mixed,NA,NA,NR,TV,12,265,0.045283019,genital fluid,NAAT,95,98,0.03103639,0.013623924,0.007681543,0.060995315,5.028581038,162.0221
#23175,Ngom 2023,NA,July,2020,March,2021,2023,2021,Senegal,WA,WA,Urban,Dakar,Cross sectional,Consecutive,Female,ANC attendees,"Pregnant women between 34 and 38 weeks of gestation, without any associated patholog",Adult,Y,16 to 46,16,46,NA,26,NA,Mixed,NA,NA,NR,NG,0,279,0,genital fluid,culture,75.7,100,0.004751222,0.004813578,0.000121313,0.017897069,0.96963046,204.0802121
#23175,Ngom 2023,NA,July,2020,March,2021,2023,2021,Senegal,WA,WA,Urban,Dakar,Cross sectional,Consecutive,Female,ANC attendees,"Pregnant women between 34 and 38 weeks of gestation, without any associated patholog",Adult,Y,16 to 46,16,46,NA,26,NA,Mixed,NA,NA,NR,TV,82,279,0.29390681,genital fluid,WM,52,100,0.568566786,0.052923749,0.468935396,0.674211313,49.79380782,87.57776403
#22608,Kinoshita-Moleka 2008,NA,April,2004,June,2004,2008,2004,Democratic Republic of Congo,CA,CA,Urban,Kinshasa,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 45,15,45,27.3,NA,NA,Mixed,529,8,1.50E-02,CT,9,521,0.017274472,genital fluid,DFA,82,98.5,0.008186948,0.00606489,0.000273599,0.022793511,1.807291013,220.752709
#22608,Kinoshita-Moleka 2008,NA,April,2004,June,2004,2008,2004,Democratic Republic of Congo,CA,CA,Urban,Kinshasa,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 45,15,45,27.3,NA,NA,Mixed,529,8,1.50E-02,NG,2,521,0.003838772,genital fluid,NAAT,93.3,99.2,0.002965495,0.002843069,8.63E-05,0.010165011,1.084750882,365.7907829
#22773,Lujan 2008,NA,March,2004,July,2004,2008,2004,Mozambique,EA,EA,Urban,Moatize and Tete,Cross sectional,Consecutive,Female,ANC attendees,First time ANC attendees,Adult,Y,15 to 45,14,45,24.7,NA,NA,Mixed,NA,NA,NR,CT,34,835,0.040718563,urine,NAAT,87,99.8,0.045829784,0.008186252,0.031244746,0.063534329,29.90551092,652.5344129
#22773,Lujan 2008,NA,March,2004,July,2004,2008,2004,Mozambique,EA,EA,Urban,Moatize and Tete,Cross sectional,Consecutive,Female,ANC attendees,First time ANC attendees,Adult,Y,15 to 45,14,45,24.7,NA,NA,Mixed,NA,NA,NR,NG,21,835,0.025149701,urine,NAAT,91.6,100,0.028594063,0.006072254,0.018029261,0.04147187,21.54034378,753.3152635
#32520,Ademe 2013,NA,November,2010,January,2011,2013,2010,Ethiopia,EA,EA,Rural,"Amhara Regional State, West Gojjam Zone",Cross sectional,Convenience,Female,ANC attendees,Pregnant women,Adult,Y,15 to 49,15,45,NA,NA,NA,Mixed,NA,NA,NR,TV,14,222,0.063063063,genital fluid,WM,52,100,0.129587694,0.032425324,0.073888415,0.201178482,13.90221179,107.2803392
#22867,Masha 2017,NA,July,2015,September,2015,2017,2015,Kenya,EA,EA,Rural,Kilifi,Cross sectional,Consecutive,Female,ANC attendees,pregnant women,Adult,Y,18 to 45,18,45,NA,26,22-31,Mixed,202,13,6.40E-02,CT,30,202,0.148514851,urine,NAAT,87,99.8,0.172631457,0.028664327,0.120077751,0.232218832,30.00926689,173.8342908
#22867,Masha 2017,NA,July,2015,September,2015,2017,2015,Kenya,EA,EA,Rural,Kilifi,Cross sectional,Consecutive,Female,ANC attendees,pregnant women,Adult,Y,18 to 45,18,45,NA,26,22-31,Mixed,202,13,6.40E-02,NG,2,202,0.00990099,urine,NAAT,91.6,100,0.016024725,0.009140883,0.003437201,0.037767002,3.024050825,188.7115563
#22867,Masha 2017,NA,July,2015,September,2015,2017,2015,Kenya,EA,EA,Rural,Kilifi,Cross sectional,Consecutive,Female,ANC attendees,pregnant women,Adult,Y,18 to 45,18,45,NA,26,22-31,Mixed,202,13,6.40E-02,TV,15,202,0.074257426,genital fluid,culture,68.8,100,0.113696242,0.027552234,0.066277177,0.173150998,15.09249997,132.744053
#22754,Lingani 2021,NA,August,2019,September,2020,2021,2020,Burkina Faso,WA,WA,Rural,Yako Health District,Cross sectional,Convenience,Female,ANC attendees,Pregnant women,Adult,Y,16 to 45,16,45,NA,24,21-30,Mixed,NA,NA,NR,CT,23,321,0.07165109,genital fluid,NAAT,88.6,99.6,0.07968841,0.016764378,0.050277816,0.114244676,20.79458904,260.9487254
#21813,Chiduo 2012,NA,May,2009,October,2010,2012,2010,Tanzania,EA,EA,Urban,Tanga,RCT,Random,Female,ANC attendees,ANCs (centres and hosp),Adult,Y,18 to 44,18,44,NA,NA,NA,Mixed,185,85,0.46,CT,3,185,0.016216216,genital fluid,NAAT,88.6,99.6,0.019848611,0.011690489,0.002699944,0.048384957,2.825452766,142.3501474
#21813,Chiduo 2012,NA,May,2009,October,2010,2012,2010,Tanzania,EA,EA,Urban,Tanga,RCT,Random,Female,ANC attendees,ANCs (centres and hosp),Adult,Y,18 to 44,18,44,NA,NA,NA,Mixed,185,85,0.46,NG,3,185,0.016216216,genital fluid,culture,75.7,100,0.028234839,0.013843159,0.008190291,0.060242593,4.042607148,143.1779756
#21813,Chiduo 2012,NA,May,2009,October,2010,2012,2010,Tanzania,EA,EA,Urban,Tanga,RCT,Random,Female,ANC attendees,ANCs (centres and hosp),Adult,Y,18 to 44,18,44,NA,NA,NA,Mixed,185,85,0.46,TV,21,185,0.113513514,genital fluid,WM,52,100,0.226667382,0.045728139,0.146125991,0.322123041,19.00103827,83.8278453
#26123,Etuketu 2015,NA,June,2013,July,2013,2015,2013,Nigeria,WA,WA,Urban,"Abeokutu, Ogun State",Cross sectional,Random,Female,ANC attendees,ANC at hospital,Adult,Y,15 to 44,35,44,NA,NA,NA,Mixed,NA,NA,NR,TV,31,300,0.103333333,genital fluid,WM,52,100,0.204004045,0.034397829,0.142822209,0.275741249,27.99795823,137.242172
#22413,Isara 2021,NA,June,2017,October,2017,2021,2017,The Gambia,WA,WA,Urban,Brikama and Bandung,Cohort,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 44,15,44,NA,25.5,22-31,Mixed,280,16,5.70E-02,CT,2,280,0.007142857,urine,DFA,82,98.5,0.006195326,0.005658887,0.000181251,0.020554577,1.191152488,192.2663022
#22413,Isara 2021,NA,June,2017,October,2017,2021,2017,The Gambia,WA,WA,Urban,Brikama and Bandung,Cohort,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 44,15,44,NA,25.5,22-31,Mixed,280,16,5.70E-02,NG,5,280,0.017857143,genital fluid,culture,75.7,100,0.028232278,0.011677994,0.010167269,0.055184186,5.679600434,201.1740048
#22413,Isara 2021,NA,June,2017,October,2017,2021,2017,The Gambia,WA,WA,Urban,Brikama and Bandung,Cohort,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 44,15,44,NA,25.5,22-31,Mixed,280,16,5.70E-02,TV,11,280,0.039285714,urine,WM,52,100,0.081758006,0.022969658,0.042948314,0.133245212,11.63345369,142.2913082
#23501,Romoren 2007,NA,October,2000,February,2001,2007,2000,Botswana,SA,SA,Urban,Gaborone,Cross sectional,NR,Female,ANC attendees,ANC clients,Adult,Y,15 to 43,15,43,NA,25,NA,Mixed,NA,NA,NR,NG,21,703,0.029871977,genital fluid,NAAT,93.3,99.2,0.025090571,0.007103016,0.0123637,0.04032139,12.16465494,484.8297413
#23501,Romoren 2007,NA,October,2000,February,2001,2007,2000,Botswana,SA,SA,Urban,Gaborone,Cross sectional,NR,Female,ANC attendees,ANC clients,Adult,Y,15 to 43,15,43,NA,25,NA,Mixed,NA,NA,NR,TV,131,703,0.186344239,genital fluid,WM,52,100,0.359824993,0.0273909,0.307808986,0.41556584,110.4762099,307.0276167
#21418,Aboyeji 2003,NA,January,2000,December,2000,2003,2000,Nigeria,WA,WA,Urban,Ilorin,Cross sectional,Random,Female,ANC attendees,Asymptomatic pregnant women,Adult,Y,19 to 43,19,43,NA,NA,NA,Mixed,NA,NA,NR,NG,3,230,0.013043478,genital fluid,culture,75.7,100,0.022723144,0.011341722,0.006169052,0.049144203,3.922802756,172.6346823
#21418,Aboyeji 2003,NA,January,2000,December,2000,2003,2000,Nigeria,WA,WA,Urban,Ilorin,Cross sectional,Random,Female,ANC attendees,Asymptomatic pregnant women,Adult,Y,19 to 43,19,43,NA,NA,NA,Mixed,NA,NA,NR,TV,11,230,0.047826087,genital fluid,WM,52,100,0.099610503,0.027753794,0.051845579,0.1593082,11.59834352,116.4369534
#22843,Mapingure 2010,NA,June,2002,March,2004,2010,2003,Tanzania,EA,EA,Urban,Moshi,Cross sectional,Consecutive,Female,ANC attendees,pregnant women in 3rd trimester,Adult,Y,14 to 43,14,43,24.6,NA,NA,Mixed,2654,184,6.90E-02,TV,127,2555,0.049706458,genital fluid,WM,52,100,0.096278805,0.008200131,0.080918065,0.112931503,124.5816963,1293.968041
#21599,Balaka 2005,NA,February,2002,June,2002,2005,2002,Togo,WA,WA,Urban,Lome,Cross sectional,Consecutive,Female,ANC attendees,All pregnant women attending first ANC visit,Adult,Y,16 to 42,16,42,NA,NA,NA,Mixed,NA,NA,NR,TV,35,306,0.114379085,genital fluid,WM,52,100,0.2246715,0.03592484,0.158864759,0.298791618,30.32438763,134.9721155
#24839,Rasheed 2021,NA,October,2018,December,2018,2021,2018,Nigeria,WA,WA,Urban,NR,Cross sectional,Random,Female,ANC attendees,Pregnant women,Adult,Y,18+,18,42,30.7,NA,NA,Mixed,161,19,0.118012422,TV,6,161,0.037267081,genital fluid,WM,52,100,0.082597521,0.030431216,0.033320364,0.151644734,6.758578033,81.82543389
#24022,Zenebe 2021,NA,August,2020,October,2020,2021,2020,Ethiopia,EA,EA,Urban,Southern Region,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,17 to 41,17,41,26.8,NA,NA,Mixed,NA,NA,NR,CT,29,350,0.082857143,genital fluid,NAAT,88.6,99.6,0.092257984,0.016833075,0.061465158,0.127035987,27.26738228,295.5558001
#24022,Zenebe 2021,NA,August,2020,October,2020,2021,2020,Ethiopia,EA,EA,Urban,Southern Region,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,17 to 41,17,41,26.8,NA,NA,Mixed,NA,NA,NR,NG,15,350,0.042857143,genital fluid,NAAT,93.3,99.2,0.040814889,0.012305857,0.019751982,0.067678238,10.55154263,258.521902
#24022,Zenebe 2021,NA,August,2020,October,2020,2021,2020,Ethiopia,EA,EA,Urban,Southern Region,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,17 to 41,17,41,26.8,NA,NA,Mixed,NA,NA,NR,TV,11,350,0.031428571,genital fluid,NAAT,95,98,0.016040635,0.009806227,0.001462685,0.038915061,2.632790901,164.1325874
#23747,Tann 2006,NA,March,2004,April,2004,2006,2004,Uganda,EA,EA,Peri-urban,Entebbe,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 40,15,40,NA,22,NA,Mixed,206,27,0.131,CT,14,236,0.059322034,genital fluid,NAAT,88.6,99.6,0.066526963,0.018155121,0.035743239,0.106134851,12.53426583,188.4088074
#23747,Tann 2006,NA,March,2004,April,2004,2006,2004,Uganda,EA,EA,Peri-urban,Entebbe,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 40,15,40,NA,22,NA,Mixed,206,27,0.131,NG,10,233,0.042918455,genital fluid,NAAT,93.3,99.2,0.041921968,0.015363968,0.016099062,0.076114768,7.133085414,170.1514905
#23747,Tann 2006,NA,March,2004,April,2004,2006,2004,Uganda,EA,EA,Peri-urban,Entebbe,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,15 to 40,15,40,NA,22,NA,Mixed,206,27,0.131,TV,43,249,0.172690763,genital fluid,culture,68.8,100,0.254420086,0.03523996,0.1875361,0.327262357,38.86209221,152.7477361
#31427,Chinyere 2012,NA,November,2006,August,2008,2012,2007,Nigeria,WA,WA,Rural,Ebonyi State,Cross sectional,Convenience,Female,ANC attendees,"gestational age of 14 – 36 weeks, with or without complaint of vaginal discharge and who were attending routine antenatal clinic",Adult,Y,15 to 40,15,40,26.16,NA,NA,Mixed,NA,NA,NR,TV,89,688,0.129360465,genital fluid,WM,52,100,0.250254035,0.024237561,0.204885018,0.300357412,79.9279129,319.3871098
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,18 to 35,18,40,25,NA,NA,Mixed,NA,NA,NR,CT,4,30,0.1333,genital fluid,NAAT,88.6,99.6,0.172687137,0.072824952,0.055038819,0.340906588,4.651888955,26.93824816
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,18 to 35,18,40,25,NA,NA,Mixed,NA,NA,NR,NG,0,30,0,genital fluid,NAAT,93.3,99.2,0.033957799,0.033673135,0.00082474,0.124982076,0.982444542,28.93133764
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,18 to 35,18,40,25,NA,NA,Mixed,NA,NA,NR,TV,3,30,0.1,genital fluid,culture,68.8,100,0.181019184,0.080446461,0.056727721,0.36302456,4.146761387,22.90785597
#26386,Bolaji 2013,NA,June,2011,July,2011,2013,2011,Nigeria,WA,WA,Mixed,NR,Cross sectional,NR,Female,ANC attendees,Asymptomatic pregnant women,Adult,Y,20 to 40,20,40,NA,NA,NA,Mixed,NA,NA,NR,TV,5,79,0.063291139,genital fluid,culture,68.8,100,0.107479679,0.042157262,0.040223255,0.205052541,5.801309592,53.97587398
#23281,Olowe 2014,NA,July,2012,April,2012,2014,2012,Nigeria,WA,WA,Urban,"Osogbo, South-Western Nigeria",Cross sectional,Random,Female,ANC attendees,Pregnant women attending ANC,Adult,Y,21 to 40,21,40,NA,NA,NA,Mixed,NA,NA,NR,TV,2,100,0.02,genital fluid,WM,52,100,0.057395966,0.033770478,0.011244638,0.142907184,2.722811802,47.43907994
#23303,Oree 2021,NA,November,2018,July,2019,2021,2019,South Africa,SA,SA,Urban,Durban,Cross sectional,NR,Female,ANC attendees,Pregnant women,Adult,Y,20 to 40,20,40,NA,27.5,24.8-32.3,Mixed,NA,NA,NR,NG,24,307,0.078175896,genital fluid,NAAT,93.3,99.2,0.078570292,0.017041828,0.048063963,0.114861781,19.58603753,249.2804473
#22389,Husen 2023,NA,NR,NR,NR,NR,2023,2020,Ethiopia,EA,EA,Unsure,Oromia Region,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women between gestational periods of 35 to 37 weeks,Adult,Y,17 to 37,17,37,26,NA,NA,Mixed,196,4,0.02,TV,15,196,0.077,genital fluid,WM,52,100,0.154740765,0.037554041,0.091116144,0.236696215,14.35112856,92.74303714
#32522,Eshete 2013,NA,December,2011,May,2012,2013,2012,Ethiopia,EA,EA,Mixed,Jimma Town,Cross sectional,NR,Female,ANC attendees,ANC,Adult,Y,15 to 36,15,36,24.4,NA,NA,Mixed,NA,NA,NR,TV,18,361,0.049861496,genital fluid,culture,68.8,100,0.076003617,0.016718135,0.04639017,0.111875193,19.09691255,251.2632062
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,18 to 35,19,34,26,NA,NA,Mixed,NA,NA,NR,CT,2,30,0.0667,genital fluid,NAAT,88.6,99.6,0.102500317,0.057398382,0.019197267,0.241874481,2.862104028,27.92287971
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,18 to 35,19,34,26,NA,NA,Mixed,NA,NA,NR,NG,0,30,0,genital fluid,NAAT,93.3,99.2,0.033995961,0.033871518,0.00071177,0.125976661,0.973115196,28.62443562
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,ANC attendees,Pregnant women,Adult,Y,18 to 35,19,34,26,NA,NA,Mixed,NA,NA,NR,TV,1,30,0.0333,genital fluid,culture,68.8,100,0.090975359,0.05864561,0.012009269,0.233723222,2.187520778,24.04520095
#23279,Oliver 2018,NA,April,2014,November,2014,2018,2014,Kenya,EA,EA,Mixed,Kisumu and surrounding villages,Cross sectional,Convenience,Female,Community members,general population - venue-based recruitment in community for observational study of NuvaRing,Adult,Y,18 to 34,18,34,NA,25,21-28,Mixed,457,67,0.147,CT,21,457,0.046,genital fluid,NAAT,88.6,99.6,0.04991751,0.011534943,0.029611211,0.075164465,17.79247059,356.4374654
#23279,Oliver 2018,NA,April,2014,November,2014,2018,2014,Kenya,EA,EA,Mixed,Kisumu and surrounding villages,Cross sectional,Convenience,Female,Community members,general population - venue-based recruitment in community for observational study of NuvaRing,Adult,Y,18 to 34,18,34,NA,25,21-28,Mixed,457,67,0.147,NG,17,457,0.039,genital fluid,NAAT,93.3,99.2,0.033613495,0.009865224,0.016488256,0.05475535,11.21926145,333.772537
#22360,Hokororo 2015,NA,April,2012,December,2012,2015,2012,Tanzania,EA,EA,Rural,"Magu, Misungwi, Ngudu, Ilemela, Nyamagana, Geita and Ukerewe Districts of the Mwanza Region",Cross sectional,Consecutive,Female,ANC attendees,ANC (mixed),Youth,Y,14 to 20,14,20,NA,19,17-20,Mixed,403,19,4.70E-02,CT,46,403,0.114143921,urine,NAAT,87,99.8,0.131571759,0.01817102,0.098592153,0.168665194,45.53031602,346.0493075
#22360,Hokororo 2015,NA,April,2012,December,2012,2015,2012,Tanzania,EA,EA,Rural,"Magu, Misungwi, Ngudu, Ilemela, Nyamagana, Geita and Ukerewe Districts of the Mwanza Region",Cross sectional,Consecutive,Female,ANC attendees,ANC (mixed),Youth,Y,14 to 20,14,20,NA,19,17-20,Mixed,403,19,4.70E-02,NG,27,403,0.066997519,urine,NAAT,91.6,100,0.075504525,0.01382397,0.050594383,0.104693889,27.57942197,365.2684672
#22360,Hokororo 2015,NA,April,2012,December,2012,2015,2012,Tanzania,EA,EA,Rural,"Magu, Misungwi, Ngudu, Ilemela, Nyamagana, Geita and Ukerewe Districts of the Mwanza Region",Cross sectional,Consecutive,Female,ANC attendees,ANC (mixed),Youth,Y,14 to 20,14,20,NA,19,17-20,Mixed,403,19,4.70E-02,TV,54,403,0.133995037,genital fluid,WM,52,100,0.261080743,0.033100901,0.199541339,0.328709755,45.96920827,176.0727649
#22862,Masatu 2022,NA,August,2017,December,2017,2022,2017,Tanzania,EA,EA,Urban,Mwanza,Cross sectional,Convenience,Female,FP attendees,Women seeking IUCD placement services,Adult,Y,18+,18,NR,NA,26,23-32,Mixed,142,8,5.63E-02,CT,34,150,0.226666667,genital fluid,rapid antigen test,56,99,0.400838082,0.063018406,0.282925911,0.529269895,24.24082101,60.47534425
#23226,Nyakambi 2022,NA,May,2021,June,2021,2022,2021,Kenya,EA,EA,Urban,Kisumu,Cross sectional,Consecutive,Female,PHC/OPD attendees,"Non-pregnant women, sexually active",Adult,Y,18 to 49,18,49,NA,NA,NA,Mixed,385,35,0.09,CT,29,385,0.075324675,genital fluid,rapid antigen test,56,99,0.12263441,0.024994076,0.077216111,0.173776475,21.12180874,172.2339494
#32095,Obiajuru 2005,NA,NR,2001,NR,2002,2005,2002,Nigeria,WA,WA,Mixed,"Owerri, Okigwe and Orlu in Imo State",Cross sectional,Random,Female,Community members,Randomly selected members of community. 1219 pregnant and 6134 non-pregnant,Adult,U,NR,NR,NR,NA,NA,NA,Mixed,7474,92,1.23E-02,NG,842,7474,0.112657212,genital fluid,culture,75.7,100,0.148992255,0.004849938,0.139650354,0.158805138,803.1349754,5390.447828
#32095,Obiajuru 2005,NA,NR,2001,NR,2002,2005,2002,Nigeria,WA,WA,Mixed,"Owerri, Okigwe and Orlu in Imo State",Cross sectional,Random,Female,Community members,Randomly selected members of community. 1219 pregnant and 6134 non-pregnant,Adult,U,NR,NR,NR,NA,NA,NA,Mixed,7474,92,1.23E-02,TV,673,7474,0.090045491,genital fluid,WM,52,100,0.173367785,0.006290104,0.161347075,0.185933543,627.9621955,3622.138876
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,South Africa,SA,SA,Urban,Durban,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,2391,0,0,CT,266,2391,0.111250523,genital fluid,NAAT,88.6,99.6,0.121921396,0.007375163,0.107901445,0.136624436,239.9661798,1968.204007
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,South Africa,SA,SA,Urban,Durban,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,2391,0,0,NG,75,2391,0.031367629,genital fluid,NAAT,93.3,99.2,0.025603135,0.003816999,0.018448515,0.033457409,43.84076732,1712.320311
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,South Africa,SA,SA,Urban,Durban,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,2391,0,0,TV,225,2391,0.094102886,genital fluid,culture,68.8,100,0.137222193,0.00863716,0.121077614,0.154500923,217.773867,1587.016377
#32527,McCormack 2010,MDP301,Sept,2005,Sep,2008,2010,2007,South Africa,SA,SA,Urban,Johannesburg,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,2499,0,0,CT,313,2499,0.1252501,genital fluid,NAAT,88.6,99.6,0.1378661,0.007627501,0.123187695,0.153477252,281.6600073,2042.996849
#32527,McCormack 2010,MDP301,Sept,2005,Sep,2008,2010,2007,South Africa,SA,SA,Urban,Johannesburg,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,2499,0,0,NG,78,2499,0.031212485,genital fluid,NAAT,93.3,99.2,0.025410896,0.003762888,0.018518958,0.033138294,44.44458134,1749.036401
#32527,McCormack 2010,MDP301,Sept,2005,Sep,2008,2010,2007,South Africa,SA,SA,Urban,Johannesburg,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,2499,0,0,TV,205,2499,0.082032813,genital fluid,culture,68.8,100,0.119676914,0.007949554,0.104486852,0.135638162,199.5158222,1667.120386
#32527,McCormack 2010,MDP301,Sept,2005,Oct,2008,2010,2007,South Africa,SA,SA,Rural,KwaZulu-Natal,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,1177,0,0,CT,63,1177,0.053525913,genital fluid,NAAT,88.6,99.6,0.05704343,0.007639382,0.043007442,0.072768836,52.57587003,921.6814236
#32527,McCormack 2010,MDP301,Sept,2005,Oct,2008,2010,2007,South Africa,SA,SA,Rural,KwaZulu-Natal,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,1177,0,0,NG,82,1177,0.069668649,genital fluid,NAAT,93.3,99.2,0.067381313,0.008024962,0.052630803,0.083874608,65.75020325,975.7928434
#32527,McCormack 2010,MDP301,Sept,2005,Oct,2008,2010,2007,South Africa,SA,SA,Rural,KwaZulu-Natal,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Recruited from health centres, family planning clinics, word of mouth, and community hotspots. ""These study populations are considered to be broadly representative of women at risk in the general population in these areas.""",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,1177,0,0,TV,152,1177,0.129141886,genital fluid,culture,68.8,100,0.189250604,0.014837133,0.159771995,0.218488497,131.9049823,696.9857921
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Tanzania,EA,EA,Urban,Mwanza,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women recruited from populations at increased risk of HIV and STIs: women who work in food and recreational facilities, including local food stalls, bars, guesthouses and brew shops.",Adult,U,16+,16,NR,NA,NA,NA,HIV negative,1146,0,0,CT,68,1146,0.059336824,genital fluid,NAAT,88.6,99.6,0.063382774,0.007744823,0.049142172,0.079239449,62.73091916,989.7155761
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Tanzania,EA,EA,Urban,Mwanza,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women recruited from populations at increased risk of HIV and STIs: women who work in food and recreational facilities, including local food stalls, bars, guesthouses and brew shops.",Adult,U,16+,16,NR,NA,NA,NA,HIV negative,1146,0,0,NG,54,1146,0.047120419,genital fluid,NAAT,93.3,99.2,0.043155501,0.006686273,0.030703922,0.057114411,39.86074795,923.6539163
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Tanzania,EA,EA,Urban,Mwanza,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women recruited from populations at increased risk of HIV and STIs: women who work in food and recreational facilities, including local food stalls, bars, guesthouses and brew shops.",Adult,U,16+,16,NR,NA,NA,NA,HIV negative,1146,0,0,TV,110,1146,0.095986038,genital fluid,culture,68.8,100,0.140344683,0.012820934,0.116662209,0.166799645,103.0094298,733.9745801
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Uganda,EA,EA,Rural,Masaka,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women recruited from populations at increased risk of HIV and STIs: women who are in discordant partnerships, i.e. husband / regular male partner is known to be HIV-positive.",Adult,U,16+,16,NR,NA,NA,NA,HIV negative,840,0,0,CT,5,840,0.005952381,genital fluid,NAAT,88.6,99.6,0.004190797,0.002964904,0.000295118,0.011366743,1.989519414,474.7352922
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Uganda,EA,EA,Rural,Masaka,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women recruited from populations at increased risk of HIV and STIs: women who are in discordant partnerships, i.e. husband / regular male partner is known to be HIV-positive.",Adult,U,16+,16,NR,NA,NA,NA,HIV negative,840,0,0,NG,24,840,0.028571429,genital fluid,NAAT,93.3,99.2,0.023437475,0.006352228,0.012114396,0.037229665,13.29442228,567.2292939
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Uganda,EA,EA,Rural,Masaka,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women recruited from populations at increased risk of HIV and STIs: women who are in discordant partnerships, i.e. husband / regular male partner is known to be HIV-positive.",Adult,U,16+,16,NR,NA,NA,NA,HIV negative,840,0,0,TV,97,840,0.11547619,genital fluid,culture,68.8,100,0.169038581,0.015888605,0.139036155,0.201619791,94.0548073,556.4102984
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Zambia,EA,EA,Rural,Mazabuka,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women who were provided with health care through their employment, or their partner's employment, on a sugar estate near the town of Mazabuka, as well as women in Mazabuka",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,1332,0,0,CT,9,1332,0.006756757,genital fluid,NAAT,88.6,99.6,0.004160385,0.002583966,0.000382212,0.010158025,2.581563553,620.5108004
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Zambia,EA,EA,Rural,Mazabuka,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women who were provided with health care through their employment, or their partner's employment, on a sugar estate near the town of Mazabuka, as well as women in Mazabuka",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,1332,0,0,NG,9,1332,0.006756757,genital fluid,NAAT,93.3,99.2,0.002082946,0.001729434,7.22E-05,0.006501816,1.447580679,694.9677796
#32527,McCormack 2010,MDP301,Sept,2005,Aug,2008,2010,2007,Zambia,EA,EA,Rural,Mazabuka,RCT,Convenience,Female,HIV/STI prevention trial participants,"MDP Trial Participants: Baseline. Women who were provided with health care through their employment, or their partner's employment, on a sugar estate near the town of Mazabuka, as well as women in Mazabuka",Adult,U,18+,18,NR,NA,NA,NA,HIV negative,1332,0,0,TV,105,1332,0.078828829,genital fluid,culture,68.8,100,0.115511397,0.010838965,0.095117071,0.137657274,100.453772,869.6438186
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Malawi,EA,EA,Urban,Blantyre,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.9,NA,NA,HIV negative,441,0,0,CT,3,441,0.006802721,urine,NAAT,87,99.8,0.008170151,0.005119863,0.001069203,0.020074008,2.525693475,309.136678
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Malawi,EA,EA,Urban,Blantyre,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.9,NA,NA,HIV negative,441,0,0,NG,7,441,0.015873016,urine,NAAT,91.6,100,0.019673084,0.006913465,0.008474365,0.035350647,7.938241515,403.5077266
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Malawi,EA,EA,Urban,Blantyre,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.9,NA,NA,HIV negative,441,0,0,TV,27,441,0.06122449,genital fluid,WM,52,100,0.121472739,0.022250124,0.081701391,0.169002376,26.18472407,215.5604975
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Malawi,EA,EA,Urban,Lilongwe,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,27.3,NA,NA,HIV negative,596,0,0,CT,2,596,0.003355705,urine,NAAT,87,99.8,0.004048612,0.003136607,0.000178447,0.011734967,1.659321085,409.8493345
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Malawi,EA,EA,Urban,Lilongwe,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,27.3,NA,NA,HIV negative,596,0,0,NG,2,596,0.003355705,urine,NAAT,91.6,100,0.005466784,0.003209077,0.001082431,0.013190566,2.886176235,527.9477143
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Malawi,EA,EA,Urban,Lilongwe,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,27.3,NA,NA,HIV negative,596,0,0,TV,67,596,0.112416107,genital fluid,WM,52,100,0.218398822,0.024484031,0.172092946,0.267284465,62.18991486,284.7538938
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,South Africa,SA,SA,Urban,Durban,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.2,NA,NA,HIV negative,702,0,0,CT,46,702,0.065527066,urine,NAAT,87,99.8,0.074506276,0.010908543,0.054683325,0.097002827,43.17434032,579.4725325
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,South Africa,SA,SA,Urban,Durban,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.2,NA,NA,HIV negative,702,0,0,NG,6,702,0.008547009,urine,NAAT,91.6,100,0.010928367,0.004145798,0.004436457,0.020292012,6.872614009,628.8784292
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,South Africa,SA,SA,Urban,Durban,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.2,NA,NA,HIV negative,702,0,0,TV,36,702,0.051282051,genital fluid,WM,52,100,0.10066759,0.015832057,0.071936745,0.133129932,36.36008573,361.1895919
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,South Africa,SA,SA,Rural,Hlabisa,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.3,NA,NA,HIV negative,346,0,0,CT,26,346,0.075144509,urine,NAAT,87,99.8,0.087535018,0.016818461,0.057048095,0.122316348,24.7176601,282.3745374
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,South Africa,SA,SA,Rural,Hlabisa,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.3,NA,NA,HIV negative,346,0,0,NG,4,346,0.011560694,urine,NAAT,91.6,100,0.015880406,0.007202236,0.005026868,0.032947445,4.784497647,301.2830875
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,South Africa,SA,SA,Rural,Hlabisa,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.3,NA,NA,HIV negative,346,0,0,TV,51,346,0.147398844,genital fluid,WM,52,100,0.286680929,0.036916799,0.218165761,0.363959863,43.0163301,150.0495004
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zambia,EA,EA,Urban,Lusaka,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,23,NA,NA,HIV negative,319,0,0,CT,10,319,0.031347962,urine,NAAT,87,99.8,0.03710707,0.01150659,0.018157176,0.062911149,10.01378054,269.8617978
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zambia,EA,EA,Urban,Lusaka,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,23,NA,NA,HIV negative,319,0,0,NG,2,319,0.006269592,urine,NAAT,91.6,100,0.010145241,0.00577356,0.002110212,0.024210018,3.05638993,301.2634275
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zambia,EA,EA,Urban,Lusaka,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,23,NA,NA,HIV negative,319,0,0,TV,21,319,0.065830721,genital fluid,WM,52,100,0.131558844,0.026566356,0.08519539,0.187957693,21.29690544,161.8812148
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zimbabwe,EA,EA,Rural,Chitungwiza,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.8,NA,NA,HIV negative,260,0,0,CT,10,260,0.038461538,urine,NAAT,87,99.8,0.045714744,0.013828355,0.022005793,0.076396022,10.42916975,228.1358011
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zimbabwe,EA,EA,Rural,Chitungwiza,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.8,NA,NA,HIV negative,260,0,0,NG,1,260,0.003846154,urine,NAAT,91.6,100,0.008269973,0.005956111,0.000876957,0.023040095,1.911948029,231.1915685
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zimbabwe,EA,EA,Rural,Chitungwiza,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,25.8,NA,NA,HIV negative,260,0,0,TV,16,260,0.061538462,genital fluid,WM,52,100,0.125618911,0.029365503,0.074197867,0.188503387,16.00058709,127.3740308
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zimbabwe,EA,EA,Urban,Harare,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,26.9,NA,NA,HIV negative,223,0,0,CT,6,223,0.02690583,urine,NAAT,87,99.8,0.03340684,0.013332848,0.01153808,0.063411559,6.06832222,181.6490946
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zimbabwe,EA,EA,Urban,Harare,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,26.9,NA,NA,HIV negative,223,0,0,NG,1,223,0.004484305,urine,NAAT,91.6,100,0.00970685,0.006572792,0.001241932,0.026373069,2.159835513,222.5063243
#22257,Guffey 2014,HPTN035,February,2005,NR,2007,2014,2006,Zimbabwe,EA,EA,Urban,Harare,RCT,Convenience,Female,HIV/STI prevention trial participants,HPTN035 Trial Participants: Baseline,Adult,U,18+,18,NR,26.9,NA,NA,HIV negative,223,0,0,TV,2,223,0.00896861,genital fluid,WM,52,100,0.02560718,0.014750295,0.005309969,0.061543382,2.936676948,114.6817766
#32521,Botswana Ministry of Health 2011,NA,NR,2007,NR,2008,2011,2008,Botswana,SA,SA,Mixed,7 Districts,Cross sectional,NR,Female,FP attendees,Women visiting FP clinic,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,CT,23,337,0.068249258,urine,NAAT,87,99.8,0.079166908,0.016374048,0.049666392,0.114195563,21.5256448,271.9020542
#32521,Botswana Ministry of Health 2011,NA,NR,2007,NR,2008,2011,2008,Botswana,SA,SA,Mixed,7 Districts,Cross sectional,NR,Female,FP attendees,Women visiting FP clinic,Adult,Y,NR,NR,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,11,337,0.03264095,urine,NAAT,91.6,100,0.038742783,0.010965972,0.020164541,0.062504817,11.99850061,309.696406
#22493,Kanyina 2017,NA,November,2013,January,2014,2017,2014,Kenya,EA,EA,Urban,Thika,Cross sectional,Convenience,Female,GYN attendees,women seeking Pap smear test at the health facility,Adult,U,15+,15,NR,42,NA,NA,Mixed,NA,NA,NR,TV,18,244,0.073770492,genital fluid,WM,52,100,0.147664735,0.032645479,0.088986116,0.218097859,17.43885433,118.0976235
#23080,Mukanyangezi 2018,NA,July,2015,October,2015,2018,2015,Rwanda,EA,EA,Urban,Butare,Cross sectional,NR,Female,GYN attendees,outpatient gyn / obstetric clinics,Adult,U,18+,18,NR,40,NA,NA,HIV negative,156,0,0,TV,9,156,0.057692308,genital fluid,WM,52,100,0.122005551,0.037490526,0.058715659,0.206072005,9.298392662,76.21286573
#23675,Squire 2019,NA,January,2016,April,2016,2019,2016,Ghana,WA,WA,Rural,"South Tongu District, Volta Region",Cross sectional,NR,Female,GYN attendees,women visiting STI and gynaecology clinics of selected health facilities; reasons for visit ranged from routine check-ups to diagnosis of observed clinical signs,Adult,U,16+,16,NR,28.5,NA,NA,Mixed,NA,NA,NR,TV,62,290,0.213793103,genital fluid,NAAT,95,98,0.210139158,0.025239103,0.163211526,0.260577482,54.75411023,260.5611949
#23675,Squire 2019,NA,January,2016,April,2016,2019,2016,Ghana,WA,WA,Urban,"Accra Metropolitan District, Greater Accra Region",Cross sectional,NR,Female,GYN attendees,women visiting STI and gynaecology clinics of selected health facilities; reasons for visit ranged from routine check-ups to diagnosis of observed clinical signs,Adult,U,16+,16,NR,29.8,NA,NA,Mixed,NA,NA,NR,TV,26,202,0.128712871,genital fluid,NAAT,95,98,0.120584733,0.025295694,0.075044501,0.174320272,19.98413957,165.7269464
#23742,Taku 2021,NA,September,2017,August,2018,2021,2018,South Africa,SA,SA,Rural,"Mthatha, Eastern Cape",Cross sectional,Convenience,Female,PHC/OPD attendees,women attending CHC for cervical cancer screening or other reasons,Adult,N,30+,30,NR,NA,45,38-53,Mixed,205,79,0.385,CT,5,205,0.024,genital fluid,NAAT,88.6,99.6,0.028006918,0.012843048,0.007563333,0.056697475,4.622293991,165.0411532
#23742,Taku 2021,NA,September,2017,August,2018,2021,2018,South Africa,SA,SA,Rural,"Mthatha, Eastern Cape",Cross sectional,Convenience,Female,PHC/OPD attendees,women attending CHC for cervical cancer screening or other reasons,Adult,N,30+,30,NR,NA,45,38-53,Mixed,205,79,0.385,NG,3,205,0.015,genital fluid,NAAT,93.3,99.2,0.013697277,0.009611803,0.000889653,0.036926665,2.002944786,146.2294102
#23742,Taku 2021,NA,September,2017,August,2018,2021,2018,South Africa,SA,SA,Rural,"Mthatha, Eastern Cape",Cross sectional,Convenience,Female,PHC/OPD attendees,women attending CHC for cervical cancer screening or other reasons,Adult,N,30+,30,NR,NA,45,38-53,Mixed,205,79,0.385,TV,32,205,0.156,genital fluid,NAAT,95,98,0.149498092,0.027046777,0.100945373,0.205824922,25.98457079,173.8120569
#23208,Nodjikouambaye 2019,GYNAUTO-STI,July,2017,July,2017,2019,2017,Chad,CA,CA,Urban,N'Djamena,Cross sectional,Convenience,Female,GYN attendees,women recruited from random districts in the community and referred to the gynecology clinic for women’s sexual health,Adult,U,18+,18,NR,NA,NA,NA,Mixed,251,9,3.60E-02,CT,3,251,0.011952191,genital fluid,NAAT,88.6,99.6,0.013899316,0.008915588,0.001292583,0.035792127,2.396669504,172.4307476
#23208,Nodjikouambaye 2019,GYNAUTO-STI,July,2017,July,2017,2019,2017,Chad,CA,CA,Urban,N'Djamena,Cross sectional,Convenience,Female,GYN attendees,women recruited from random districts in the community and referred to the gynecology clinic for women’s sexual health,Adult,U,18+,18,NR,NA,NA,NA,Mixed,251,9,3.60E-02,NG,1,251,0.003984064,genital fluid,NAAT,93.3,99.2,0.005625424,0.005202195,0.000143243,0.019042618,1.162752765,206.6960113
#23208,Nodjikouambaye 2019,GYNAUTO-STI,July,2017,July,2017,2019,2017,Chad,CA,CA,Urban,N'Djamena,Cross sectional,Convenience,Female,GYN attendees,women recruited from random districts in the community and referred to the gynecology clinic for women’s sexual health,Adult,U,18+,18,NR,NA,NA,NA,Mixed,251,9,3.60E-02,TV,1,251,0.003984064,genital fluid,NAAT,95,98,0.004855845,0.004664284,0.000130713,0.017553299,1.078563504,222.1165371
#22430,Jary 2021,NA,May,2018,June,2018,2021,2018,Mali,WA,WA,Urban,Sikasso,Cross sectional,NR,Female,PHC/OPD attendees,Women attending cervical cancer screening at clinic specialising in HIV,Adult,U,18+,18,NR,NA,37,29-44,Mixed,140,44,0.31,CT,6,144,0.041666667,genital fluid,NAAT,88.6,99.6,0.049856918,0.020289035,0.017476137,0.094141043,5.737425699,115.0778249
#22430,Jary 2021,NA,May,2018,June,2018,2021,2018,Mali,WA,WA,Urban,Sikasso,Cross sectional,NR,Female,PHC/OPD attendees,Women attending cervical cancer screening at clinic specialising in HIV,Adult,U,18+,18,NR,NA,37,29-44,Mixed,140,44,0.31,NG,2,144,0.013888889,genital fluid,NAAT,93.3,99.2,0.015864711,0.011838556,0.000757295,0.045258042,1.767346223,111.4010999
#22430,Jary 2021,NA,May,2018,June,2018,2021,2018,Mali,WA,WA,Urban,Sikasso,Cross sectional,NR,Female,PHC/OPD attendees,Women attending cervical cancer screening at clinic specialising in HIV,Adult,U,18+,18,NR,NA,37,29-44,Mixed,140,44,0.31,TV,10,144,0.069444444,genital fluid,NAAT,95,98,0.059707367,0.023209251,0.021046579,0.112342194,6.222954594,104.2242335
#22473,Kahsay 2023,NA,February,2018,June,2018,2023,2018,Ethiopia,EA,EA,Urban,"Mekelle, Tigrai",Cross sectional,Consecutive,Male,PHC/OPD attendees,"Private, non-profit clinic attendees (reason not reported)",Adult,U,15+,15,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,8,101,0.079207921,genital fluid,culture,87.6,100,0.099812284,0.031718506,0.047437972,0.171771118,8.914061339,89.30825898
#22473,Kahsay 2023,NA,February,2018,June,2018,2023,2018,Ethiopia,EA,EA,Urban,"Mekelle, Tigrai",Cross sectional,Consecutive,Female,PHC/OPD attendees,"Private, non-profit clinic attendees (reason not reported)",Adult,U,15+,15,NR,NA,NA,NA,Mixed,NA,NA,NR,NG,15,128,0.1171875,genital fluid,culture,75.7,100,0.162030165,0.036815355,0.096885849,0.240317995,16.23163038,100.1765958
#21993,Donders 2016,NA,NR,NR,NR,NR,2016,2013,Uganda,EA,EA,Urban,Kampala,Cross sectional,Consecutive,Female,PHC/OPD attendees,consecutive women presenting at OPD. 41% were pregnant,Adult,U,NR,NR,NR,28.3,NA,NA,Mixed,NA,NA,NR,CT,5,360,0.013888889,genital fluid,NAAT,88.6,99.6,0.014254256,0.007529817,0.002577305,0.0310703,3.532524042,247.8224156
#21993,Donders 2016,NA,NR,NR,NR,NR,2016,2013,Uganda,EA,EA,Urban,Kampala,Cross sectional,Consecutive,Female,PHC/OPD attendees,consecutive women presenting at OPD. 41% were pregnant,Adult,U,NR,NR,NR,28.3,NA,NA,Mixed,NA,NA,NR,NG,6,360,0.016666667,genital fluid,NAAT,93.3,99.2,0.012689963,0.007559156,0.001402215,0.030121972,2.782451625,219.2639667
#21993,Donders 2016,NA,NR,NR,NR,NR,2016,2013,Uganda,EA,EA,Urban,Kampala,Cross sectional,Consecutive,Female,PHC/OPD attendees,consecutive women presenting at OPD. 41% were pregnant,Adult,U,NR,NR,NR,28.3,NA,NA,Mixed,NA,NA,NR,TV,24,360,0.066666667,genital fluid,NAAT,95,98,0.05273907,0.014441188,0.026772544,0.083677035,12.63364671,239.5500458
#22353,Hoffman 2019,NA,NR,2016,NR,2016,2019,2016,South Africa,SA,SA,Rural,"Mopani District, Limpopo Province",Cross sectional,Consecutive,Female,PHC/OPD attendees,"Attendees of mobile clinic that provides health information and screening services for HIV, tuberculosis, noncommunicable diseases and cervical cancer. Stationed in rural areas for several days at a time. Assuming services are equivalent to PHC.",Adult,N,18 to 75,18,75,NA,34,NA,Mixed,251,28,0.11,CT,21,251,0.083665339,genital fluid,NAAT,88.6,99.6,0.093599467,0.019813021,0.05837394,0.135422799,20.22858497,216.1185908
#22353,Hoffman 2019,NA,NR,2016,NR,2016,2019,2016,South Africa,SA,SA,Rural,"Mopani District, Limpopo Province",Cross sectional,Consecutive,Female,PHC/OPD attendees,"Attendees of mobile clinic that provides health information and screening services for HIV, tuberculosis, noncommunicable diseases and cervical cancer. Stationed in rural areas for several days at a time. Assuming services are equivalent to PHC.",Adult,N,18 to 75,18,75,NA,34,NA,Mixed,251,28,0.11,NG,16,251,0.06374502,genital fluid,NAAT,93.3,99.2,0.064111575,0.017283336,0.033988214,0.101572367,12.87780376,200.8655035
#22353,Hoffman 2019,NA,NR,2016,NR,2016,2019,2016,South Africa,SA,SA,Rural,"Mopani District, Limpopo Province",Cross sectional,Consecutive,Female,PHC/OPD attendees,"Attendees of mobile clinic that provides health information and screening services for HIV, tuberculosis, noncommunicable diseases and cervical cancer. Stationed in rural areas for several days at a time. Assuming services are equivalent to PHC.",Adult,N,18 to 75,18,75,NA,34,NA,Mixed,251,28,0.11,TV,12,251,0.047808765,genital fluid,NAAT,95,98,0.03355085,0.014303897,0.009202275,0.063836416,5.317130189,158.4797457
#23174,Ngombe Mouabata 2024,NA,February,2021,May,2021,2024,2021,Congo,CA,CA,Urban,Brazzaville,Cross sectional,Consecutive,Female,GYN attendees,gynecology clinic attendees,Adult,N,21 to 71,21,71,41,NA,NA,Mixed,NA,NA,NR,CT,23,131,0.175572519,genital fluid,NAAT,88.6,99.6,0.200094696,0.037185487,0.132838059,0.278306014,23.16129245,115.7516563
#21750,Butcher 2023,NA,September,2019,February,2021,2023,2020,The Gambia,WA,WA,Unsure,Jarra Soma and 8 surrounding villages in Lower River Region,Cross sectional,Convenience,Female,HIV/STI prevention trial participants,Females >= 15 years participating in the HANDS trial and their mothers/female guardians (for participants < 15 years).,Adult,N,15 to 69,15,69,NA,25,19-36,Mixed,NA,NA,NR,CT,9,420,0.021,urine,NAAT,87,99.8,0.024841806,0.008514885,0.010164295,0.043627311,8.300109034,334.1185843
#21750,Butcher 2023,NA,September,2019,February,2021,2023,2020,The Gambia,WA,WA,Unsure,Jarra Soma and 8 surrounding villages in Lower River Region,Cross sectional,Convenience,Female,HIV/STI prevention trial participants,Females >= 15 years participating in the HANDS trial and their mothers/female guardians (for participants < 15 years).,Adult,N,15 to 69,15,69,NA,25,19-36,Mixed,NA,NA,NR,NG,1,420,0.002,urine,NAAT,91.6,100,0.005209477,0.003609961,0.000624227,0.014205572,2.07164287,397.6681365
#21750,Butcher 2023,NA,September,2019,February,2021,2023,2020,The Gambia,WA,WA,Unsure,Jarra Soma and 8 surrounding villages in Lower River Region,Cross sectional,Convenience,Female,HIV/STI prevention trial participants,Females >= 15 years participating in the HANDS trial and their mothers/female guardians (for participants < 15 years).,Adult,N,15 to 69,15,69,NA,25,19-36,Mixed,NA,NA,NR,TV,32,420,0.076,urine,NAAT,66.9,98.3,0.09416937,0.020119826,0.057940763,0.136844287,19.84348346,210.7212076
#26059,Moses 2015,NA,April,2014,June,2014,2015,2014,Uganda,EA,EA,Urban,"Kisenyi, Kampala",RCT,Convenience,Female,Community members,Community members who consented to participate in pilot RCT comparing two screening approaches for cervical cancer,Adult,N,30 to 65,30,65,39.1,NA,NA,Mixed,500,47,9.40E-02,CT,12,359,0.033426184,genital fluid,NAAT,88.6,99.6,0.036376645,0.011240912,0.017936422,0.061536642,10.09135531,277.4130307
#26059,Moses 2015,NA,April,2014,June,2014,2015,2014,Uganda,EA,EA,Urban,"Kisenyi, Kampala",RCT,Convenience,Female,Community members,Community members who consented to participate in pilot RCT comparing two screening approaches for cervical cancer,Adult,N,30 to 65,30,65,39.1,NA,NA,Mixed,500,47,9.40E-02,NG,5,359,0.013927577,genital fluid,NAAT,93.3,99.2,0.010085424,0.006982387,0.000556131,0.02665791,2.065276239,204.7783293
#22950,Menendez 2010,NA,August,2000,October,2000,2010,2000,Mozambique,EA,EA,Rural,Manhica,Cross sectional,NR,Female,ANC and FP attendees,59% were enrolled at the ANC and 7% at the family planning clinic (FPC),Adult,Y,14 to 61,14,61,NA,NA,NA,Mixed,256,30,0.12,CT,19,253,0.08,genital fluid,NAAT,88.6,99.6,0.084362544,0.019064609,0.050706629,0.124987986,17.92945498,212.5286184
#22950,Menendez 2010,NA,August,2000,October,2000,2010,2000,Mozambique,EA,EA,Rural,Manhica,Cross sectional,NR,Female,ANC and FP attendees,59% were enrolled at the ANC and 7% at the family planning clinic (FPC),Adult,Y,14 to 61,14,61,NA,NA,NA,Mixed,256,30,0.12,NG,34,250,0.14,genital fluid,culture,75.7,100,0.183698967,0.029129176,0.132666968,0.244004826,32.46439993,176.7260891
#22950,Menendez 2010,NA,August,2000,October,2000,2010,2000,Mozambique,EA,EA,Rural,Manhica,Cross sectional,NR,Female,ANC and FP attendees,59% were enrolled at the ANC and 7% at the family planning clinic (FPC),Adult,Y,14 to 61,14,61,NA,NA,NA,Mixed,256,30,0.12,TV,78,254,0.31,genital fluid,WM,52,100,0.592348865,0.054616862,0.491482069,0.699836563,47.95018547,80.94923156
#23895,Vieira-Baptista 2017,NA,NR,2015,NR,2015,2017,2015,Sao Tome and Principe,CA,CA,Urban,Principe Island,Cross sectional,Consecutive,Female,GYN attendees,"women invited (radio, religious service, word of mouth) for free appointment including PAP test, 23% of women were pregnant",Adult,N,21 to 60,21,60,34.8,NA,NA,Mixed,100,2,0.02,CT,3,100,0.03,genital fluid,NAAT,88.6,99.6,0.039930538,0.022039063,0.007956809,0.094065721,3.151568175,78.9262639
#23895,Vieira-Baptista 2017,NA,NR,2015,NR,2015,2017,2015,Sao Tome and Principe,CA,CA,Urban,Principe Island,Cross sectional,Consecutive,Female,GYN attendees,"women invited (radio, religious service, word of mouth) for free appointment including PAP test, 23% of women were pregnant",Adult,N,21 to 60,21,60,34.8,NA,NA,Mixed,100,2,0.02,NG,2,100,0.02,genital fluid,NAAT,93.3,99.2,0.024130587,0.017123603,0.001556367,0.065015775,1.937926037,80.30994167
#23895,Vieira-Baptista 2017,NA,NR,2015,NR,2015,2017,2015,Sao Tome and Principe,CA,CA,Urban,Principe Island,Cross sectional,Consecutive,Female,GYN attendees,"women invited (radio, religious service, word of mouth) for free appointment including PAP test, 23% of women were pregnant",Adult,N,21 to 60,21,60,34.8,NA,NA,Mixed,100,2,0.02,TV,8,100,0.08,genital fluid,NAAT,95,98,0.072774228,0.028912291,0.023570757,0.135978095,5.87456484,80.72314841
#22712,Lazenby 2014,NA,NR,NR,NR,NR,2014,2011,Tanzania,EA,EA,Rural,Arusha District,Cross sectional,NR,Female,GYN attendees,Ob/Gyn clinic attendees,Adult,N,30 to 60,30,60,NA,NA,NA,Mixed,319,5,1.57E-02,CT,0,324,0,genital fluid,NAAT,88.6,99.6,0.003459609,0.003362216,9.89E-05,0.012839727,1.055110037,304.9795729
#22712,Lazenby 2014,NA,NR,NR,NR,NR,2014,2011,Tanzania,EA,EA,Rural,Arusha District,Cross sectional,NR,Female,GYN attendees,Ob/Gyn clinic attendees,Adult,N,30 to 60,30,60,NA,NA,NA,Mixed,319,5,1.57E-02,NG,0,324,0,genital fluid,NAAT,93.3,99.2,0.003342252,0.003343596,9.46E-05,0.012330337,0.995856419,297.9597243
#22712,Lazenby 2014,NA,NR,NR,NR,NR,2014,2011,Tanzania,EA,EA,Rural,Arusha District,Cross sectional,NR,Female,GYN attendees,Ob/Gyn clinic attendees,Adult,N,30 to 60,30,60,NA,NA,NA,Mixed,319,5,1.57E-02,TV,31,297,0.104377104,genital fluid,NAAT,95,98,0.093278069,0.018871651,0.05908032,0.132460941,22.15202328,237.4837256
#30256,Agabi 2023,NA,NR,NR,NR,NR,2023,2020,Nigeria,WA,WA,Urban,Jos North,Cross sectional,NR,Female,GYN attendees,Gynecology clinic attendees,Adult,N,16 to 57,16,57,NA,NA,NA,Mixed,NA,NA,NR,TV,8,150,0.053,genital fluid,WM,52,100,0.113633331,0.036334158,0.053900977,0.193162916,8.669512659,76.29374751
#30264,Eyong 2023,NA,February,2022,July,2022,2023,2022,Cameroon,CA,CA,Mixed,North-West Region,Cross sectional,Random,Female,PHC/OPD attendees,Patients randomly selected among hospital attendees,Adult,Y,17 to 53,17,53,NA,NA,NA,Mixed,NA,NA,NR,TV,51,258,0.198,genital fluid,WM,52,100,0.3841365,0.04789167,0.295721526,0.485325604,39.6219326,103.1454511
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Kenya,EA,EA,Urban,Kisumu,Cohort,Convenience,Female,HIV/STI prevention trial participants,"HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation. In Kenya, 60% reported engaging in sex for money/gifts and median partners in last 60 days was 6.",Adult,Y,18 to 50,18,50,NA,24,22-27,HIV negative,82,0,0,CT,12,82,0.146,genital fluid or urine,NAAT,87,99.6,0.17451701,0.045338182,0.094853364,0.272575718,12.23081637,70.08380675
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Kenya,EA,EA,Urban,Kisumu,Cohort,Convenience,Female,HIV/STI prevention trial participants,"HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation. In Kenya, 60% reported engaging in sex for money/gifts and median partners in last 60 days was 6.",Adult,Y,18 to 50,18,50,NA,24,22-27,HIV negative,82,0,0,NG,5,82,0.061,genital fluid or urine,NAAT,91.6,99.2,0.069132767,0.030727074,0.019725925,0.138891007,4.712085984,68.15995097
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Botswana,SA,SA,Urban,Gaborone,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,26,22-30,HIV negative,150,0,0,CT,31,150,0.207,genital fluid or urine,NAAT,87,99.6,0.238164647,0.037713357,0.168057386,0.317635066,30.38262731,127.5698461
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Botswana,SA,SA,Urban,Gaborone,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,26,22-30,HIV negative,150,0,0,NG,8,150,0.052,genital fluid or urine,NAAT,91.6,99.2,0.056630334,0.021631486,0.020722956,0.106543115,6.465579559,114.1716652
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Malawi,EA,EA,Urban,Blantyre and Lilongwe,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,27,22-32,HIV negative,180,0,0,CT,13,180,0.072,genital fluid or urine,NAAT,87,99.6,0.083729432,0.02292597,0.044136149,0.133415517,12.22150201,145.964229
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Malawi,EA,EA,Urban,Blantyre and Lilongwe,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,27,22-32,HIV negative,180,0,0,NG,8,180,0.044,genital fluid or urine,NAAT,91.6,99.2,0.045410197,0.017393048,0.016516011,0.0843969,6.506870548,143.2909553
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Mozambique,EA,EA,Urban,Maputo,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,23,19-26,HIV negative,26,0,0,CT,5,26,0.192,genital fluid or urine,NAAT,87,99.6,0.24317556,0.090272452,0.091397544,0.446834261,5.491924077,22.58419418
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Mozambique,EA,EA,Urban,Maputo,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,23,19-26,HIV negative,26,0,0,NG,1,26,0.038,genital fluid or urine,NAAT,91.6,99.2,0.071068059,0.052189854,0.004970346,0.198651082,1.722505567,24.23740831
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,South Africa,SA,SA,Urban,"Cape Town, Durban, Johannesburg, Soweto, Vulindlela",Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,24,21-29,HIV negative,1019,0,0,CT,208,1019,0.204,genital fluid or urine,NAAT,87,99.6,0.231605464,0.014283467,0.204301351,0.260983538,202.0294076,872.2998315
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,South Africa,SA,SA,Urban,"Cape Town, Durban, Johannesburg, Soweto, Vulindlela",Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,24,21-29,HIV negative,1019,0,0,NG,59,1019,0.058,genital fluid or urine,NAAT,91.6,99.2,0.055976757,0.008059775,0.040930587,0.072533929,45.53573388,813.4757434
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Tanzania,EA,EA,Urban,Mbeya,Cohort,Convenience,Female,HIV/STI prevention trial participants,"HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation. In tanzania, 39% reported engaging in sex for money/gifts and median partners in last 60 days was 3.",Adult,Y,18 to 50,18,50,NA,27,24-36,HIV negative,33,0,0,CT,5,33,0.152,genital fluid or urine,NAAT,87,99.6,0.194454967,0.072804602,0.072872224,0.355876091,5.746590425,29.55229436
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Tanzania,EA,EA,Urban,Mbeya,Cohort,Convenience,Female,HIV/STI prevention trial participants,"HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation. In tanzania, 39% reported engaging in sex for money/gifts and median partners in last 60 days was 3.",Adult,Y,18 to 50,18,50,NA,27,24-36,HIV negative,33,0,0,NG,3,33,0.091,genital fluid or urine,NAAT,91.6,99.2,0.117250806,0.059237113,0.026782091,0.251026573,3.458447838,29.49615404
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Zimbabwe,EA,EA,Urban,Harare,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,27,24-32,HIV negative,434,0,0,CT,52,434,0.12,genital fluid or urine,NAAT,87,99.6,0.135713577,0.018236315,0.101590873,0.173572138,47.8663285,352.701104
#22966,Mgodi 2021,HVTN703 / HPTN081,May,2016,September,2018,2021,2017,Zimbabwe,EA,EA,Urban,Harare,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN 703/HPTN 081 baseline. HIV-negative heterosexual women who had engaged in vaginal and/or anal intercourse with a male partner 6 months before randomisation.,Adult,Y,18 to 50,18,50,NA,27,24-32,HIV negative,434,0,0,NG,25,434,0.058,genital fluid or urine,NAAT,91.6,99.2,0.057113246,0.012624545,0.034537581,0.084170523,19.29753181,337.8818937
#24009,Yirenya-Tawiah 2014,NA,October,2005,March,2006,2014,2006,Ghana,WA,WA,Rural,Volta Basin Area,Cross sectional,Convenience,Female,Community members,Cross-sectional survey of community,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,NA,NA,NR,CT,12,191,0.062827225,genital fluid,NAAT,88.6,99.6,0.071170983,0.020019066,0.036154582,0.115226943,11.73962075,164.9495376
#24009,Yirenya-Tawiah 2014,NA,October,2005,March,2006,2014,2006,Ghana,WA,WA,Rural,Volta Basin Area,Cross sectional,Convenience,Female,Community members,Cross-sectional survey of community,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,NA,NA,NR,NG,5,191,0.02617801,genital fluid,NAAT,93.3,99.2,0.025178789,0.013737946,0.004351236,0.056443542,3.274545633,130.0517531
#21635,Behanzin 2012,NA,NR,2008,NR,2008,2012,2008,Benin,WA,WA,Urban,Cotonou,Cross sectional,Random,Male,Population-representative survey participants,Cluster survey: General population,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,1040,0,0.02,CT,23,1040,0.022,urine,NAAT,87.8,99.3,0.01827696,0.005199633,0.008773459,0.029401415,12.1297407,663.6629131
#21635,Behanzin 2012,NA,NR,2008,NR,2008,2012,2008,Benin,WA,WA,Urban,Cotonou,Cross sectional,Random,Male,Population-representative survey participants,Cluster survey: General population,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,1040,0,0.02,NG,3,1040,0.003,urine,NAAT,80.9,99.9,0.003550447,0.00234005,0.000323706,0.009241324,2.293882504,646.0827915
#21635,Behanzin 2012,NA,NR,2008,NR,2008,2012,2008,Benin,WA,WA,Urban,Cotonou,Cross sectional,Random,Female,Population-representative survey participants,Cluster survey: General population,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,1241,0,0.04,CT,21,1230,0.017,urine,NAAT,87,99.8,0.018238555,0.004392987,0.010514272,0.028052331,16.92259554,927.8474042
#21635,Behanzin 2012,NA,NR,2008,NR,2008,2012,2008,Benin,WA,WA,Urban,Cotonou,Cross sectional,Random,Female,Population-representative survey participants,Cluster survey: General population,Adult,Y,15 to 49,15,49,NA,NA,NA,Mixed,1241,0,0.04,NG,8,1241,0.006,urine,NAAT,91.6,100,0.007952366,0.002623823,0.003598021,0.013753599,9.112893541,1145.934912
#23092,Mulu 2015,NA,May,2013,November,2013,2015,2013,Ethiopia,EA,EA,Mixed,Bahir Dar,Cross sectional,Random,Female,ANC and GYN attendees,ANC and GYN attendees,Adult,Y,15 to 49,15,49,NA,28,15-49,Mixed,NA,NA,NR,NG,2,214,0.009345794,genital fluid,culture,75.7,100,0.01846882,0.010678764,0.003809259,0.045262943,2.935894502,158.9649205
#23092,Mulu 2015,NA,May,2013,November,2013,2015,2013,Ethiopia,EA,EA,Mixed,Bahir Dar,Cross sectional,Random,Female,ANC and GYN attendees,ANC and GYN attendees,Adult,Y,15 to 49,15,49,NA,28,15-49,Mixed,NA,NA,NR,TV,3,214,0.014018692,genital fluid,WM,52,100,0.035448289,0.017477026,0.009554362,0.077279607,3.968085381,111.94011
#22587,Kharsany 2020,HIPSS,June,2014,June,2015,2020,2015,South Africa,SA,SA,Rural and peri-urban,KwaZulu-Natal,Cross sectional,Random,Male,Population-representative survey participants,Household survey participants,Adult,Y,15 to 49,15,49,NA,26,20-35,Mixed,3529,734,0.208,CT,188,3529,0.053272882,urine,NAAT,87.8,99.3,0.053406843,0.004282675,0.045130722,0.062203269,147.2065046,2756.322904
#22587,Kharsany 2020,HIPSS,June,2014,June,2015,2020,2015,South Africa,SA,SA,Rural and peri-urban,KwaZulu-Natal,Cross sectional,Random,Male,Population-representative survey participants,Household survey participants,Adult,Y,15 to 49,15,49,NA,26,20-35,Mixed,3529,734,0.208,NG,69,3529,0.019552281,urine,NAAT,80.9,99.9,0.023248588,0.002999181,0.017738347,0.029547342,58.69103138,2524.498705
#22587,Kharsany 2020,HIPSS,June,2014,June,2015,2020,2015,South Africa,SA,SA,Rural and peri-urban,KwaZulu-Natal,Cross sectional,Random,Male,Population-representative survey participants,Household survey participants,Adult,Y,15 to 49,15,49,NA,26,20-35,Mixed,3529,734,0.208,TV,155,3528,0.04393424,urine,NAAT,96,97.7,0.022601624,0.003688416,0.015754171,0.030100793,36.70043104,1623.79623
#22587,Kharsany 2020,HIPSS,June,2014,June,2015,2020,2015,South Africa,SA,SA,Rural and peri-urban,KwaZulu-Natal,Cross sectional,Random,Female,Population-representative survey participants,Household survey participants,Adult,Y,15 to 49,15,49,NA,27,21-36,Mixed,6249,2756,0.441,CT,555,6249,0.08881421,genital fluid,NAAT,88.6,99.6,0.096274197,0.003967974,0.08862621,0.104280896,532.0089559,5525.976532
#22587,Kharsany 2020,HIPSS,June,2014,June,2015,2020,2015,South Africa,SA,SA,Rural and peri-urban,KwaZulu-Natal,Cross sectional,Random,Female,Population-representative survey participants,Household survey participants,Adult,Y,15 to 49,15,49,NA,27,21-36,Mixed,6249,2756,0.441,NG,226,6249,0.036165787,genital fluid,NAAT,93.3,99.2,0.030597254,0.002557922,0.025706894,0.035756237,138.7057437,4533.2743
#22587,Kharsany 2020,HIPSS,June,2014,June,2015,2020,2015,South Africa,SA,SA,Rural and peri-urban,KwaZulu-Natal,Cross sectional,Random,Female,Population-representative survey participants,Household survey participants,Adult,Y,15 to 49,15,49,NA,27,21-36,Mixed,6249,2756,0.441,TV,1002,6249,0.160345655,genital fluid,NAAT,95,98,0.151315879,0.00502709,0.141531167,0.161353026,768.9211651,5081.562954
#23733,Tadesse 2016,NA,November,2014,April,2015,2016,2015,Ethiopia,EA,EA,Urban,Hawassa,Cross sectional,Consecutive,Female,GYN attendees,Non-pregnant women who had not taken antibiotics,Adult,Y,15 to 49,15,49,29.6,NA,NA,Mixed,NA,NA,NR,NG,1,322,0.00310559,genital fluid,culture,75.7,100,0.00800465,0.005489572,0.000939257,0.021814627,2.109198073,263.4966089
#22196,Ginindza 2017,NA,June,2015,July,2015,2017,2015,Eswatini,SA,SA,Mixed,National,Cross sectional,Random,Female,PHC/OPD attendees,women of reproductive age attending OPD,Adult,Y,15 to 49,15,49,32.2,NA,NA,Mixed,655,276,0.421,CT,38,655,0.058015267,genital fluid,NAAT,88.6,99.6,0.062804667,0.010399405,0.043977991,0.084674971,34.18196048,544.2582894
#22196,Ginindza 2017,NA,June,2015,July,2015,2017,2015,Eswatini,SA,SA,Mixed,National,Cross sectional,Random,Female,PHC/OPD attendees,women of reproductive age attending OPD,Adult,Y,15 to 49,15,49,32.2,NA,NA,Mixed,655,276,0.421,NG,35,655,0.053435115,genital fluid,NAAT,93.3,99.2,0.050503757,0.009815462,0.03253405,0.071809594,25.13733011,497.7318821
#22196,Ginindza 2017,NA,June,2015,July,2015,2017,2015,Eswatini,SA,SA,Mixed,National,Cross sectional,Random,Female,PHC/OPD attendees,women of reproductive age attending OPD,Adult,Y,15 to 49,15,49,32.2,NA,NA,Mixed,655,276,0.421,TV,51,655,0.077862595,genital fluid,NAAT,95,98,0.063295255,0.011431264,0.042489606,0.086804077,28.71815631,453.7173623
#21869,Cowley 2021,NA,May,2016,July,2016,2021,2016,Guinea-Bissau,WA,WA,Rural,Bubaque Island,Cross sectional,Random,Male,Population-representative survey participants,General population,Adult,Y,16 to 49,16,49,25.6,NA,NA,Mixed,NA,NA,NR,CT,2,195,0.01025641,urine,NAAT,87.8,99.3,0.011755267,0.00935442,0.000415938,0.035451063,1.560614914,132.7587788
#21869,Cowley 2021,NA,May,2016,July,2016,2021,2016,Guinea-Bissau,WA,WA,Rural,Bubaque Island,Cross sectional,Random,Male,Population-representative survey participants,General population,Adult,Y,16 to 49,16,49,25.6,NA,NA,Mixed,NA,NA,NR,NG,7,195,0.035897436,urine,NAAT,80.9,99.9,0.049602007,0.017366586,0.020836835,0.087744497,7.753095009,156.3060762
#21869,Cowley 2021,NA,May,2016,July,2016,2021,2016,Guinea-Bissau,WA,WA,Rural,Bubaque Island,Cross sectional,Random,Male,Population-representative survey participants,General population,Adult,Y,16 to 49,16,49,25.6,NA,NA,Mixed,NA,NA,NR,TV,0,195,0,urine,NAAT,96,97.7,0.005303025,0.005261197,0.000143156,0.019602308,1.010576167,190.5659887
#21869,Cowley 2021,NA,May,2016,July,2016,2021,2016,Guinea-Bissau,WA,WA,Rural,Bubaque Island,Cross sectional,Random,Female,Population-representative survey participants,General population,Adult,Y,16 to 49,16,49,NA,NA,NA,Mixed,NA,NA,NR,CT,16,283,0.056537102,genital fluid or urine,NAAT,87,99.6,0.064617026,0.016414912,0.036771761,0.100284337,14.49460064,224.3155009
#21869,Cowley 2021,NA,May,2016,July,2016,2021,2016,Guinea-Bissau,WA,WA,Rural,Bubaque Island,Cross sectional,Random,Female,Population-representative survey participants,General population,Adult,Y,16 to 49,16,49,NA,NA,NA,Mixed,NA,NA,NR,NG,11,283,0.038869258,genital fluid or urine,NAAT,91.6,99.2,0.037580743,0.013215364,0.015312411,0.066470528,7.782816086,207.0958563
#21869,Cowley 2021,NA,May,2016,July,2016,2021,2016,Guinea-Bissau,WA,WA,Rural,Bubaque Island,Cross sectional,Random,Female,Population-representative survey participants,General population,Adult,Y,16 to 49,16,49,NA,NA,NA,Mixed,NA,NA,NR,TV,28,283,0.098939929,genital fluid or urine,NAAT,66.9,98,0.125261125,0.027678741,0.076524401,0.184755569,17.91506487,143.0217463
#23109,Muvunyi 2011,NA,November,2007,March,2010,2011,2009,Rwanda,EA,EA,Urban,Kigali,Cross sectional,Convenience,Female,Community members,Infertility study: Controls. Fertile controls who had recently delivered were recruited from the community through random selection of neighbourhoods,Adult,Y,21 to 45,21,45,NA,NA,NA,Mixed,312,50,0.16,CT,12,312,0.038461538,genital fluid,NAAT,88.6,99.6,0.042838173,0.013124517,0.020454815,0.072131342,10.19719163,238.0398342
#23109,Muvunyi 2011,NA,November,2007,March,2010,2011,2009,Rwanda,EA,EA,Urban,Kigali,Cross sectional,Convenience,Female,Community members,Infertility study: Controls. Fertile controls who had recently delivered were recruited from the community through random selection of neighbourhoods,Adult,Y,21 to 45,21,45,NA,NA,NA,Mixed,312,50,0.16,NG,15,312,0.048076923,genital fluid,NAAT,93.3,99.2,0.046307042,0.01357194,0.02381321,0.076012462,11.10244889,239.7572466
#22394,Huyveneers 2023,IPM027,March,2014,November,2015,2023,2015,South Africa,SA,SA,Rural,"Elandsdoorn, Elias Motsoaledi Municipality, Sekhukhune District in Limpopo",RCT,Convenience,Female,HIV/STI prevention trial participants,"IMP 027 baseline. Women were hiv-negative, sexually active, non-pregnant",Adult,Y,18 to 45,18,45,NA,NA,NA,HIV negative,119,0,0,CT,31,119,0.261,genital fluid,NAAT,88.6,99.6,0.295408262,0.046327783,0.210043123,0.391449133,28.64836164,96.97887734
#22394,Huyveneers 2023,IPM027,March,2014,November,2015,2023,2015,South Africa,SA,SA,Rural,"Elandsdoorn, Elias Motsoaledi Municipality, Sekhukhune District in Limpopo",RCT,Convenience,Female,HIV/STI prevention trial participants,"IMP 027 baseline. Women were hiv-negative, sexually active, non-pregnant",Adult,Y,18 to 45,18,45,NA,NA,NA,HIV negative,119,0,0,NG,4,119,0.034,genital fluid,NAAT,93.3,99.2,0.0361277,0.019387708,0.006541673,0.081796058,3.346934431,92.64177912
#22394,Huyveneers 2023,IPM027,March,2014,November,2015,2023,2015,South Africa,SA,SA,Rural,"Elandsdoorn, Elias Motsoaledi Municipality, Sekhukhune District in Limpopo",RCT,Convenience,Female,HIV/STI prevention trial participants,"IMP 027 baseline. Women were hiv-negative, sexually active, non-pregnant",Adult,Y,18 to 45,18,45,NA,NA,NA,HIV negative,119,0,0,TV,9,119,0.076,genital fluid,rapid antigen test,83.3,98.8,0.085415128,0.030647775,0.034476096,0.152807341,7.103881416,83.16889029
#24745,Lokken 2022,Microbiota and Preterm Birth Study,April,2017,March,2020,2022,2019,Kenya,EA,EA,Urban,Nairobi and Mombasa,Cohort,Consecutive,Female,FP attendees,Microbiota and Preterm Birth Study baseline. HIV-negative women who are currently planning to become pregnant (not using contraception other than condoms for HIV/STI prevention),Adult,Y,18 to 45,18,45,NA,29,25-34,HIV negative,691,0,0,CT,51,691,0.074,genital fluid,NAAT,88.6,99.6,0.080669339,0.011121543,0.0601024,0.104041789,48.3680563,599.5841411
#24745,Lokken 2022,Microbiota and Preterm Birth Study,April,2017,March,2020,2022,2019,Kenya,EA,EA,Urban,Nairobi and Mombasa,Cohort,Consecutive,Female,FP attendees,Microbiota and Preterm Birth Study baseline. HIV-negative women who are currently planning to become pregnant (not using contraception other than condoms for HIV/STI prevention),Adult,Y,18 to 45,18,45,NA,29,25-34,HIV negative,691,0,0,NG,5,691,0.007,genital fluid,NAAT,93.3,99.2,0.003502501,0.002865102,0.00013121,0.010468131,1.489198287,425.181408
#24745,Lokken 2022,Microbiota and Preterm Birth Study,April,2017,March,2020,2022,2019,Kenya,EA,EA,Urban,Nairobi and Mombasa,Cohort,Consecutive,Female,FP attendees,Microbiota and Preterm Birth Study baseline. HIV-negative women who are currently planning to become pregnant (not using contraception other than condoms for HIV/STI prevention),Adult,Y,18 to 45,18,45,NA,29,25-34,HIV negative,691,0,0,TV,6,691,0.009,genital fluid,NAAT,95,98,0.002447955,0.002387694,7.32E-05,0.00874355,1.048540272,428.3332153
#24650,Delany-Moretlwe 2022,HPTN084,November,2017,November,2020,2022,2019,"Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda, Zimbabwe",Multiple,EA,Mixed,Multiple,RCT,Convenience,Female,HIV/STI prevention trial participants,"HPTN084 baseline: women reporting at least two episodes of vaginal intercourse in prev 30 days, at risk of HIV based on an HIV risk score, and agreed to use a long-acting reversible contraceptive method",Adult,Y,18 to 45,18,45,NA,25,22-30,HIV negative,3189,0,0,CT,604,3189,0.189401066,genital fluid,NAAT,88.6,99.6,0.21041478,0.007666952,0.195614881,0.225174068,594.7110939,2826.375092
#24650,Delany-Moretlwe 2022,HPTN084,November,2017,November,2020,2022,2019,"Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda, Zimbabwe",Multiple,EA,Mixed,Multiple,RCT,Convenience,Female,HIV/STI prevention trial participants,"HPTN084 baseline: women reporting at least two episodes of vaginal intercourse in prev 30 days, at risk of HIV based on an HIV risk score, and agreed to use a long-acting reversible contraceptive method",Adult,Y,18 to 45,18,45,NA,25,22-30,HIV negative,3189,0,0,NG,210,3189,0.065851364,genital fluid,NAAT,93.3,99.2,0.06281591,0.004704025,0.053939573,0.072028032,167.1186759,2660.451417
#24650,Delany-Moretlwe 2022,HPTN084,November,2017,November,2020,2022,2019,"Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda, Zimbabwe",Multiple,EA,Mixed,Multiple,RCT,Convenience,Female,HIV/STI prevention trial participants,"HPTN084 baseline: women reporting at least two episodes of vaginal intercourse in prev 30 days, at risk of HIV based on an HIV risk score, and agreed to use a long-acting reversible contraceptive method",Adult,Y,18 to 45,18,45,NA,25,22-30,HIV negative,3189,0,0,TV,270,3133,0.086179381,genital fluid,rapid antigen test,83.3,98.8,0.090607283,0.006101523,0.078959034,0.103019922,200.5400729,2213.288664
#32524,Odaranle 2020,NA,June,2017,December,2017,2020,2017,Nigeria,WA,WA,Urban,"Sagamu, Ogun State",Cross sectional,Consecutive,Female,FP attendees,women using contraception,Adult,Y,20 to 45,20,45,NA,NA,NA,Mixed,NA,NA,NR,TV,6,406,0.014778325,genital fluid,WM,52,100,0.032708411,0.012312824,0.013524302,0.061252438,6.825916291,208.6899359
#24232,Senkoro 2024,NA,May,2022,November,2022,2024,2022,Tanzania,EA,EA,Mixed,Dodoma and Dar es Salaam,Cross sectional,Consecutive,Female,GYN attendees,Reproductive and child health clinic attendees,Adult,Y,18 to 45,18,45,28,NA,NA,Mixed,NA,NA,NR,NG,10,400,0.025,genital fluid,culture,75.7,100,0.036202158,0.010579853,0.01844484,0.060114319,11.28484592,311.7174916
#24232,Senkoro 2024,NA,May,2022,November,2022,2024,2022,Tanzania,EA,EA,Mixed,Dodoma and Dar es Salaam,Cross sectional,Consecutive,Female,GYN attendees,Reproductive and child health clinic attendees,Adult,Y,18 to 45,18,45,28,NA,NA,Mixed,NA,NA,NR,TV,39,400,0.098,genital fluid,WM,52,100,0.191301584,0.028511878,0.138267388,0.250862304,36.40592522,190.3064496
#26009,Nnaemeka 2016,NA,NR,NR,NR,NR,2016,2013,Nigeria,WA,WA,Mixed,Ebonyi State,Cross sectional,Random,Female,Population-representative survey participants,"Women of childbearing age from community, excluding pregnant women. Randomly sampled.",Adult,Y,22 to 42,22,42,NA,NA,NA,Mixed,NA,NA,NR,TV,263,1000,0.263,genital fluid,WM,52,100,0.506835231,0.02684323,0.456047965,0.560874018,175.8150632,346.888007
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,FP attendees,"Reference group, recruited from FP clinic",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,110,0,0,CT,4,110,0.036363636,genital fluid,NAAT,88.6,99.6,0.046278237,0.022335371,0.012920952,0.097309287,4.094387714,88.47328721
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,FP attendees,"Reference group, recruited from FP clinic",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,110,0,0,NG,1,110,0.009090909,genital fluid,NAAT,93.3,99.2,0.014261019,0.012522807,0.000438381,0.047225569,1.278379159,89.64150259
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Consecutive,Female,FP attendees,"Reference group, recruited from FP clinic",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,110,0,0,TV,3,110,0.027272727,genital fluid,culture,68.8,100,0.051497352,0.024916152,0.013992726,0.108580484,4.051784944,78.67948131
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Consecutive,Female,FP attendees,"Reference group, recruited from FP clinic",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,109,0,0,CT,18,109,0.165137615,genital fluid,NAAT,88.6,99.6,0.190393479,0.040167864,0.120157557,0.275448323,18.18949539,95.536336
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Consecutive,Female,FP attendees,"Reference group, recruited from FP clinic",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,109,0,0,NG,1,109,0.009174312,genital fluid,NAAT,93.3,99.2,0.014661615,0.012943814,0.000458289,0.048323417,1.264225393,86.22688371
#22440,Jespers 2014,NA,NR,2010,NR,2011,2014,2011,South Africa,SA,SA,Urban,Johannesburg,Cross sectional,Consecutive,Female,FP attendees,"Reference group, recruited from FP clinic",Adult,Y,18 to 35,18,35,25,NA,NA,HIV negative,109,0,0,TV,5,109,0.04587156,genital fluid,culture,68.8,100,0.07861806,0.030606702,0.030334259,0.148376917,6.07926766,77.32660478
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,Kenya,EA,EA,Urban,Kisumu,RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,901,0,0,CT,99,901,0.11,genital fluid,NAAT,88.6,99.6,0.120948818,0.012091707,0.09859321,0.145371456,87.95128527,727.1777157
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,Kenya,EA,EA,Urban,Kisumu,RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,901,0,0,NG,27,901,0.03,genital fluid,NAAT,93.3,99.2,0.024801536,0.006112462,0.014091772,0.038225778,16.05527754,647.3501167
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,Eswatini,SA,SA,Urban,Manzini,RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,502,0,0,CT,80,502,0.16,genital fluid,NAAT,88.6,99.6,0.177225708,0.018986807,0.142414715,0.215160634,71.68532945,404.4860657
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,Eswatini,SA,SA,Urban,Manzini,RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,502,0,0,NG,25,502,0.05,genital fluid,NAAT,93.3,99.2,0.046871041,0.010731531,0.027253511,0.069942023,18.181827,387.9117386
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,South Africa,SA,SA,Mixed,"Brits, Cape Town, Durban, East London, Edendale, Johannesburg, Ladysmith, Soshanguve",RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,5768,0,0,CT,1231,5768,0.213580097,genital fluid,NAAT,88.6,99.6,0.237502162,0.00620949,0.225315823,0.249960012,1115.480286,4696.716351
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,South Africa,SA,SA,Mixed,"Brits, Cape Town, Durban, East London, Edendale, Johannesburg, Ladysmith, Soshanguve",RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,5768,0,0,NG,312,5768,0.054242372,genital fluid,NAAT,93.3,99.2,0.05000843,0.003268122,0.043813528,0.056625058,222.4383971,4448.018001
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,Zambia,EA,EA,Urban,Lusaka,RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,658,0,0,CT,59,658,0.09,genital fluid,NAAT,88.6,99.6,0.09872089,0.012852903,0.075090601,0.125834505,53.1710179,538.5994596
#21935,Deese 2021,ECHO,December,2015,September,2017,2021,2016,Zambia,EA,EA,Urban,Lusaka,RCT,Convenience,Female,FP attendees,"Non-pregnant, HIV-seronegative women aged 16–35 years participating in ECHO trial who were seeking effective contraception",Adult,Y,16 to 35,16,35,NA,NA,NA,HIV negative,658,0,0,NG,19,658,0.03,genital fluid,NAAT,93.3,99.2,0.02406563,0.00719,0.011589453,0.0394862,10.93345146,454.3181109
#32528,Gray 2021,HVTN702,October,2016,June,2019,2021,2018,South Africa,SA,SA,Mixed,Multiple,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN702 baseline: HIV negative participants,Adult,Y,18 to 35,18,35,NA,NA,NA,HIV negative,3389,0,0,CT,779,3389,0.23,genital fluid,NAAT,88.6,99.6,0.256073287,0.008180749,0.240516809,0.272398788,728.9077364,2846.480961
#32528,Gray 2021,HVTN702,October,2016,June,2019,2021,2018,South Africa,SA,SA,Mixed,Multiple,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN702 baseline: HIV negative participants,Adult,Y,18 to 35,18,35,NA,NA,NA,HIV negative,3389,0,0,NG,179,3389,0.05,genital fluid,NAAT,93.3,99.2,0.048781847,0.004153793,0.040803337,0.05712004,131.1918392,2689.35776
#32528,Gray 2021,HVTN702,October,2016,June,2019,2021,2018,South Africa,SA,SA,Mixed,Multiple,Cohort,Convenience,Female,HIV/STI prevention trial participants,HVTN702 baseline: HIV negative participants,Adult,Y,18 to 35,18,35,NA,NA,NA,HIV negative,3389,0,0,TV,192,3389,0.06,genital fluid,rapid antigen test,83.3,98.8,0.054723732,0.004789193,0.045677894,0.064587443,123.42001,2255.328815
#32528,Gray 2021,HVTN702,October,2016,June,2019,2021,2018,South Africa,SA,SA,Mixed,Multiple,Cohort,Convenience,Male,HIV/STI prevention trial participants,HVTN702 baseline: HIV negative participants,Adult,Y,18 to 35,18,35,NA,NA,NA,HIV negative,1252,0,0,CT,199,1252,0.16,urine,NAAT,87.8,99.3,0.175031841,0.011978181,0.151640737,0.198735774,176.1528108,1006.404377
#32528,Gray 2021,HVTN702,October,2016,June,2019,2021,2018,South Africa,SA,SA,Mixed,Multiple,Cohort,Convenience,Male,HIV/STI prevention trial participants,HVTN702 baseline: HIV negative participants,Adult,Y,18 to 35,18,35,NA,NA,NA,HIV negative,1252,0,0,NG,39,1252,0.03,urine,NAAT,80.9,99.9,0.038102088,0.006160826,0.026773119,0.051317022,36.79159305,965.6056938
#23319,Otieno 2015,Kisumu Incidence Cohort Study (KICoS),January,2007,March,2009,2015,2008,Kenya,EA,EA,Peri-urban,Kisumu,Cross sectional,Convenience,Male,Community members,"Cohort Study: HIV-negative individuals. Healthy adults, sexually active at least once in the past three months, HIV-negative, and not pregnant. individuals recruited for HIV incidence cohort study (recruitment in multiple venues such as market centers, truck stops, beaches, churches, women’s groups, community groups, formal and informal work-based groups, colleges and schools, and HIV Voluntary Counseling and Testing centers)",Adult,Y,18 to 34,18,34,NA,NA,NA,HIV negative,422,0,0,CT,12,422,0.028436019,urine,NAAT,87.8,99.3,0.027083979,0.00970882,0.010988753,0.047622084,7.571246061,279.5470401
#23319,Otieno 2015,Kisumu Incidence Cohort Study (KICoS),January,2007,March,2009,2015,2008,Kenya,EA,EA,Peri-urban,Kisumu,Cross sectional,Convenience,Male,Community members,"Cohort Study: HIV-negative individuals. Healthy adults, sexually active at least once in the past three months, HIV-negative, and not pregnant. individuals recruited for HIV incidence cohort study (recruitment in multiple venues such as market centers, truck stops, beaches, churches, women’s groups, community groups, formal and informal work-based groups, colleges and schools, and HIV Voluntary Counseling and Testing centers)",Adult,Y,18 to 34,18,34,NA,NA,NA,HIV negative,422,0,0,NG,0,422,0,urine,NAAT,80.9,99.9,0.002881495,0.002922878,7.24E-05,0.010654106,0.969083321,336.3127222
#23319,Otieno 2015,Kisumu Incidence Cohort Study (KICoS),January,2007,March,2009,2015,2008,Kenya,EA,EA,Peri-urban,Kisumu,Cross sectional,Convenience,Female,Community members,"Cohort Study: HIV-negative individuals. Healthy adults, sexually active at least once in the past three months, HIV-negative, and not pregnant. individuals recruited for HIV incidence cohort study (recruitment in multiple venues such as market centers, truck stops, beaches, churches, women’s groups, community groups, formal and informal work-based groups, colleges and schools, and HIV Voluntary Counseling and Testing centers)",Adult,Y,18 to 34,18,34,NA,NA,NA,HIV negative,424,0,0,CT,12,424,0.028301887,genital fluid,NAAT,88.6,99.6,0.030260187,0.009376177,0.014061679,0.050919186,10.10059254,333.7914803
#23319,Otieno 2015,Kisumu Incidence Cohort Study (KICoS),January,2007,March,2009,2015,2008,Kenya,EA,EA,Peri-urban,Kisumu,Cross sectional,Convenience,Female,Community members,"Cohort Study: HIV-negative individuals. Healthy adults, sexually active at least once in the past three months, HIV-negative, and not pregnant. individuals recruited for HIV incidence cohort study (recruitment in multiple venues such as market centers, truck stops, beaches, churches, women’s groups, community groups, formal and informal work-based groups, colleges and schools, and HIV Voluntary Counseling and Testing centers)",Adult,Y,18 to 34,18,34,NA,NA,NA,HIV negative,424,0,0,NG,20,424,0.047169811,genital fluid,NAAT,93.3,99.2,0.044360441,0.011019052,0.024971456,0.067935926,15.4880719,349.1415247
#21932,de Walque 2012,NA,February,2009,April,2012,2012,2011,Tanzania,EA,EA,Rural,"Kilombero/Ulanga districts, Ifakaraa HDSS",RCT,Convenience,Male,HIV/STI prevention trial participants,Community based,Adult,Y,18 to 30,18,30,NA,NA,NA,Mixed,2399,85,3.54E-02,CT,20,1195,0.016736402,urine,NAAT,87.8,99.3,0.012117346,0.004164632,0.004716391,0.021072208,8.363094762,690.175474
#21932,de Walque 2012,NA,February,2009,April,2012,2012,2011,Tanzania,EA,EA,Rural,"Kilombero/Ulanga districts, Ifakaraa HDSS",RCT,Convenience,Male,HIV/STI prevention trial participants,Community based,Adult,Y,18 to 30,18,30,NA,NA,NA,Mixed,2399,85,3.54E-02,NG,5,1195,0.0041841,urine,NAAT,80.9,99.9,0.004976337,0.002390433,0.001155836,0.010474026,4.312210081,866.5430295
#21932,de Walque 2012,NA,February,2009,April,2012,2012,2011,Tanzania,EA,EA,Rural,"Kilombero/Ulanga districts, Ifakaraa HDSS",RCT,Convenience,Male,HIV/STI prevention trial participants,Community based,Adult,Y,18 to 30,18,30,NA,NA,NA,Mixed,2399,85,3.54E-02,TV,102,1195,0.085355649,urine,NAAT,96,97.7,0.067362239,0.008788455,0.050633179,0.085691328,54.79248663,813.400609
#21932,de Walque 2012,NA,February,2009,April,2012,2012,2011,Tanzania,EA,EA,Rural,"Kilombero/Ulanga districts, Ifakaraa HDSS",RCT,Convenience,Female,HIV/STI prevention trial participants,Community based,Adult,Y,18 to 30,18,30,NA,NA,NA,Mixed,2399,85,3.54E-02,CT,32,1204,0.02657807,urine,NAAT,87,99.8,0.029204816,0.005228059,0.019594403,0.04011303,30.2939314,1037.292307
#21932,de Walque 2012,NA,February,2009,April,2012,2012,2011,Tanzania,EA,EA,Rural,"Kilombero/Ulanga districts, Ifakaraa HDSS",RCT,Convenience,Female,HIV/STI prevention trial participants,Community based,Adult,Y,18 to 30,18,30,NA,NA,NA,Mixed,2399,85,3.54E-02,NG,17,1204,0.0141196,urine,NAAT,91.6,100,0.016316122,0.003862108,0.009475724,0.024436268,17.55660664,1076.028181
#21932,de Walque 2012,NA,February,2009,April,2012,2012,2011,Tanzania,EA,EA,Rural,"Kilombero/Ulanga districts, Ifakaraa HDSS",RCT,Convenience,Female,HIV/STI prevention trial participants,Community based,Adult,Y,18 to 30,18,30,NA,NA,NA,Mixed,2399,85,3.54E-02,TV,195,1204,0.161960132,urine,NAAT,66.9,98.3,0.223205521,0.016144412,0.191057793,0.255021157,148.4812199,665.221985
#22337,Heffron 2021,NA,August,2019,February,2020,2021,2020,Kenya,EA,EA,Urban,Thika and Kisumu,Cross sectional,Consecutive,Female,GYN attendees,Women seeking post-abortion services,Adult,Y,15 to 30,15,30,NA,21,19-22,HIV negative,198,0,0,CT,36,198,0.181818182,urine,NAAT,87,99.8,0.210368113,0.031214966,0.153124508,0.271993891,35.86400292,170.4821253
#22337,Heffron 2021,NA,August,2019,February,2020,2021,2020,Kenya,EA,EA,Urban,Thika and Kisumu,Cross sectional,Consecutive,Female,GYN attendees,Women seeking post-abortion services,Adult,Y,15 to 30,15,30,NA,21,19-22,HIV negative,198,0,0,NG,4,198,0.02020202,urine,NAAT,91.6,100,0.027234351,0.012067367,0.009221652,0.055325755,4.954698645,181.9282821
#23326,Oware 2023,DoxyPEP,February,2020,November,2021,2023,2021,Kenya,EA,EA,Urban,"Lumumba, Kisumu",Cohort,NR,Female,HIV/STI prevention trial participants,"DoxyPEP study baseline. HIV-negative, cisgender young women with a current prescription for HIV PrEP according to the national guidelines of Kenya",Adult,Y,18 to 30,18,30,NA,24,21-27,HIV negative,448,0,0,CT,63,448,0.141,genital fluid,NAAT,88.6,99.6,0.156449062,0.018603581,0.121822343,0.194996748,59.6573719,381.3213788
#23326,Oware 2023,DoxyPEP,February,2020,November,2021,2023,2021,Kenya,EA,EA,Urban,"Lumumba, Kisumu",Cohort,NR,Female,HIV/STI prevention trial participants,"DoxyPEP study baseline. HIV-negative, cisgender young women with a current prescription for HIV PrEP according to the national guidelines of Kenya",Adult,Y,18 to 30,18,30,NA,24,21-27,HIV negative,448,0,0,NG,17,448,0.038,genital fluid,NAAT,93.3,99.2,0.034740477,0.009862402,0.017621608,0.055608129,11.97706052,344.7580931
#22428,Jarolimova 2023,AHRI HDSS,March,2020,May,2021,2023,2021,South Africa,SA,SA,Rural,"uMkhanyakude District, KwaZulu-Natal",RCT,Random,Male,Population-representative survey participants,"baseline data from RCT, participants randomly selected from HDSS",Adult,Y,16 to 29,16,29,NA,21.2,18.8-25.3,Mixed,NA,NA,NR,CT,57,386,0.147,urine,NAAT,87.8,99.3,0.164051342,0.020814265,0.125802303,0.205116358,51.92984175,316.5462791
#22428,Jarolimova 2023,AHRI HDSS,March,2020,May,2021,2023,2021,South Africa,SA,SA,Rural,"uMkhanyakude District, KwaZulu-Natal",RCT,Random,Male,Population-representative survey participants,"baseline data from RCT, participants randomly selected from HDSS",Adult,Y,16 to 29,16,29,NA,21.2,18.8-25.3,Mixed,NA,NA,NR,NG,18,386,0.046,urine,NAAT,80.9,99.9,0.05939133,0.013338953,0.035287503,0.087258885,18.64711301,313.970291
#22428,Jarolimova 2023,AHRI HDSS,March,2020,May,2021,2023,2021,South Africa,SA,SA,Rural,"uMkhanyakude District, KwaZulu-Natal",RCT,Random,Male,Population-representative survey participants,"baseline data from RCT, participants randomly selected from HDSS",Adult,Y,16 to 29,16,29,NA,21.2,18.8-25.3,Mixed,NA,NA,NR,TV,3,386,0.007,urine,NAAT,96,97.7,0.003709754,0.003463187,0.00010539,0.012976038,1.143205182,308.1619879
#22428,Jarolimova 2023,AHRI HDSS,March,2020,May,2021,2023,2021,South Africa,SA,SA,Rural,"uMkhanyakude District, KwaZulu-Natal",RCT,Random,Female,Population-representative survey participants,"baseline data from RCT, participants randomly selected from HDSS",Adult,Y,16 to 29,16,29,NA,22.5,18.9-25.8,Mixed,NA,NA,NR,CT,87,414,0.21,genital fluid,NAAT,88.6,99.6,0.235587022,0.02237078,0.193090883,0.280013361,84.77513839,359.8463864
#22428,Jarolimova 2023,AHRI HDSS,March,2020,May,2021,2023,2021,South Africa,SA,SA,Rural,"uMkhanyakude District, KwaZulu-Natal",RCT,Random,Female,Population-representative survey participants,"baseline data from RCT, participants randomly selected from HDSS",Adult,Y,16 to 29,16,29,NA,22.5,18.9-25.8,Mixed,NA,NA,NR,NG,22,414,0.053,genital fluid,NAAT,93.3,99.2,0.050924893,0.012307655,0.02871184,0.078011287,16.24838384,319.0656477
#22428,Jarolimova 2023,AHRI HDSS,March,2020,May,2021,2023,2021,South Africa,SA,SA,Rural,"uMkhanyakude District, KwaZulu-Natal",RCT,Random,Female,Population-representative survey participants,"baseline data from RCT, participants randomly selected from HDSS",Adult,Y,16 to 29,16,29,NA,22.5,18.9-25.8,Mixed,NA,NA,NR,TV,42,414,0.101,genital fluid,NAAT,95,98,0.089295562,0.016474689,0.058687199,0.122909718,26.75486399,299.6214304
#23515,Rutherford 2014,Crane Survey,September,2008,April,2009,2014,2009,Uganda,EA,EA,Urban,Kampala,Cross sectional,Respondent-driven sampling,Female,Students,5 universities in Kampala - students already made sexual debut,Youth,Y,19 to 25,19,25,NA,NA,NA,Mixed,280,2.52,9.00E-03,CT,7,280,0.025,genital fluid,NAAT,88.6,99.6,0.027879415,0.011202395,0.009829731,0.053481157,6.020959258,215.964334
#23515,Rutherford 2014,Crane Survey,September,2008,April,2009,2014,2009,Uganda,EA,EA,Urban,Kampala,Cross sectional,Respondent-driven sampling,Female,Students,5 universities in Kampala - students already made sexual debut,Youth,Y,19 to 25,19,25,NA,NA,NA,Mixed,280,2.52,9.00E-03,NG,3,280,0.010714286,genital fluid,NAAT,93.3,99.2,0.008714601,0.006681739,0.00046039,0.025499245,1.686221853,193.4938764
#23515,Rutherford 2014,Crane Survey,September,2008,April,2009,2014,2009,Uganda,EA,EA,Urban,Kampala,Cross sectional,Respondent-driven sampling,Female,Students,5 universities in Kampala - students already made sexual debut,Youth,Y,19 to 25,19,25,NA,NA,NA,Mixed,280,2.52,9.00E-03,TV,2,247,0.008097166,genital fluid,culture,68.8,100,0.017643405,0.009952807,0.003646129,0.042599947,3.087043795,174.9687067
#23515,Rutherford 2014,Crane Survey,September,2008,April,2009,2014,2009,Uganda,EA,EA,Urban,Kampala,Cross sectional,Respondent-driven sampling,Male,Students,5 universities in Kampala - students already made sexual debut,Youth,Y,19 to 25,19,25,NA,NA,NA,Mixed,360,1.44,4.00E-03,CT,3,360,0.008333333,urine,NAAT,87.8,99.3,0.006906882,0.005760813,0.000210031,0.021453079,1.427534136,206.6828735
#23515,Rutherford 2014,Crane Survey,September,2008,April,2009,2014,2009,Uganda,EA,EA,Urban,Kampala,Cross sectional,Respondent-driven sampling,Male,Students,5 universities in Kampala - students already made sexual debut,Youth,Y,19 to 25,19,25,NA,NA,NA,Mixed,360,1.44,4.00E-03,NG,0,360,0,urine,NAAT,80.9,99.9,0.003385961,0.003291251,0.000108866,0.012048912,1.054797088,311.5206987
#21936,Delany-Moretlwe 2023,HPTN082,October,2016,October,2018,2023,2017,South Africa,SA,SA,Urban,Cape Town and Johannesburg,Cohort,Convenience,Female,HIV/STI prevention trial participants,HPTN082 baseline: HIV negative women who had vaginal or anal sex in last month and were ready to initiate PrEP,Youth,Y,16 to 25,16,25,NA,NA,NA,HIV negative,303,0,0,CT,106,303,0.349834983,genital fluid,NAAT,88.6,99.6,0.393382188,0.030540405,0.334487762,0.454383554,100.6456362,255.8469581
#21936,Delany-Moretlwe 2023,HPTN082,October,2016,October,2018,2023,2017,South Africa,SA,SA,Urban,Cape Town and Johannesburg,Cohort,Convenience,Female,HIV/STI prevention trial participants,HPTN082 baseline: HIV negative women who had vaginal or anal sex in last month and were ready to initiate PrEP,Youth,Y,16 to 25,16,25,NA,NA,NA,HIV negative,303,0,0,NG,27,303,0.089108911,genital fluid,NAAT,93.3,99.2,0.090960821,0.01786679,0.058751682,0.127196674,23.56124788,259.0263335
#21936,Delany-Moretlwe 2023,HPTN082,October,2016,October,2018,2023,2017,South Africa,SA,SA,Urban,Cape Town and Johannesburg,Cohort,Convenience,Female,HIV/STI prevention trial participants,HPTN082 baseline: HIV negative women who had vaginal or anal sex in last month and were ready to initiate PrEP,Youth,Y,16 to 25,16,25,NA,NA,NA,HIV negative,303,0,0,TV,17,303,0.056105611,genital fluid,rapid antigen test,83.3,98.8,0.057761892,0.016353499,0.029271304,0.092080137,11.75498633,203.5076402
#21936,Delany-Moretlwe 2023,HPTN082,October,2016,October,2018,2023,2017,Zimbabwe,SA,SA,Urban,Harare,Cohort,Convenience,Female,HIV/STI prevention trial participants,HPTN082 baseline: HIV negative women who had vaginal or anal sex in last month and were ready to initiate PrEP,Youth,Y,16 to 25,16,25,NA,NA,NA,HIV negative,148,0,0,CT,30,148,0.202702703,genital fluid,NAAT,88.6,99.6,0.230091766,0.038204936,0.161163634,0.312007634,27.92557796,121.3671329
#21936,Delany-Moretlwe 2023,HPTN082,October,2016,October,2018,2023,2017,Zimbabwe,SA,SA,Urban,Harare,Cohort,Convenience,Female,HIV/STI prevention trial participants,HPTN082 baseline: HIV negative women who had vaginal or anal sex in last month and were ready to initiate PrEP,Youth,Y,16 to 25,16,25,NA,NA,NA,HIV negative,148,0,0,NG,8,148,0.054054054,genital fluid,NAAT,93.3,99.2,0.055858733,0.021066418,0.020241501,0.103308233,6.638007429,118.8356249
#21936,Delany-Moretlwe 2023,HPTN082,October,2016,October,2018,2023,2017,Zimbabwe,SA,SA,Urban,Harare,Cohort,Convenience,Female,HIV/STI prevention trial participants,HPTN082 baseline: HIV negative women who had vaginal or anal sex in last month and were ready to initiate PrEP,Youth,Y,16 to 25,16,25,NA,NA,NA,HIV negative,148,0,0,TV,11,148,0.074324324,genital fluid,rapid antigen test,83.3,98.8,0.083234319,0.028067659,0.034510972,0.146105761,8.062149076,96.86087634
#21775,Celum 2022,POWER,June,2017,September,2020,2022,2019,Kenya,EA,EA,Urban,Kisumu,Cohort,NR,Female,FP attendees,"POWER baseline: HIV negative, had vaginal intercourse in the prior 3 months and interested in PrEP. AGYW seeking family planning, SRH services and primary care.",Youth,Y,16 to 25,16,25,NA,21,19-23,HIV negative,1000,0,0,CT,172,1000,0.172,genital fluid,NAAT,88.6,99.6,0.191299311,0.013277769,0.165771047,0.21699155,167.8666549,877.5078907
#21775,Celum 2022,POWER,June,2017,September,2020,2022,2019,Kenya,EA,EA,Urban,Kisumu,Cohort,NR,Female,FP attendees,"POWER baseline: HIV negative, had vaginal intercourse in the prior 3 months and interested in PrEP. AGYW seeking family planning, SRH services and primary care.",Youth,Y,16 to 25,16,25,NA,21,19-23,HIV negative,1000,0,0,NG,61,1000,0.061,genital fluid,NAAT,93.3,99.2,0.058251302,0.008178071,0.042832143,0.075104695,47.77982593,820.2361927
#21775,Celum 2022,POWER,June,2017,September,2020,2022,2019,South Africa,SA,SA,Urban,Kisumu,Cohort,NR,Female,FP attendees,"POWER baseline: HIV negative, had vaginal intercourse in the prior 3 months and interested in PrEP. AGYW seeking family planning, SRH services and primary care.",Youth,Y,16 to 25,16,25,NA,21,19-23,HIV negative,1550,0,0,CT,495,1550,0.319354839,genital fluid,NAAT,88.6,99.6,0.357765421,0.013408102,0.33148498,0.384042165,457.2521822,1278.078191
#21775,Celum 2022,POWER,June,2017,September,2020,2022,2019,South Africa,SA,SA,Urban,Kisumu,Cohort,NR,Female,FP attendees,"POWER baseline: HIV negative, had vaginal intercourse in the prior 3 months and interested in PrEP. AGYW seeking family planning, SRH services and primary care.",Youth,Y,16 to 25,16,25,NA,21,19-23,HIV negative,1550,0,0,NG,160,1550,0.103225806,genital fluid,NAAT,93.3,99.2,0.103524264,0.008473787,0.087350074,0.120548782,133.8035793,1292.485205
#22456,Jongen 2021,EVRI,October,2012,July,2013,2021,2013,South Africa,SA,SA,Urban,Western Cape,Cross sectional,NR,Female,PHC/OPD attendees,"Non- pregnant, HIV-negative women participating in EVRI trial (Efficacy of HPV Vaccine to Reduce HIV Infection)",Youth,Y,16 to 24,16,24,NA,20,19-22,HIV negative,365,0,0,CT,123,365,0.336986301,urine,NAAT,87,99.8,0.386765972,0.02883062,0.330692913,0.443592059,110.3607877,285.3425472
#22456,Jongen 2021,EVRI,October,2012,July,2013,2021,2013,South Africa,SA,SA,Urban,Western Cape,Cross sectional,NR,Female,PHC/OPD attendees,"Non- pregnant, HIV-negative women participating in EVRI trial (Efficacy of HPV Vaccine to Reduce HIV Infection)",Youth,Y,16 to 24,16,24,NA,20,19-22,HIV negative,365,0,0,NG,38,365,0.104109589,urine,NAAT,91.6,100,0.116044087,0.017246501,0.083743368,0.151938548,40.01977629,344.8670004
#22864,Masese 2017,NA,August,2014,March,2015,2017,2015,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Convenience,Female,Students,University or high school students,Youth,Y,15 to 24,15,24,NA,18,17-19,Mixed,NA,NA,NR,CT,16,451,0.035476718,urine,NAAT,87,99.8,0.04081308,0.010062859,0.023328758,0.061851896,15.7782644,386.5982298
#22864,Masese 2017,NA,August,2014,March,2015,2017,2015,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Convenience,Female,Students,University or high school students,Youth,Y,15 to 24,15,24,NA,18,17-19,Mixed,NA,NA,NR,NG,7,451,0.015521064,urine,NAAT,91.6,100,0.019183818,0.00679533,0.008221998,0.03464936,7.816936278,407.475519
#22864,Masese 2017,NA,August,2014,March,2015,2017,2015,Kenya,EA,EA,Urban,Mombasa,Cross sectional,Convenience,Female,Students,University or high school students,Youth,Y,15 to 24,15,24,NA,18,17-19,Mixed,NA,NA,NR,TV,3,451,0.006651885,urine,NAAT,66.9,98.3,0.004655767,0.004486636,0.000138927,0.016317184,1.071800713,230.2092597
#22123,Francis 2018,NA,October,2016,January,2017,2018,2017,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Random,Male,Population-representative survey participants,random sample of HDSS area; issue with enrollment rates - but are above 60%,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,82,7,8.50E-02,CT,10,188,0.053191489,urine,NAAT,87.8,99.3,0.058350543,0.019499488,0.024789777,0.100307143,8.432039553,144.5066179
#22123,Francis 2018,NA,October,2016,January,2017,2018,2017,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Random,Male,Population-representative survey participants,random sample of HDSS area; issue with enrollment rates - but are above 60%,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,82,7,8.50E-02,NG,3,188,0.015957447,urine,NAAT,80.9,99.9,0.02469874,0.012732885,0.006463395,0.054495449,3.669735015,148.5798491
#22123,Francis 2018,NA,October,2016,January,2017,2018,2017,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Random,Male,Population-representative survey participants,random sample of HDSS area; issue with enrollment rates - but are above 60%,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,82,7,8.50E-02,TV,1,188,0.005319149,urine,NAAT,96,97.7,0.006537629,0.006503748,0.000170256,0.024232239,1.003840159,153.5480499
#22123,Francis 2018,NA,October,2016,January,2017,2018,2017,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Random,Female,Population-representative survey participants,random sample of HDSS area; issue with enrollment rates - but are above 60%,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,148,29,0.196,CT,29,259,0.111969112,genital fluid,NAAT,88.6,99.6,0.125958404,0.022765023,0.084956906,0.173560235,26.75778944,212.4335377
#22123,Francis 2018,NA,October,2016,January,2017,2018,2017,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Random,Female,Population-representative survey participants,random sample of HDSS area; issue with enrollment rates - but are above 60%,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,148,29,0.196,NG,5,259,0.019305019,genital fluid,NAAT,93.3,99.2,0.016589552,0.009703083,0.002447463,0.039733951,2.874647824,173.2806199
#22123,Francis 2018,NA,October,2016,January,2017,2018,2017,South Africa,SA,SA,Rural,KwaZulu-Natal,Cross sectional,Random,Female,Population-representative survey participants,random sample of HDSS area; issue with enrollment rates - but are above 60%,Youth,Y,15 to 24,15,24,NA,NA,NA,Mixed,148,29,0.196,TV,12,259,0.046332046,genital fluid,NAAT,95,98,0.031942304,0.014151107,0.007875922,0.063735685,4.932338355,154.4139841
#22853,Martin 2021,CHIEDZA,June,2019,January,2020,2021,2020,Zimbabwe,EA,EA,Urban,Harare,Cohort,Consecutive,Male,Community members,STICH (nested in CHIEDZA) trial participants accessing a community-based sexual and reproductive service,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,NA,NA,NR,CT,22,300,0.0733,urine,NAAT,87.8,99.3,0.079177727,0.017016167,0.048993621,0.115089795,19.93693481,251.7997858
#22853,Martin 2021,CHIEDZA,June,2019,January,2020,2021,2020,Zimbabwe,EA,EA,Urban,Harare,Cohort,Consecutive,Male,Community members,STICH (nested in CHIEDZA) trial participants accessing a community-based sexual and reproductive service,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,NA,NA,NR,NG,7,300,0.0233,urine,NAAT,80.9,99.9,0.031474783,0.011387184,0.012958414,0.057087393,7.399523555,235.0937106
#22853,Martin 2021,CHIEDZA,June,2019,January,2020,2021,2020,Zimbabwe,EA,EA,Urban,Harare,Cohort,Consecutive,Female,Community members,STICH (nested in CHIEDZA) trial participants accessing a community-based sexual and reproductive service,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,NA,NA,NR,CT,178,1201,0.1482,urine,NAAT,87,99.8,0.169111763,0.011605228,0.146522974,0.192349141,176.4342381,1043.299618
#22853,Martin 2021,CHIEDZA,June,2019,January,2020,2021,2020,Zimbabwe,EA,EA,Urban,Harare,Cohort,Consecutive,Female,Community members,STICH (nested in CHIEDZA) trial participants accessing a community-based sexual and reproductive service,Youth,Y,16 to 24,16,24,NA,NA,NA,Mixed,NA,NA,NR,NG,27,1201,0.0225,urine,NAAT,91.6,100,0.025484528,0.004843517,0.016945458,0.03611979,26.97864921,1058.628564
#22920,Mcharo 2022,NA,March,2019,January,2020,2022,2020,Tanzania,EA,EA,Urban,Mbeya Region,Cross sectional,Random,Female,Students,Students,Youth,Y,18 to 24,18,24,NA,NA,NA,Mixed,186,3,1.60E-02,CT,25,186,0.134408602,urine,NAAT,87,99.8,0.157034544,0.029053865,0.102864729,0.217776128,24.62591406,156.8184514
#22920,Mcharo 2022,NA,March,2019,January,2020,2022,2020,Tanzania,EA,EA,Urban,Mbeya Region,Cross sectional,Random,Female,Students,Students,Youth,Y,18 to 24,18,24,NA,NA,NA,Mixed,186,3,1.60E-02,NG,1,186,0.005376344,urine,NAAT,91.6,100,0.011655416,0.008322595,0.001376426,0.032548871,1.938413599,166.31012
#22920,Mcharo 2022,NA,March,2019,January,2020,2022,2020,Tanzania,EA,EA,Urban,Mbeya Region,Cross sectional,Random,Male,Students,Students,Youth,Y,18 to 24,18,24,NA,NA,NA,Mixed,260,0,0,CT,24,260,0.092307692,urine,NAAT,87.8,99.3,0.101732919,0.02024919,0.06495814,0.144536727,22.67321874,222.8700292
#22920,Mcharo 2022,NA,March,2019,January,2020,2022,2020,Tanzania,EA,EA,Urban,Mbeya Region,Cross sectional,Random,Male,Students,Students,Youth,Y,18 to 24,18,24,NA,NA,NA,Mixed,260,0,0,NG,4,260,0.015384615,urine,NAAT,80.9,99.9,0.022457774,0.010572595,0.006246808,0.047094861,4.410682461,196.3989138
#22220,Gorgens 2020,NA,NR,2016,NR,2016,2020,2016,Eswatini,SA,SA,Mixed,National,Cross sectional,Random,Female,HIV/STI prevention trial participants,"AGYW, HIV negative, eligible for school enrolment",Youth,Y,15 to 22,15,22,18.22,NA,NA,HIV negative,4533,0,0,TV,150,4533,0.033090668,genital fluid,rapid antigen test,83.3,98.8,0.026031644,0.003235975,0.020126488,0.0326185,63.02859674,2421.229983
#22934,Mehta 2023,CaCHe study,March,2018,April,2018,2023,2018,Kenya,EA,EA,Unsure,Siaya County,Cohort,Random,Female,Students,Secondary school girls,Youth,Y,14 to 22,14,22,NA,NA,NA,Mixed,436,7,1.61E-02,CT,43,436,0.098623853,genital fluid,NAAT,88.6,99.6,0.109085795,0.016158561,0.079898011,0.143199553,40.60382235,372.2191543
#22934,Mehta 2023,CaCHe study,March,2018,April,2018,2023,2018,Kenya,EA,EA,Unsure,Siaya County,Cohort,Random,Female,Students,Secondary school girls,Youth,Y,14 to 22,14,22,NA,NA,NA,Mixed,436,7,1.61E-02,NG,27,436,0.061926606,genital fluid,NAAT,93.3,99.2,0.060650036,0.012486478,0.037885625,0.086411639,22.16203508,365.4084427
#22934,Mehta 2023,CaCHe study,March,2018,April,2018,2023,2018,Kenya,EA,EA,Unsure,Siaya County,Cohort,Random,Female,Students,Secondary school girls,Youth,Y,14 to 22,14,22,NA,NA,NA,Mixed,436,7,1.61E-02,TV,6,436,0.013761468,genital fluid,rapid antigen test,83.3,98.8,0.007776688,0.006096927,0.000320921,0.022657879,1.614272063,207.5783465
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,South Africa,SA,SA,Urban,Cape Town and Johannesburg,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,127,0,0,CT,45,127,0.354330709,genital fluid,NAAT,88.6,99.6,0.400478362,0.048603491,0.305021414,0.496079381,40.70315296,101.636335
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,South Africa,SA,SA,Urban,Cape Town and Johannesburg,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,127,0,0,NG,16,127,0.125984252,genital fluid,NAAT,93.3,99.2,0.13273325,0.031490094,0.076230868,0.200423481,15.40863736,116.0872457
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,South Africa,SA,SA,Urban,Cape Town and Johannesburg,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,127,0,0,TV,6,127,0.047244094,genital fluid,rapid antigen test,83.3,98.8,0.051867847,0.024210313,0.01311748,0.107254416,4.351755665,83.90083518
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,Uganda,EA,EA,Urban,Kampala,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,60,0,0,CT,16,60,0.266666667,genital fluid,NAAT,88.6,99.6,0.30625213,0.063735952,0.190511809,0.444892771,16.01736048,52.30122148
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,Uganda,EA,EA,Urban,Kampala,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,60,0,0,NG,3,60,0.05,genital fluid,NAAT,93.3,99.2,0.061028101,0.032610092,0.012359643,0.135138365,3.288578942,53.8863063
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,Uganda,EA,EA,Urban,Kampala,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,60,0,0,TV,1,60,0.016666667,genital fluid,rapid antigen test,83.3,98.8,0.031068156,0.026075493,0.001178704,0.094933377,1.375495328,44.27347815
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,Zimbabwe,EA,EA,Urban,Harare,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,60,0,0,CT,6,60,0.1,genital fluid,NAAT,88.6,99.6,0.123503676,0.045998534,0.049326867,0.225370039,6.318614704,51.16134948
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,Zimbabwe,EA,EA,Urban,Harare,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,60,0,0,NG,2,60,0.033333333,genital fluid,NAAT,93.3,99.2,0.044322161,0.029484972,0.004768071,0.113716524,2.15949367,48.72266251
#24387,Nair 2023,MTN-034/REACH,February,2019,September,2021,2023,2020,Zimbabwe,EA,EA,Urban,Harare,RCT,NR,Female,HIV/STI prevention trial participants,"REACH trial baseline: healthy, sexually active, hiv-negative, non-pregnant",Youth,Y,16 to 21,16,21,NA,NA,NA,HIV negative,60,0,0,TV,6,60,0.1,genital fluid,rapid antigen test,83.3,98.8,0.123275509,0.048302762,0.044583036,0.232696595,5.710482783,46.32293008
#30140,Galappaththi-Arachchige 2016,NA,NR,2011,NR,2013,2016,2012,South Africa,SA,SA,Rural,KwaZulu-Natal,Cohort,Consecutive,Female,Students,High school students,Youth,Y,16 to 20,16,20,NA,18,NA,Mixed,1351,241,0.171,CT,328,1325,0.24754717,genital fluid,NAAT,88.6,99.6,0.276584728,0.013618805,0.250388672,0.303622315,298.3774773,1078.792311
#30140,Galappaththi-Arachchige 2016,NA,NR,2011,NR,2013,2016,2012,South Africa,SA,SA,Rural,KwaZulu-Natal,Cohort,Consecutive,Female,Students,High school students,Youth,Y,16 to 20,16,20,NA,18,NA,Mixed,1351,241,0.171,NG,145,1325,0.109433962,genital fluid,NAAT,93.3,99.2,0.11043099,0.009263492,0.092604475,0.129301618,126.418929,1144.777644
#30140,Galappaththi-Arachchige 2016,NA,NR,2011,NR,2013,2016,2012,South Africa,SA,SA,Rural,KwaZulu-Natal,Cohort,Consecutive,Female,Students,High school students,Youth,Y,16 to 20,16,20,NA,18,NA,Mixed,1351,241,0.171,TV,245,1371,0.178701678,genital fluid,NAAT,95,98,0.171294738,0.010961756,0.150632805,0.193571527,202.3614924,1181.364325
#24013,Yuh 2020,Kenya Girls Study (KGS),NR,2014,NR,2016,2020,2015,Kenya,EA,EA,Urban,Thika,Cohort,Convenience,Female,Students,Cohort of low risk girls with no history of sexual intercourse or sex with only one partner,Youth,Y,16 to 20,16,20,NA,18.6,NA,HIV negative,373,0,0,CT,41,373,0.109919571,genital fluid,NAAT,88.6,99.6,0.121929013,0.018077829,0.088996542,0.159237232,39.94396561,327.6001711
#24013,Yuh 2020,Kenya Girls Study (KGS),NR,2014,NR,2016,2020,2015,Kenya,EA,EA,Urban,Thika,Cohort,Convenience,Female,Students,Cohort of low risk girls with no history of sexual intercourse or sex with only one partner,Youth,Y,16 to 20,16,20,NA,18.6,NA,HIV negative,373,0,0,NG,5,373,0.013404826,genital fluid,NAAT,93.3,99.2,0.009500435,0.006476409,0.000690966,0.025071063,2.131438299,224.351654
#24013,Yuh 2020,Kenya Girls Study (KGS),NR,2014,NR,2016,2020,2015,Kenya,EA,EA,Urban,Thika,Cohort,Convenience,Female,Students,Cohort of low risk girls with no history of sexual intercourse or sex with only one partner,Youth,Y,16 to 20,16,20,NA,18.6,NA,HIV negative,373,0,0,TV,3,373,0.008042895,genital fluid,NAAT,95,98,0.004106117,0.0038394,0.000135764,0.014213625,1.139066164,277.4071311
#25083,Gill 2020,UChoose,September,2015,July,2017,2020,2016,South Africa,SA,SA,Peri-urban,Cape Town,RCT,Convenience,Female,HIV/STI prevention trial participants,"UChoose baseline: healthy, sexually active, HIV-negative female",Youth,Y,15 to 19,15,19,NA,17,16-18,HIV negative,130,0,0,CT,43,130,0.33,genital fluid,NAAT,88.6,99.6,0.373255609,0.046277619,0.2856108,0.469396166,40.77191749,109.2332346
#25083,Gill 2020,UChoose,September,2015,July,2017,2020,2016,South Africa,SA,SA,Peri-urban,Cape Town,RCT,Convenience,Female,HIV/STI prevention trial participants,"UChoose baseline: healthy, sexually active, HIV-negative female",Youth,Y,15 to 19,15,19,NA,17,16-18,HIV negative,130,0,0,NG,13,130,0.1,genital fluid,NAAT,93.3,99.2,0.106397802,0.028681169,0.056789873,0.168515489,12.29747208,115.5801324
#25083,Gill 2020,UChoose,September,2015,July,2017,2020,2016,South Africa,SA,SA,Peri-urban,Cape Town,RCT,Convenience,Female,HIV/STI prevention trial participants,"UChoose baseline: healthy, sexually active, HIV-negative female",Youth,Y,15 to 19,15,19,NA,17,16-18,HIV negative,130,0,0,TV,12,130,0.09,genital fluid,NAAT,95,98,0.084727284,0.027511369,0.037714418,0.145482025,8.681058681,102.458834
#25301,Francis 2019,NA,November,2013,June,2014,2019,2014,Tanzania,EA,EA,Urban,Mwanza,Cross sectional,Convenience,Female,Students,Government-funded secondary schools,Youth,Y,17 to 18,17,18,NA,NA,NA,Mixed,386,3,7.77E-03,CT,9,386,0.023316062,genital fluid,NAAT,88.6,99.6,0.024620433,0.008871703,0.009608419,0.044216221,7.511920936,305.109218
#25301,Francis 2019,NA,November,2013,June,2014,2019,2014,Tanzania,EA,EA,Urban,Mwanza,Cross sectional,Convenience,Female,Students,Government-funded secondary schools,Youth,Y,17 to 18,17,18,NA,NA,NA,Mixed,386,3,7.77E-03,NG,8,386,0.020725389,genital fluid,NAAT,93.3,99.2,0.016405742,0.00805679,0.003244344,0.034274254,4.078342356,248.5923733
#25301,Francis 2019,NA,November,2013,June,2014,2019,2014,Tanzania,EA,EA,Urban,Mwanza,Cross sectional,Convenience,Female,Students,Government-funded secondary schools,Youth,Y,17 to 18,17,18,NA,NA,NA,Mixed,386,3,7.77E-03,TV,17,386,0.044041451,genital fluid,culture,68.8,100,0.067258284,0.015814706,0.039739191,0.101881698,16.87060768,250.833156
#22571,Kerubo 2016,NA,August,2012,November,2013,2016,2012,Kenya,EA,EA,Rural,Western Kenya,Cross sectional,Consecutive,Female,Students,participants in pilot examining the feasibility of menstrual solutions for girls in rural primary schools,Youth,Y,14 to 17,14,17,NA,NA,NA,Mixed,NA,NA,NR,CT,13,511,0.025440313,genital fluid,NAAT,88.6,99.6,0.026643447,0.008171919,0.012407318,0.043974888,10.3467675,388.3419195
#22571,Kerubo 2016,NA,August,2012,November,2013,2016,2012,Kenya,EA,EA,Rural,Western Kenya,Cross sectional,Consecutive,Female,Students,participants in pilot examining the feasibility of menstrual solutions for girls in rural primary schools,Youth,Y,14 to 17,14,17,NA,NA,NA,Mixed,NA,NA,NR,NG,3,511,0.005870841,genital fluid,NAAT,93.3,99.2,0.003768118,0.0034255,9.84E-05,0.012422283,1.20548429,319.9167938
#22571,Kerubo 2016,NA,August,2012,November,2013,2016,2012,Kenya,EA,EA,Rural,Western Kenya,Cross sectional,Consecutive,Female,Students,participants in pilot examining the feasibility of menstrual solutions for girls in rural primary schools,Youth,Y,14 to 17,14,17,NA,NA,NA,Mixed,NA,NA,NR,TV,13,512,0.025390625,genital fluid,culture,68.8,100,0.039642275,0.010727146,0.021933028,0.063220396,13.11540669,330.8439454
#25821,Akinbo 2017,NA,NR,NR,NR,NR,2017,2014,Nigeria,WA,WA,Urban,Benin City,Cross sectional,NR,Female,Students,Secondary school students,Youth,Y,13 to 17,13,17,NA,NA,NA,Mixed,NA,NA,NR,TV,25,272,0.091911765,genital fluid,culture,68.8,100,0.13824111,0.025521013,0.09210708,0.193199347,25.28508232,182.9056661
